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The overall aim was to understand the process of healthcare provider influence by 
exploring associations between professional influence measures and patient engagement in health 
behavior modification in women with Gestational Diabetic Mellitus (GDM). An integrative 
literature review resulted in defining and developing the Healthcare Provider Influence (HPI) 
conceptual model based on the Integrated Theory of Health Behavior Change and 
Transformational Leadership theory. HPI is defined as a process wherein a purposeful 
interpersonal interactive, collaborative, and transformative relationship develops between a 
patient and a healthcare provider working together toward a specific focus of health behavior 
modification outcomes.   
 
Measures for testing the HPI conceptual model were identified, modified, translated, and 
content validated. Using an observational, prospective, longitudinal, correlational and exploratory 
design, participants in control, non-GDMs (N=117) and study, GDMs (N=78) groups completed 
questionnaires at an initial high-risk GDM screening and subsequently at 34-36 weeks gestational 
age. To test the relationships in GDM patients, eight healthy eating, physical activity, and glucose 
monitoring behaviors were separately regressed on professional influence variables 
(social/professional influence, quality of information and interaction). Patient and healthcare 
provider characteristics were included in regression models to test for moderating effects. Self-
efficacy was examined for a mediating effect. Differences in health behavior modification 
outcomes, by time and group (GDM, non-GDM) were explored.  
 
Professional influence by maternity healthcare providers (HPs), and quality of 
information and interaction during teaching encounters by HPs and diabetic nurse-educators were 
significantly associated with increased breakfast frequency/weekly and self-efficacy (p ≤ .10). 
Gender, race and language concordance and HP leadership style and specialty influenced healthy 
eating, physical activity and glucose monitoring behaviors (p ≤ .10). Three healthy eating and one 
physical activity outcomes differences were found by group and time, for which variance was 
explained with small effects (2-9%) by language, race, and GDM history.  
 
Patients’ perception of their healthcare providers’ influence, quality of information and 
interaction in teaching encounters and leadership style, and race, language, and gender 
concordance influence GDM patients’ engagement in health behavior modifications. Self-
reflection on practice, interaction, and leadership style could impact individual professional 
transformation and increase influencing potential for patient engagement in health behaviors. 
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Chapter 1: Introduction 
 
 
Diabetes mellitus (DM) and obesity are becoming increasingly prevalent and 
correlated global health problems. Type 2 Diabetes Mellitus (T2DM), a sub classification 
of DM, and heretofore simply called DM, is one of the top six leading causes of death in 
both the United States (US) and Canada with a mortality rate of 3.1% in the US and 3.6% 
in Canada, and approximately 40-50% greater than a rate of 1.9% in the rest of the world 
(Guariguata, Whiting, Weil, & Unwin, 2011; Toporowski et al., 2012). Globally, the 
average rate of obesity is 12%; however, the prevalence is much higher at 24% in the US 
and 15.3% in Canada (Toporowski et al., 2012).  Obesity increases the risk of DM and is 
also one of the major risk factors for developing gestational diabetes mellitus (GDM), a 
type of glucose intolerance diagnosed initially in pregnancy (American Diabetes 
Association [ADA], 2013; C. Kim, Newton, & Knopp, 2002; Simmons, 2011). More than 
60% of child-bearing age women in the US are either overweight or obese, prior to 
pregnancy (Center for Disease Control and Prevention [CDC], 2014; Sarwer, Allison, 
Gibbons, Markowitz, & Nelson, 2006). A history of GDM in one pregnancy increases the 
risk of developing GDM in a subsequent pregnancy and DM later in life (Bellamy, Casas, 
Hingorani, & Williams, 2009; Diabetes Prevention Program, 2002). During and 
following pregnancy, GDM can have significant consequences for women and children. 
Addressing GDM during pregnancy and vigilant follow-up in the postpartum period 
provides an opportunity to decrease the prevalence of DM and prevent these 




To improve health outcomes in the US, an evidence-based care systems approach 
using a simultaneous focus on three aims: improving the experience of care, improving 
the health of a population, and reducing the per capita costs of health care costs, has been 
recommended as a feasible and effective approach (Berwick, Nolan, & Whittington, 
2008).  Utilization of treatments and counseling determined to be evidence-based practice 
(EBP), including preventative care practices shown to improve patient health outcomes, 
care coordination to prevent fragmented care and subsequent complications, and 
measures to decrease wasteful spending (Berwick & Hackbarth, 2012) are strategies that 
have been suggested to accomplish these aims. On an individual level, these aims can be 
addressed in part by exploring the interaction between the patient and the healthcare 
provider (HP) and the influence the HP has on the patient’s health behavior modification. 
In the case of GDM, the positive influence of the HP on the patient’s modification of 
health behaviors, which have been determined to effectively treat and control GDM in 
pregnancy, can delay or prevent the future diagnosis of DM and its consequences. 
Continuation of these behaviors after pregnancy further contributes to DM prevention. 
An increased awareness of the interaction between the HP and the patient can also lead to 
improving the patient care experience and improving their health. This subsequently can 
reduce higher costs that can result from poor care experiences, including non-adherence, 
lack of follow-up, or lack of knowledge of preventative or treatment measures.  
Gestational Diabetes Mellitus: A Global Health Problem with Long Term Maternal 
and Neonatal Consequences  
Gestational diabetes mellitus (GDM) is defined as impaired glucose tolerance 




increased pregnancy weight gain are associated with increased risk of GDM. The 
percentage of GDM that was attributed to overweight and obesity was 46% in one study 
(S. Y. Kim et al., 2010), while obesity was found to be a determinant for developing 
GDM at rates of 59.2% (p<0.001) when compared to those without GDM in a second 
study (Bener, Saleh, & Al-Hamaq, 2011). Results from a meta-analysis including 20 
studies found that high maternal weight is associated with substantially higher risk of 
GDM: 2.14-fold higher if overweight, 3.56-fold higher if obese and 8.56-fold higher if 
severely obese compared to normal-weight pregnant woman (Chu et al., 2007).  
Concurrent with the escalation of obesity and DM over the past several decades, GDM 
prevalence rates have been reported in the US as approximately 9.2% (DeSisto, Kim, & 
Sharma, 2014). The range of GDM is reported to affect 1-19% and steadily rising 
incidence rates expected of up to 25% of all pregnancies in the US and 2.28-25.13% of 
all pregnancies globally (ADA, 2007; Guariguata, Linnenkamp, Beagley, Whiting, & 
Cho, 2014; Hartling et al., 2012; Nicholson et al., 2008; Vandorsten et al., 2013). The 
range of rates both in the US and globally depends on the screening and diagnostic 
criteria used and the population and demographics. Additional risk factors for GDM are 
advanced maternal age, higher parity, a family history of DM, non-white race, lower 
economic status, unhealthy eating habits, and lack of physical activity (PA) (Hunsberger, 
Rosenberg, & Donatelle, 2010; King, 1998; Ruchat & Mottola, 2013).  
The prevalence of GDM is said to reflect the prevalence of DM and certain 
subsets of adult populations in the US, such as American Indians/Alaskan Native (15.9 
%), Asian/Pacific Islanders (9.0%), African-Americans (13.2%), and Hispanic-




immigrating from Central and South America (8.5%) are more vulnerable and at 
disparately higher risk for GDM and DM and the resulting complications (Bermudez & 
Tucker, 2003; DeSisto et al., 2014; DHHS, 2014; Ferrara, 2007; Fujimoto, Samoa, & 
Wotring, 2013).  Other factors such as acculturation also increase the risk of obesity, DM, 
and GDM due to U.S. patterns of decreased physical activity levels and a substantial 
change in dietary patterns, with the introduction of more processed food, meats, dairy and 
sweets, and approximately two-thirds of calories derived from carbohydrates (Bermudez 
& Tucker, 2003). 
Numerous immediate and long-term maternal and neonatal complications can 
result from GDM. These include preterm delivery, polyhydramnios, macrosomia, 
possible maternal and fetal birth injury related to shoulder dystocia, neonatal 
hypoglycemia, neonatal jaundice, transient neonatal morbidity, ketonemia, urinary tract 
infections in mother and infants, increased induction of labor or operative Cesarean 
delivery, increased rates of stillbirth or fetal death, and development of obesity later in 
baby’s life (Bener et al., 2011; Langer, Yogev, Most, & Xenakis, 2005). Even more 
serious complications of maternal hypoglycemia, miscarriage, genetic malformation, and 
pre-eclampsia can occur in women who have DM prior to pregnancy. Improperly 
managed GDMs experience a four-fold higher rate of infant mortality in the US 
(Fujimoto et al., 2013). GDM can reoccur in subsequent pregnancies at a rate of 35-50% 
and the risk for developing DM later in life is 15-74% (Bellamy, Casas, Hingorani, & 
Williams, 2009; Diabetes Prevention Program, 2002; Kim et al., 2002). Therefore, 




incidence of GDM or DM in a future pregnancy as well as DM in women and children 
later in life.  
GDM and DM Prevention: Role of the Patient and the HP 
Arriving at the diagnosis and effective treatment of GDM are the mutual 
responsibilities of the patient and the HP. During pregnancy, it is important that all 
women are tested for GDM. The Gestational Diabetes Act was enacted in August 2012 in 
the U.S. to ensure that all pregnant women would receive routine and if high-risk, early 
screening for GDM (Fujimoto et al., 2013). Testing for GDM, including type and timing 
has been discussed by multiple national and international organizations. Despite 
differences in recommendations regarding screening/diagnostic laboratory tests and 
results, there is general agreement that routine screening should occur in the second 
trimester, after 24 weeks gestation. Women identified as having greater risk factors, such 
as, obesity, previous history of GDM, first degree relative with DM, history of previous 
stillborn infant should be tested in the first trimester (American College of Obstetrics and 
Gynecology [ACOG], 2013; Moyer, 2014; Vandorsten et al., 2013). As soon as the GDM 
diagnosis is determined, patients should be informed about the disease, and receive 
education and counseling regarding blood glucose monitoring, dietary modifications, and 
physical activity (PA) recommendations. Timely implementation of EBP guidelines for 
treating GDM in pregnancy and immediate and consistent patient initiation of appropriate 
health behavior modifications is recommended and encouraged throughout the pregnancy 
to decrease pregnancy-related complications (Ruchat & Mottola, 2013).  
Involvement and support from partner and family for health behavior 




social support with GDM as a barrier to self-care in pregnancy (Collier et al., 2011). 
Strong social supports were identified as key influencers in helping women modify and 
maintain their health behaviors through pregnancy and the postpartum period (Collier et 
al., 2011). HPs may play a role in providing significant social support if lacking from 
partner or family sources. 
Health behavior modifications initiated in pregnancy should be continued into the 
postpartum period to prevent the development of subsequent GDM and DM later in life 
(Ruchat & Mottola, 2013). Education regarding screening for DM in the postpartum 
period as well as on a routine basis for life should also be initiated in the pregnancy and 
repeated in the postpartum period. Most women who had a diagnosis of GDM reported 
that they were unaware of the recommendation for postpartum screening and their future 
increased risk for developing DM later in life and thought their diabetes would go away 
when they delivered and that they could eat the way they wanted to (Collier et al., 2011; 
Stasenko et al, 2010, 2011). Increased counseling efforts have been shown to increase 
adherence to postpartum screening follow-up (Stasenko et al, 2010, 2011). HPs should 
provide appropriate care and support postpartum as well as between pregnancies to 
prevent DM or reoccurrence of GDM (Tieu, Bain, Middleton, & Crowther, 2013).  
Other barriers to care that women with GDM identified were HP-related 
communication difficulties, including a lack of time for discussion, not being heard about 
their needs and inability to control sugars, not receiving enough information verbally or 
in written form about how to self-care for GDM, and language barriers (Collier et al., 
2011). A full understanding of HP-patient communication issues that impact health 




Communication and Behavior Modification Outcomes 
Extensive research has been conducted on communication in the healthcare 
setting involving the HP and patient. Numerous findings have been described regarding 
HP-patient non-verbal and verbal communication patterns, interactions, characteristics, 
training models and recommendations for improving skills, and barriers. Barriers 
affecting HP-patient interaction include insufficient time spent as well as discordance 
factors of race, culture, attitude, age, gender, and language.  These barriers have 
contributed to inequalities in healthcare and outcomes (Akgun, Kostak, Unsar, Kurt, & 
Erol, 2012; Durant, Bartman, Person, Collins, & Austin, 2009; Toporowski et al., 2012). 
Effective communication and patient-centered (PC) communication have also emerged as 
key concepts and strategies to improve the HP-patient relationship and health outcomes. 
Effective communication with a strong focus on patient involvement is called 
patient-centered (PC) communication. PC care as defined by the Institute of Medicine 
(IOM), is care that is respectful and in which patient values guide clinical decision-
making (National Research Council [NRC], 2001). PC research initiatives have been 
implemented to increase health quality outcomes. These require a PC approach, 
facilitating patient involvement in asking questions to influence decision-making and 
determine outcomes, with an “underlying imperative to improve patients’ care 
experience, decision making, and health outcomes” (Selby, Beal, & Frank, 2012; Tinetti 
& Basch, 2013). Effective and PC communication are integral to a positive HP-patient 
relationship. They have been found to positively correlate to patient satisfaction and serve 
as a critical element in improving quality health care and short and long-term outcomes, 




Partnership [NPP], 2008). The importance of the emphasis placed on listening and 
involvement in PC decision making allows the different perspectives on what is most 
important to each individual patient to be heard rather than treating them the same as one 
of the other millions of people with the same chronic condition, e.g. DM (Tinetti & 
Basch, 2013).  
To solve an individual’s healthcare problem and improve outcomes, HPs must be 
effective in diagnosing the problem and communicating treatment recommendations to 
the patient. However, to improve outcomes, it is also important for patients to adhere to 
these recommendations for managing their self-care by modifying health behaviors. In 
the clinical setting, experienced HPs see the variety of patient responses to their own and 
their professional colleagues’ recommendations for modification. Responses range from 
non-adherence or no changes in a patient’s perception, understanding, attitude, or 
behavior regarding the diagnosis of a healthcare problem to that of a completely 
transformed lifestyle pattern including embracing and modifying every behavior to 
optimize sleep, diet, exercise, and therapy. In PC care, “what researchers and clinicians 
may consider non-adherence, patients may consider a reasoned decision within the 
context of their own priorities and preferences” (Tinetti & Basch, 2013). This presents a 
situation of health outcome goal incongruence. Non-adherence can be a patient choice 
but non-adherence in health behavior modification is also a significant variable leading to 
poorer outcomes. The two cannot co-exist as a solution for the same goal and this 
dilemma can add to an already challenging health environment.  
Indisputably, research findings endorse the awareness, learning, and utilization of 




social and family context, and provide PC and culturally competent care. Despite the 
elimination of all barriers including communication issues, and the implementation of 
measures and interventions for increasing education and support for improved treatment 
adherence, a wide variation of patient responses still occurs. This calls the question as to 
whether PC care alone is enough to solve the poor health outcomes that result from 
patient non-adherence. The role of PC communication in assisting and motivating 
patients to make health behavior modifications has been explored and found to be 
effective, however the influence of or by HPs has not been studied. Effective and PC 
communication skills may contribute to only part of the process of how a HP can be 
influential in health behavior modification.  
HPI: A New Framework for Exploring the Impact of HP-Patient Interaction on 
Outcomes  
A review of the healthcare literature into the role and process by which HPs 
influence the health behavior modification and health outcomes of patients with acute or 
chronic health problems or diseases revealed a large gap. Many variables have been 
found that “influence” outcomes from an action and cause-effect inference but the 
process of influence that HPs have on patients’ health behavior modification has not been 
described. Social or societal influence has been explored within contexts that have 
focused primarily on family, cultural, and colleague or peer influence. HP influence has 
not been yet explored as a distinct concept.  
To explore the influence that HPs have on patient responses to treatment 
recommendations and modification of health behaviors, understand reasons for non-




name, define and develop a conceptual model to describe the concept. Termed 
“healthcare provider influence” (HPI), it is defined as a process wherein a purposeful 
interpersonal interactive, collaborative, and transformative relationship develops between 
a patient and a HP working toward a specific focus of health behavior modification 
(Fryzelka & Weiss, unpublished). HPI is defined, conceptualized and developed as a 
framework utilizing a PC approach involving effective communication and incorporating 
transformative leadership skills. Transformational leadership theory incorporates the use 
of social influence, a form of power that involves the movement of expert power from the 
HP to the patient via referent power to bring about behavior modification.  A PC 
approach was utilized to better understand and explore the role of the HP and the process 
of how the HP impacts patient adherence to recommendations (Tinetti & Basch, 2013). 
Population outcome disparities, discrepancy in adherence, screening, awareness, 
and follow-up, the resistance of some GDM diagnosed women to make health altering 
modifications even when barriers are eliminated, and recommendations provided, 
stimulated this researcher to pursue exploring the demographic and leadership 
characteristics of HPs and the overall influence that they have on the women they are 
caring for. The leap from diagnosis to treatment and prevention can at times be more than 
some individuals are able to or care to pursue and it is the notion of how HPs influence 
the ability or choice of patients to initiate or modify health behaviors necessary for self-
care management that is of utmost interest to this researcher.  
This research, utilizing the newly developed HPI conceptual model, was intended 
to provide insight on how HPs influence patients to make health behavior modifications 




It is projected that the HPI conceptual model will be used in several additional research 
endeavors. The hope is it will generate opportunities to increase HPs awareness of 
patients' knowledge, attitudes, beliefs, biases, and behaviors that may influence their 
overall engagement in self-care management.  Secondly, the HPI framework may be 
effective in assisting HPs to improve their approach in involving, inspiring, motivating, 
and altering patients’ perspective, attitude, and approach to health behavior modification 
and thus increase the overall quality of care. Finally, it may be useful as a guide to focus 
on the process of HPI with several health problems, to increase health quality and 
outcomes and decrease disparities for vulnerable populations. Access, advocacy, support, 
education and provision of options by the HP to patients is important but the role and 
responsibility that come from the influence that a HP can have on a patient may be more 
powerful and has the potential for substantial transformation.  
Purpose of the Study 
The purpose of this research study was to explore the relationship of HPI and 
health behavior modification, specifically healthy eating (HE), physical activity (PA), 
and glucose monitoring (GM) in women with GDM, a disease where treatment, control, 
and prevention center on patient self-management through dietary modifications and 
increases in PA. Specific aims were: a) to determine if HPI was associated with patient 
engagement in health behavior modification of healthy eating, physical activity and 
glucose monitoring in women with GDM; b) to determine if patient characteristics 
moderated the relationship between HPI and patient engagement in health behavior 
modification of healthy eating, physical activity and glucose monitoring in women with 




between HPI and patient engagement in health behavior modification of healthy eating, 
physical activity and glucose monitoring in women with GDM; d) to determine if self-
efficacy mediated the relationship between HPI and patient engagement in health 
behavior modification of HE, PA, and GM in women with GDM; and e) to determine if 
there were differences in the pattern of patient engagement in healthy eating and physical 
activity during pregnancy for women with and without a GDM diagnosis.  
Relevance to Nursing Practice, Education, Policy, Research, and Vulnerable 
Populations 
Nurses make up the largest group of HPs globally and spend the most time 
interacting and engaging with, caring for, and teaching patients. Exploring the 
correlations of HPI to health behavior modification is beneficial to the patient as well as 
to the HP. The patient benefits from improved individual health status and long-term 
outcomes by modifying health behaviors. The HPs benefit from an awareness and 
understanding of additional processes that can be employed to facilitate improved 
individual patient health status and the unique leadership role in which they are able to 
engage. Understanding HPI can be instrumental in improving patient relationships, 
behaviors, and outcomes for multiple diseases and populations. Understanding the 
conceptual model of HPI overall with specific exposure to PC principles fits with current 
national research initiatives of improving patient’s experiences of care, improving health 
outcomes, and decreasing the cost of healthcare (Berwick et al., 2008).  
HPs are taught how to communicate but there is no evidence in the research 
literature about understanding and teaching HPs how to influence.  Learning to be 




principles within the context of PC communication. This approach, once validated, could 
be incorporated into pre-licensure and HP educational preparation in new strategies for 
patient education and behavior modification. Early academic exposure should provide for 
more natural and progressive utilization throughout HP students’ education and extend 
into their professional careers, setting the stage for the development of strong nursing and 
healthcare leaders who may pursue a variety of pathways in their professional careers, 
including education, politics and research. Nursing faculty, likewise, with an 
understanding of HPI, can adapt and transfer the same principles in the learning 
environment to potentiate the modification of student learning behaviors for improved 
student personal growth and achievement.  
Exploring HPI is a beginning step to grooming nurses to strive to impact future 
health outcomes by actively combining the utilization of PC communication and 
transformative leadership skills to positively augment and influence the patient’s self-
efficacy, motivation, and engagement in health behavior modification. Understanding the 
conceptual model of HPI is essential to embrace, instruct, model and direct modifications 
in the process of HPI for positively impacting cost, quality, and outcomes of health for 
patients.  
Finding new measures of incentive for improved health outcomes may affect 
insurance, governmental and legislative policy changes. Governmental assistance 
programs, such as Women Infants Children (WIC), can perhaps be convinced to modify 
the foods distributed and the dissemination of patient GDM-education to match the focus 
of dietary modification beneficial for GDM/DMs, including carbohydrate restriction, 




process and educational component of HPI.  Increased reimbursement to the HP could be 
argued because of the mutual HP-patient success of improved health status and outcomes. 
Similarly, albeit controversial, patient rewards in addition to the intrinsic value of 
improved health outcomes, could be implemented because of engagement in behavior 
modifications related to HE and PA. GDM was selected as a good case exemplar for the 
exploration of the relationship of HPI to health behavior modification outcomes. More 
women are likely to access care during a pregnancy than at any other time of their life. 
The diagnosis of GDM allows for measurement of the immediate and short-term health 
behavior modifications for proximal outcomes, which are the same ones intended to 
continue into the long-term for distal health outcome improvement.  Women are more 
vulnerable during pregnancy and those with GDM are even more vulnerable due to 
potential health consequences to themselves and their fetuses/newborns. It is socially just 
and imperative to work toward improving the health status of all, every individual, in all 
countries regardless of economic status, racial or ethnic make-up, gender, education, or 
any other descriptor. It is even more important in the process to address the needs of 
those most affected and vulnerable, to decrease healthcare outcome disparities between 
populations. Research efforts utilizing the HPI model can be replicated for improvement 






Chapter 2: Review of the Literature 
 
 
A review of the healthcare literature was conducted to determine whether and 
how healthcare providers (HPs) influence the health behavior modification of patients 
diagnosed with Gestational Diabetes Mellitus (GDM). Initially, an integrative review of 
the literature related to health provider influence was conducted to understand the 
definition, concepts and process whereby HPs exert influence. To address the identified 
gap in the literature regarding this concept, a conceptual model of healthcare provider 
influence (HPI) was developed and serves as the conceptual framework for this study 
(Fryzelka & Weiss, 2013) (Appendix B). This integrative review of the literature includes 
a definition, description, and conceptual diagram representing the necessary components, 
conditions, and outcomes of healthcare provider influence and the theoretical basis for 
the model.  
In this second chapter, the nursing and socio-psychological theories selected to 
provide the foundation and framework for the HPI conceptual model will be described. 
Following the development of the conceptual model for HPI, presented in manuscript 
format (Appendix B), a literature review was conducted to review and explicate the 
additional concepts included in this research proposal, including self-efficacy and health 
behavior modification. A review of these concepts in relation to GDM when appropriate 
was conducted as well and described in this chapter. Finally, the philosophical 
underpinnings, the assumptions for this proposal, and the Conceptual-Theoretical-
Empirical structure (CTES) are also described.  
Healthcare Provider Influence 




collaborative, and transformative relationship develops between a patient and a 
healthcare provider working together toward a specific focus of health behavior 
modification (Fryzelka & Weiss, unpublished). The development of the conceptual model 
of HPI is based on two theories, the Integrated Theory of Health Behavior Change 
(ITHBC) developed by P. Ryan (2009) and Transformational Leadership (TFL) by Bass 
(1985; Bass & Riggio, 2006). The concepts included in HPI conceptual model are 
divided into three sections: conditions, components, and outcomes. The condition and 
outcomes concepts are specific to the patient, as the primary focus of patient-
centeredness is incorporated throughout the model and describe the salient elements 
necessary for the HPI to occur: mental/physical resources and the cognitive/psychological 
and behavioral/physical benefits of a positive influence. Included in the model are five 
components and three process descriptors. The five components are categorized as 
logistics, concordance factors, emotive, cognitive, and social/communication. The 
process descriptors are interaction, collaboration and transformation. These conditions, 
components, process descriptors, and outcomes are unique yet closely linked within the 
model. 
A full description of the development of HPI is included in an Integrative Review 
of the Literature and Development of Conceptual Model of Healthcare Provider Influence 
(HPI) Manuscript form (Fryzelka & Weiss, 2013) (Appendix B) for review.  A 
description and rationale for the selection of the theories are included in the manuscript; 
however, each will be more thoroughly described later, as they together provide 
explanatory strength to the model and subsequently, the research design. 




There are several theories that provide the framework for this research project as 
well as for the development of a conceptual model. The central theory providing the 
foundation for this specific inquiry focus is ITHBC (P. Ryan, 2009). The secondary 
theory, TFL (Bass, 1985) is a theoretical model that provides the foundation for the 
development of the HPI model as well as provides the explanatory basis for the process 
of HPI.  
Integrated Theory of Health Behavior Change 
Following a review and synthesis of the healthcare literature, a lack of a 
comprehensive description regarding the process of influence by HPs was discovered. 
Reference to social influence, wherein professional influence is a component, however 
was found within the work of the ITHBC (P. Ryan, 2009).  
The ITHBC was developed following a review of the literature and the resultant 
identification of a gap in the comprehensive understanding of health behavior change 
including prediction of long-term changes. The ITHBC integrated several theories and 
proposed to fill in that gap, explaining the variables involved in health behavior change 
or modification. The ITHBC includes theories of health behavior change, self-regulation, 
social support theory, and self-management of chronic illness (P. Ryan, 2009).  
It was determined that ITHBC could serve as a central foundation for this 
research inquiry for several reasons. It provides the foundation and describes the linkage 
between health problem to health improvement including a central focus on the patient 
and his or her role in changing behaviors while accounting for the number of variables 
that also play a role in effecting these changes.  It includes an undefined concept within 




facilitation via social influence by professionals or healthcare providers.  A more robust 
development of the social professional influence component of the ITHBC is needed. The 
HPI conceptual model could explicate and complement this integrated theory quite well.  
The ITHBC is described as a descriptive middle-range theory. Descriptive mid-
range theories are “based on deductive and inductive processes and reveal the substance 
of a situation yet without structured linkages showing the specific nature of relationships 
among components (Rodgers, 2005). Over time, parts of the theories can be explored 
further to clarify vague aspects or to identify the scope of the contexts in which it is 
reasonable to apply the theory” (Rodgers, 2005). Thus, extracted from a position within 
this theory and providing direction, the HPI conceptual model (Fryzelka & Weiss, 
unpublished) was conceived and developed to better understand and explain the process 
by which the social influence by HPs within their clinical practice setting, in their 
professional relationship with patients, impacts the health behavior modification of 
individual patients and improves their health outcomes as a result.  
The ITHBC is based on several assumptions: “behavior change is a dynamic, 
iterative process”; change and progress require desire, motivation and self-reflection; 
interventions that are person-centered rather than standardized are more effective; and 
social influences and relationships, which are positive, are beneficial in effecting 
immediate and sustained health behavior modification and improved health (P. Ryan, 
2009). Outcomes are projected to be both proximal, to ensure engagement in self-
management behaviors and that the behavior change has occurred, and distal, to ensure 




ITHBC purports that several factors are helpful in and associated within the 
facilitation of successful changes in health behavior. Factors include interventions that 
address and foster specific knowledge and beliefs, increase self-regulation skills and 
abilities, and enhance social facilitation (P. Ryan, 2009). The constructs of the ITHBC 
theory include knowledge and health beliefs that are linked to engagement in self-
regulation.  Engagement in self-regulation behaviors increases skills and abilities, which 
enhances self-efficacy and leads to engagement in and enhancement of self-management 
behaviors and when enhanced by social facilitation has a direct and positive effect on 
health status (P. Ryan, 2009; P. Ryan & Sawin, 2009). The concepts of social facilitation, 
specifically social influence, self-efficacy, and health behavior modification from the 
ITHBC provide the focal interest of this study.  
The concept of “social facilitation” includes the concepts of social influence, 
social support, and negotiated collaboration between individuals and families and 
healthcare professionals” (P. Ryan & Sawin, 2009). The component of social influence 
encompasses the potential influences and influencers of the individual patient’s 
engagement in health behavior change.  Influencers identified include parents, siblings, 
peers, and professionals.  There are undoubtedly many variables and personal 
relationships that comprise influences on individual behavior, including but not limited to 
parents, siblings, peers, and professionals. People experience social influence when there 
is an attempt to alter, modify, or change their attitudes, reactions or behaviors by another 
(Gabel, 2012a). If this person is knowledgeable or in a position of perceived authority 
and they sway the thinking and motivation of another leading to engagement in behavior 




(Gabel, 2012a). One of the potential sources of social influence is the healthcare provider 
(HP) who via means of emotional, instrumental, and informational social support 
facilitates engagement in health behavior (P. Ryan, 2009). Social influence and the 
recently developed conceptual model of Healthcare Provider Influence (HPI), self-
efficacy, and health behavior modification are described later in greater detail.  
 As a middle- range theory, the ITHBC is meant to guide clinical practice 
(Higgins & Moore, 2000) and specifically, this theory was conceptualized to guide the 
facilitation of patient health behavior change for improved outcomes (P. Ryan, 2009). 
The ITHBC is applicable to individuals in the healthcare clinical practice setting. ITHBC 
is intended to describe the components involved in the facilitation of health behavior 
change related to management of chronic conditions and health promotions (P. Ryan, 
2009). In addition, ITHBC explains how health behavior change is facilitated via the 
interrelatedness of these components. Despite the population to be studied having GDM, 
although not considered chronic, is highly correlated to increased future risk of a 
progression to its chronic form, Diabetes Mellitus (DM) (Tieu et al., 2013). The proximal 
outcomes of patient self-management of health behavior modification, specific to GDM, 
were healthy eating/diet per dietary recommendations, increased physical activity, and 
adherence to glucose monitoring.  
A number of research studies have been conducted using the ITBHC framework 
as a guide. Weight retention and weight management have been studied in postpartum 
women using the ITHBC (Ohlendorf, 2014; Ohlendorf, Weiss, & Ryan, 2012; P. Ryan, 
Weiss, Traxel, & Brondino, 2011). The use of a cardio-metabolic health nurse to manage 




smoking cessation self-management intervention in construction workers was explored 
using ITHBC, as well (Bondy & Bercovitz, 2013). ITHBC guided the designing and 
testing of a computerized intervention for prevention of osteoporosis and self-
management applications for intake of vitamin D and calcium (P. Ryan, Maierle, Csuka, 
Thomson, & Szabo, 2013; P. Ryan, Pumilia, Henak, & Chang, 2009). 
For purposes of this research study and for the development of the HPI model, the 
ITHBC was selected as an appropriate framework because of its concentration on the 
individual and related health behavior change outcomes. An additional theory was chosen 
to provide an explanatory basis for the process of HPI. 
Transformational Leadership 
HPI, consistent with and situated within ITHBC, is centrally based on a leadership 
theory derived from work within the field of social psychology called Transformational 
Leadership (TFL) (Bass, 1985).  A detailed description of TFL is warranted, as it 
provides a strong basis for the research inquiry and assumptions of this project.  
Several leadership theories have emerged over the years describing and 
classifying leadership as a trait, a style, and a behavior (Northouse, 2007). Extensive 
research has been undertaken within many disciplines, including the following: 
healthcare, politics, education, military, business, and other realms, wherein leadership 
styles have been described and correlated to performance and behavior change (Bass & 
Riggio, 2006; Northouse, 2007). Different leadership styles have been found to correlate 
with various behaviors towards subordinates and colleagues. One of these leadership 
theories, called TFL, was first named by Downton in 1973, however did not emerge until 




thereafter, other social psychology researchers reintroduced TFL and have continued to 
explore, define, and refine TFL (Bass, 1985; Bass, 1998; Bass & Avolio, 1995; Bass & 
Riggio, 2006). This major work related to TFL was continued by Bass and several 
colleagues in their efforts to distinguish it from all other classifications of leadership, 
including transactional leadership. It has been described as similar to charismatic 
leadership but later described as encompassing charisma as one of its essential elements 
(Bass, 1998; Conger & Kanungo, 1988) 
According to Burns (1978), leadership was well differentiated from power; 
however, those who continued the work of describing TFL could not do so without 
describing the concept of power as not only necessary but fundamental to leadership 
(Bass, 1998). French and Raven (1959) defined and described the many sources of 
power: legitimate, reward, coercive, expert, and referent. TFL is based on the two latter 
components of expert power and referent power (Bass, 1998). Expert power refers to 
having the expertise or knowledge in how to do your work. Referent power refers to the 
power that is referred from the expert and results in empowerment. Social influence 
requires referent power, the transfer from one to another. Power has been defined as 
social influence (Raven, 2008). Authentic TFL is also referred to as socialized leadership 
(Howell & Avolio, 1993). TFL characterizes leadership wherein a leader responds to the 
follower’s needs, aligns goals and objectives, and though empowerment stimulates, 
inspires and moves followers to meet and exceed performance expectations as well as to 
strive for higher levels of potential (Bass & Riggio, 2006). 
The current description and model of TFL, after several modifications over the 




idealized influence and charisma, inspirational motivation, intellectual stimulation, and 
individual consideration (Bass & Riggio, 2006).  Idealized influence or charisma 
describes leaders who act as strong role models for followers, are deeply respected and 
trusted by followers who want to emulate the leaders who provide them with a vision and 
mission (Bass & Riggio, 2006). Inspirational motivation or inspiration is descriptive of 
leaders who communicate high expectations to followers and inspire them through 
motivation to become committed, focusing their efforts to achieve more than they would 
if on their own (Northouse, 2007). Intellectual stimulation incites followers to be 
creative, innovative and to challenge their beliefs and values, as well as encourages them 
to think things out and engage in problem-solving (Northouse, 2007). Finally, 
individualized consideration provides a supportive environment in which the leader 
listens carefully to the need of the individual follower (as a coach and advisor), while 
assisting him or her in becoming fully actualized either with caring, strong affiliation, or 
specific directive (Northouse, 2007). TFL emphasizes these four components and 
requires leaders to be aware of how their own behaviors relate to the needs of their 
subordinates (Northouse, 2007). These are representative of a positive trajectory of TFL. 
When TFL is inauthentic, instead of positive characteristics it can have negative ones 
(Howell & Avolio, 1993). 
Relevant to this research and to HPI, the HP is the expert, has expert power, is the 
social source of referent power, and is the socializing leader.  The expert power results 
from the visibility of the HP’s advanced education and knowledge of disease pathology 
and related prevention and treatment measures, as well as the quality, depth and 




skills, the HP can transfer or refer this expert power to the patient. This transfer of power 
from the expert to others can affect several potential variables that can improve one’s 
health outcome and status, including knowledge, internal motivation, and self-efficacy 
(Gabel, 2012a). When this transfer of power results in an ability or increased ability to 
and engagement in healthy behavior modification, this is called referent power (Gabel, 
2012a). TFL emphasizes internal motivation and follower development and implies that a 
process that changes and transforms people is concerned with emotions, values, ethics, 
standards, and long-term goals, includes followers’ motives, satisfying their needs and 
treating them as full human beings (Northouse, 2007).  
The Full Range of Leadership (FRL) Model was designed to include three types 
of leadership and presents them in a continuum to differentiate their characteristics and 
effectiveness (Antonakis, Avolio, & Sivasubramaniam, 2003). TFL, described as 
producing greater effects than the other two as well as more than is expected, sits on a 
continuum at one end with transactional leadership in the middle and laissez-faire 
leadership, essentially described as the absence of leadership or non-leadership on the 
other end (Bass, 1985; Bass & Avolio, 1990). 
TFL styles have been found to correlate highly with positive individual and group 
behavior modification (Bass & Avolio, 1995). In management literature, results from 
outcome studies have found that different components of TFL predict or positively 
correlate to effectiveness or satisfaction between leaders and employees (Bass & Avolio, 
1994; Bryman, 1992).  
Substantial work evaluating the TFL qualities of HPs in healthcare settings in 




medicine has also been undertaken (Bycio, Hackett, & Allen, 1995; Gellis, 2001). Using 
the TFL model in the development of physician leadership has been recommended to 
improve health care quality and cost control (Xirasagar, Samuels, & Stoskopf, 2005). 
However, a gap was identified in the literature in regard to evaluating TFL and patients, 
and the relationship between HP’s leadership style and patients, including their 
engagement in health behavior modification in response to either preventative or curative 
treatment recommendations.  No research has been found in which patients were asked 
their perception or assessment of their HP’s leadership characteristics.  Gable (2012a, 
2012b), recognizing the lack of leadership research in the healthcare setting involving 
patient and HPs, recommended exploring the use of Bass’s TFL model in the medical 
arena. The incorporation of power and leadership study into medical education has been 
proposed, as well as, strategies recommended to achieve this (Gable, 2012a, 2012b). Use 
of TFL and evaluation of TFL in physicians for improvement in patient health outcomes 
have also been recommended (Gable, 2012a, 2012b).  
Other transformational leadership perspectives have been presented in the 
literature (Northouse, 2007).  Strategies used by leaders with followers in transforming 
organizations have been described (Bennis & Nanus, 1985). Practice guidelines for how 
to behave as an effective leader to accomplish extraordinary things using five 
fundamental practices include: model the way, inspire a shared vision, challenge the 
process, enable others to act, and encourage the heart (Kouzes & Posner, 1987, 2002) has 
also been described (Northouse, 2007). These were reviewed for appropriateness of fit for 
this research. However, they are not as relevant to the HP-patient relationship and 




research as the theory selected, as they are more focused on organizational outcomes and 
more suitable and effective for training and development purposes (Northouse, 2007).  
Self-Efficacy 
Self-efficacy is a concept that was explored in this research. Although not 
explicitly included in the conceptual model of HPI, self-efficacy is encompassed within 
its emotive/cognitive component as well as a cognitive/psychological outcome. Self-
efficacy is also a component of the ITBHC under the category of knowledge and beliefs 
(P. Ryan, 2009). It is described within that model as affected by knowledge, beliefs, and 
practice of skills, and augmented as a result of self-regulation (P. Ryan, 2009). It is 
purported to enhance engagement in health behavior modification (P. Ryan, 2009).   
Self-efficacy theory, a form of social cognitive theory was developed and 
described by Bandura to describe the relationship between the necessary but insufficient 
components of how knowledge, transformational operations, and constituent skills 
progress into performance or action (Bandura, 1986). “Perceived self-efficacy is defined 
by people’s judgments of their capabilities to organize and execute courses of action 
required to attain designated types of performances,” and addresses the process of how 
personal judgments or sense of capability affect motivation and behavior to do what they 
need to do or can do to control whatever affects their lives with the skills they have 
(Bandura, 1986, p. 391). People tend to do those things they think they are capable of and 
avoid doing those things that they do not think they can do, or which will take significant 
effort. People must make decisions in many aspects of their lives, one of which involves 
their health. To do so, they must exercise efficacy, the belief in their capability to 




determinant for behavior, thoughts and reactions. Self-efficacy is one of the psychosocial 
determinants regulating psychosocial functioning and impacts health status by 
influencing biological functioning (Bandura, 1986).  Competent functioning requires both 
skills, social, behavioral, and cognitive as well as the self-efficacy beliefs to use or 
organize them effectively to accomplish an outcome if the person judges that he or she 
can or wants to. 
It is important to distinguish the difference between self-efficacy and outcome 
expectation. An outcome expectation is a judgment of the likely consequence the 
behavior will produce, therefore not the act but its consequence (Bandura, 1986). How 
one behaves largely determines the outcomes one experiences; however, it is not the 
performance that is generally measured or cared about, but rather the outcome. Since 
outcomes are contingent on performance, the perception of what one can do or whether 
he or she is able to achieve the outcome will likely determine what actions are taken.  
Strategies or ways to alter a people’s self-efficacy can occur because of cognitive 
processing when information is communicated actively, vicariously, physiologically or 
persuasively. These strategies are performance attainment/skills mastery, vicarious 
experience/modeling, physiological states/reinterpretations of symptoms and 
verbal/social persuasion (Bandura, 1986). Mastery experiences will instill a strong sense 
of efficacy; with each success a more robust sense is built. Modeling is when people 
judge their own capabilities by comparison with what others can do or the opinion of 
others. They increase their own beliefs and self-efficacy when they see or experience 
vicariously through others. The opposite is also possible in that a decrease in beliefs of 




providing people with the skills to reduce physiological reactions to modify how they 
interpret somatic information. Finally, social persuasion is used via influence to convince 
people they have the capability to achieve and succeed. When the objectives are realistic, 
the influence can lead to great success. The strength of belief in one’s capacity to do a 
specific task is a good predictor of motivation and behavior. Enhanced perceived self-
efficacy is the belief that the self has the capability to mobilize the motivation, cognitive 
resources, and course of action needed to meet situational demands and leads to improved 
behavior, motivation, thinking patterns, and emotional well-being (Bandura, 1986). 
Performance attainment or actual experience of the success of one’s actions is the most 
influential source of self-efficacy beliefs because it is based on actual skill mastery. 
Theory and research have linked self-efficacy and TFL. Self-efficacy has been 
suggested as a possible mediating mechanism through which transformational leadership 
affects followers’ performance in the self-concept motivation theory of leadership work 
of Shamir, House, and Arthur (1993). Leaders with TFL are said to enhance a follower’s 
perceived self-efficacy and role commitment by communicating high performance 
expectations and positive visions, providing training, coaching and opportunities for 
development, and expressing confidence in their abilities to contribute to the mission and 
goals of their organization (Shamir et al., 1993).  Leaders with TFL were believed to 
increase self-efficacy, leading to higher team morale, which resulted in greater team 
innovation directly benefitting patients in a teaching hospital (Wilson-Evered, Hartel, & 
Neale, 2001). In a study of bankers, TFL was also found to positively and significantly 
relate to self-efficacy (p≤.05) in regard to individual job performance (Walumbwa, 




goals, was found to mediate the relationship between leader TFL factors and increased 
performance in business students (N=282) (Kirkpatrick & Locke, 1996). When leaders 
understand how their followers view themselves and providing regular and adequate 
feedback, this can transform a follower’s belief that they can be successful at more 
challenging tasks.  
Self-efficacy has been explored in relation to self-management. It refers to the 
confidence and beliefs that contribute to self-management of behaviors, such as health 
behavior modification. Health behavior modification is a major outcome variable in self-
efficacy research as well as the outcome for this research study.  Bandura’s self-efficacy 
theory provides the framework for much of the research regarding self-management 
interventions (Lorig et al., 1996).  Multiple self-efficacy instruments for several chronic 
health conditions, as well as related health behavior measures have been developed and 
used in research demonstrating repeatedly the correlation between the two concepts of 
self-efficacy and self-management of health behavior modification (Lorig & Holman, 
2003; Lorig, Ritter, & González, 2003). Health behavior modification, such as in diet 
management and physical activity is increased when self-efficacy is enhanced (Lorig, 
González, & Ritter, 1999; Lorig, Ritter, & Jacquez, 2005; Lorig, Ritter, Villa, & Armas, 
2009).  
Self-Management Health Behavior Modification 
Self-management refers to the process of engaging in specific behaviors 
enhancing a person’s ability to manage an illness, usually chronic in duration and nature, 
or risk behaviors.  Self-management includes learning tasks such as medical or 




Holman, 2003). Five core skills include problem-solving, decision-making, resource 
utilization, forming a patient-HP partnership, and taking action (Center for the 
Advancement of Health, 2002). The fourth skill is consistent with the interactive and 
social communication within the HP-patient relationship and the patient-centeredness of 
the HPI conceptual model. Health behavior modification is a central concept included as 
an outcome in the behavioral/physical component of the HPI model. Health behavior 
modification is used synonymously with health behavior change.  Engagement in self-
management behaviors is one of the proximal outcomes of the ITHBC (P. Ryan, 2009). 
Self-management for the individual is the primary focus in the work of Lorig, rather than 
family or community (P. Ryan & Sawin, 2009). Self-management tasks described as 
maintaining good nutrition and appropriate diet and maintaining adequate exercise and 
physical activity (PA) (Lorig et al., 1996) represent the outcome measures for health 
behavior modification in this proposal. For the purposes of this proposal, health behavior 
modification was defined as “the adaptation or changes made to current practices that 
affect one’s health and overall outcomes, such as healthy eating and physical activity 
(PA)” (Fryzelka & Weiss, 2013).  
Health behavior modification has been studied extensively throughout the 
healthcare professions in relation to many chronic diseases or preventative health 
promotion strategies. The predominant foci of self-management of health behavior 
modification research are correlation studies with health outcomes that usually involve 
chronic conditions or diseases, such as DM, arthritis, asthma, hypertension, and cancer 
(Heisler, Smith, Hayward, Krein, & Kerr, 2003; Lorig et al., 2003; Lorig et al., 2005; 




behavior change or modification, dietary or eating pattern changes and exercise or 
physical activity changes, others include smoking or drug and alcohol cessation, stress or 
pain management, and coping strategies. Health behavior modification among all of 
these, but especially smoking or drug and alcohol cessation has been increasingly shown 
to prevent or delay the onset of chronic health problem diagnoses as well as improve or 
slow deterioration once they occur (Lorig et al., 1996). Treatment and prevention 
programs usually aim at least some efforts toward health behavior modification (Lorig et 
al., 1996). Improving healthy behaviors can improve physical, mental and social health 
and functioning, while prolonging and prompting independence and autonomy (Lorig et 
al., 1996).  
Several variables representing health behaviors that have been studied in 
correlation with self-efficacy including diet and exercise (Lorig et al., 1996) in people 
with DM (Kara, van der Bijl, Shortridge-Baggett, Asti, & Erguney, 2006; Leung Hui, 
Sevenhuysen, Harvey, & Salamon, 2014; Lorig & González, 2000; Rapley, Passmore, & 
Phillips, 2003).  To engage in health behavior modification, individuals must perceive 
that they can do so, they need to perceive themselves at risk, and they need to see more 
benefits than costs in making the changes. HPs can enhance patient self-efficacy by 
providing information actively, vicariously, physiologically, and persuasively. This can 
lead to influencing and empowering them, increase their controllability along with their 
knowledge, beliefs, confidence and success regarding health behavior modification. This 
can in turn increase physical and emotional well-being and contribute to prevention of 




Regarding GDM, it has been suggested that it is important to help patients 
increase their perception of their ability to deal with GDM before communicating risk 
information (Snoek & Rubin, 2005). Women with recent GDM diagnosis pass through a 
period of transition requiring knowledge about the disease and treatment, with the 
potential for conflicting self-perception about their capability to modify their behaviors 
and their body’s response (Leung Hui et al., 2014; Parsons, Ismail, Amiel, & Forbes, 
2014). To treat GDM or prevent future DM, the patients need to perceive that they can do 
what is needed regarding health behavior modification of diet and physical activity to 
achieve that outcome. In postpartum women with a recent diagnosis of GDM, 
engagement in healthy dietary behaviors were found to positively correlate with social 
support, and engagement in sufficient or increased physical activity levels were positively 
correlated with high self-efficacy and high social support, often reported to be verbal 
encouragement from family and friends or someone exercising with them (Kim, 
McEwen, Kieffer, Herman, & Piette, 2008; Smith, Cheung, Bauman, Zehle, & McLean, 
2005). Decreased self-efficacy for PA related to time pressures and fatigue and barriers to 
PA reported were a lack of childcare and insufficient time (Smith et al., 2005). Women 
with GDM have experienced stress over losing control of GDM by not being able to 
follow recommendations or success in achieving glucose targets with dietary 
management (Leung Hui et al., 2014). Factors negatively affecting patient engagement 
self-management in DMs include inadequate self-efficacy, ineffective HP relationships, 
limited DM knowledge, inadequate family and community support among others 
(Rodriguez, 2013). These results support the notion of exploring measures to increase 




information, support, knowledge, goals and use of verbal persuasion to build self-efficacy 
to promote healthy behaviors in this patient population (Rodriguez, 2013). 
Physical activity has been found to be effective in preventing and managing GDM 
(Ruchat & Mottola, 2013). However, understanding women’s beliefs about and behaviors 
related to exercise as well as barriers and sources of social influence were deemed 
important to develop interventions to increase exercise in GDMs (Symons Downs & 
Ulbrecht, 2006). A diabetes prevention program found that in cases of people diagnosed 
with impaired glucose tolerance and thus determined to be at high risk of developing 
DM, implementation of interventions that modify health behaviors and lifestyles have 
been shown to significantly reduce the incidence of DM and all the social and human 
costs (Snoek & Rubin, 2005). Patients with GDM who were expected to have had more 
difficulty in controlling their blood sugars because of physiological glucose impairment 
usually had better-controlled blood sugars with greater motivation (Snoek & Rubin, 
2005). It also found that barriers to prevent onset or delay diagnosis of DM were 
attributed to a lack of knowledge among the public and physicians about the correlation 
between impaired glucose tolerance and previous GDM diagnosis and the risk of 
developing DM (Jones, Roche, & Appel, 2009; Snoek & Rubin, 2005). The perception of 
general risk versus personal risk of future DM in postpartum women varied in two studies 
(C. Kim et al., 2007; Zera, Nicklas, Levkoff, & Seely, 2013). Most postpartum women 
with recent GDM, 90-95%, were aware, that previous GDM was a risk for DM but only 
16% that believed they were personally at risk for developing DM in the future.  
Increased knowledge and motivation certainly play a role in health outcome 




highly efficacious for behavior changes in smoking cessation, alcoholism, and dietary 
adherence and physical activity for diabetics (Leyva-Mora, 2007). However, reported 
conclusions from self-management research findings indicate that knowledge alone is 
insufficient as a predictor of these changes; motivation is not always inherent in those 
diagnosed or at risk for acute or chronic illness and disease, and readiness or ability to 
make changes that are necessary to prevent or treat illness is not a given (Lorig et al., 
1996).  
A concept related to self-efficacy that is prevalent in health behavior modification 
research is patient activation, extensively studied by Hibbard and colleagues (Hibbard, 
Stockard, Mahoney, & Tusler, 2004; Lorig et al., 2009; Hibbard & Greene, 2013; 
Hibbard, Greene, & Overton, 2013). Patient activation is used to describe the skills and 
confidence that equip patients to become more actively engaged in their healthcare and is 
defined as “understanding one’s own role in the care process and having the knowledge, 
skills, and confidence to take on that role” (Hibbard et al., 2004; Hibbard, Greene, & 
Overton, 2013). Patient activation, in multiple studies, has been found to lead to 
improved health outcomes, decreased healthcare costs, and increased patient care 
experiences (Hibbard & Greene, 2013). Patient activation has been studied in research 
involving healthy behaviors, DM and in multiple populations (Lorig et al., 2009; Rask et 
al., 2009; Hibbard & Greene, 2013).   
Patient activation is measured by a 13-item tool called patient activation measure 
(PAM), developed to measure four domains: confidence, beliefs, knowledge, skills. 
Scores increase as levels of activation increase from least to most activated and testing 




& Tusler, 2007).  PAM was linked to health behavior activation and better health 
outcomes, including biometric measurements of hemoglobin A1c (Hibbard & Green, 
2013). In one study, very low activation levels were significantly associated with higher 
health care costs and predictive of higher future costs. On the contrary, higher activation 
levels and more confidence, knowledge and skills in health self-management increased 
navigation of health care system and incurred less costs (Hibbard, Greene, & Overton, 
2013). Higher PAM scores were significantly correlated with health and preventative 
behaviors in multiple studies including eating a healthy diet, increasing physical activity, 
and avoiding health-damaging behavior (Hibbard et al., 2004; Hibbard, Mahoney, 
Stockard, & Tusler, 2005).   
Due to the proximity in conceptual construction and fair amount of overlap 
between patient activation and self-efficacy, it was necessary to determine which one 
would be a better fit for this study’s conceptual design. Both include elements of 
knowledge, skills and confidence. Both have engagement in health behavior modification 
as their end. Both have been studied in patient populations similar to the sample of this 
study, as well as in patients with DM. The difference between the two at initial glance 
appears to be related to “perception of beliefs in one’s capability” present in self-efficacy 
versus “understanding one’s role” in patient activation.  As a mediating variable in this 
study the self-efficacy appears to have a better fit with transformative leadership and 
patient activation with transactional leadership. This interpretation may result in part due 
to the different strategies recommended for increasing engagement suggested by Bandura 
for self-efficacy (performance mastery, modeling, re-interpretation of symptoms, and 




(interventions and system support). Self-efficacy represents a process of transforming   
the individual’s cognitive-psychological perception of capability in psychosocial 
interaction with others, thus fits better with the social influence component of the ITHBC 
model, described “when a knowledgeable person in a position of perceived authority, 
such as a HP, sways their thinking and motivation leading to engagement in behavior” (P. 
Ryan, 2009). The focus of this research was on the influence of patient engagement in 
health behavior modification via a collaborative-psychosocial interaction involved in the 
HP-patient relationships leading to transformation in the patient’s emotive-cognitive and 
physical-behavioral status. This focus encompassed the perception of capability that 
affects motivation and engagement in behavior modification, consistent with self-
efficacy. The HPI conceptual model includes this strong link to self-efficacy as well as 
multiple other inter-related components that via utilization of transformational leadership 
skills by the HP may increase patient engagement. Differentially, patient activation 
relates more to cognitive-only and is focused more on the individual-
institutional/organization interaction versus person-person with utilization of strategies of 
interventions and support to increase their understanding of their role. Patient activation 
has a better fit with the social support component of the social facilitation aspect of the 
ITHBC, consisting of “emotional, instrumental, or informational support, which 
facilitates engagement in a health behavior” (P. Ryan, 2009) rather than the inter-personal 
social influence aspect.  
Despite the use of self-efficacy and patient activation with similar research 
objectives and goals, such as health care reform, the improvement of health outcomes, 




is determined to be a better fit for this research purpose.  In summary, patient self-
efficacy, that is the self-perception of their capability, including knowledge, beliefs, and 
confidence, that can transform into skills and taking opportunities to engage in health 
behavior modification is a more suitable measure with this study than assessing their 
“understanding of their role in the process”, consistent with patient activation.  
The patient’s perception of their HP’s role and TFL characteristics were assessed 
and tested in association with outcomes of patient engagement, health behavior 
modification. Patient self-efficacy was also assessed for a mediating effect on the 
relationship between HPI and outcomes of patient engagement, health behavior 
modification. Measurements for self-efficacy specific to the context of the study, GDM, 
the Diabetes Self-Efficacy Scale (DSES), are readily available; however, there is no 
measure of PAM specific to diabetes or gestational diabetes.  
Gaps 
A gap identified in the research is the need for HPs to better understand how 
health behavior change is made and their role in facilitating and supporting change as 
well as understanding how to maintain these behavioral changes over time (P. Ryan, 
2009). A similar recommendation from the patient activation research called for a focus 
on the HPs role for patient engagement in health behavior modification (Hibbard & 
Greene, 2013). This research was proposed to better understand the role and influence of 
HPs via the patients’ perception of their HP’s leadership characteristics and the 
association with their engagement in health behavior modification. As has been 
described, several studies have found a correlation between increased self-efficacy and 




a measure of self-efficacy and addressed whether the degree of self-efficacy affected the 
relationship between HPI and patient engagement in health behavior modification. 
Additional research recommendations have been proposed due to the gaps related to TFL 
leadership research involving patients and HPs. The evaluation and development of TFL 
skills in HPs for use in their relationship with patients may have an impact on the 
improving health outcomes, containing/decreasing healthcare costs, and improving 
healthcare quality (Gabel, 2012a, 2012b; Xirasagar et al., 2005). These suggestions from 
individuals involved in health behavior modification research and P. Ryan’s 
conceptualization of the ITHBC (2009) that provided the space for HPI to emerge and 
develop, all serve to confirm the gap in the literature about the process of HPI and its 
relationship to patient health behaviors and outcome.   
This study intended to not only fill in some of those gaps, but also to provide an 
opportunity for initial testing of the newly-developed HPI conceptual model, a new 
structure and perspective from which to explore the range of factors that could contribute 
to improvement in patient health status and outcomes. This allowed for inquiry into the 
role and responsibility of the HP from a social leadership lens, which has not yet been 
described in the literature. Additionally, it provided a foundation for future research into 
how to augment engagement in the self-management of health behaviors, as well as 
perceived self-efficacy to drive self-directed modification of health-promoting behaviors. 
Furthermore, it had and still has the potential to guide curriculum and professional 
development and augments HP-patient communication in the clinical setting. 
Additionally, it contributed to increased increases in the efficiency and effectiveness of 





The purpose of this study was to explore the relationship of HPI and health 
behavior modification, specifically healthy eating, physical activity, and glucose 
monitoring in women with GDM, a disease where treatment, control, and prevention 
center on patient self-management through dietary modifications and increases in PA. 
The specific research aims were: a) to determine if HPI was associated with patient 
engagement in health behavior modification of healthy eating, physical activity, and 
glucose monitoring in women with GDM; b) to determine if patient characteristics 
moderated the relationship between HPI and patient engagement in health behavior 
modification of healthy eating, physical activity, and glucose monitoring in women with 
GDM; c) to determine if healthcare provider characteristics moderated the relationship 
between HPI and patient engagement in health behavior modification of healthy 
eating/diet, PA, and glucose monitoring in women with GDM; d) to determine if self-
efficacy mediated the relationship between HPI and patient engagement in health 
behavior modification of healthy eating, physical activity and glucose monitoring in 
women with GDM; and e) to determine if there were differences in the pattern of patient 
engagement in healthy eating and physical activity during pregnancy for women with and 
without a GDM diagnosis.  
Philosophical Underpinnings for the Study of Healthcare Provider Influence  
Reflection on the philosophical paradigms underlying this research revealed that 
the overarching paradigm or worldview from which this research inquiry initially arose 
within the researcher was from critical social theory (CST). With a major focus on health 




ultimately, a global one, the intent of the researcher is to address in the social setting and 
within social institutions, such as within health care, measures to improve or encourage 
opportunities for patient self-empowerment and self-actualization as a result of exploring 
and correcting power issues. In this inquiry, interest in how HPs influence patient 
engagement in healthcare behavior modification emerged from the desire to understand 
how HPs, those with expert power, using transformational leadership can or should 
transfer their power to the patient for improvement in healthcare status. Toward this end, 
a review of the literature and conceptualization of the HPI model ensued. Historically and 
socio-politically, CST sets the paradigm for a more negative and destructive form of 
power; however, the perspective in this case is to recognize that there exists a power 
differential and to effect movement of the power for positive and transformative 
purposes.  These power concepts are included in the TFL theory that provided the 
foundation for the HPI conceptual model. CST is concerned with the study of social 
institutions, issues of power and alienation, and envisioning new opportunities (Gillis & 
Jackson, 2002). Personal meaning is shaped by societal structure of the healthcare setting 
and communication processes (Campbell & Bunting, 1991). Both the setting and the 
social-communication interaction between the HP and the patient are components of the 
HPI conceptual model. The empowerment of patients to increase their engagement in 
health behavior modification to improve health outcomes and the opportunity to 
experience transformation because of their experiences and interaction with expert 
leaders all appear to be a good fit for CST. The research inquiry, the intentions of the 
researcher, the ontology of critical realist, the outcomes related to the process of the 




consistent with the tenets of CST. However, despite all these considerations, the 
epistemology and methodology do not support this paradigm specific to this specific 
inquiry. The epistemology, the nature of how the knowledge is learned was not subjective 
and the researcher and participant were not engaging in a participatory manner. Nor was 
the methodology, how data was collected, analyzed, and selected for this research design, 
consistent with CST (Guba, 1990).   
The paradigm that motivated this specific proposal, with consideration of the 
ontology, epistemology, and methodology aligned with post-positivism on all three of 
these levels. Post-positivism began emerging as a group of philosophers questioned and 
rejected the notion that acquisition of all knowledge be reduced or deduced, and derived 
by reasoning and strict objectivity alone, as is reflected rigidly with the positivist stance. 
Although initially accepted due to its philosophical foundation for much of medical 
research, positivism has historically been questioned from a global nursing perspective as 
to whether it was even an appropriate fit for this discipline. The major critique is due to 
the lack and devaluing of holism, patient-centeredness, and humanity, which are critical 
tenets of nursing (Guba, 1990).  
The ‘objectivist’ epistemology of positivism was critiqued and a post-positivist 
“modified objectivist” epistemology proposed as an alternative. Regarding the modified 
objectivist, it is suggested that knowledge, while objectively acquired by sensory 
experience, is biased in that the researcher knows and believes also because of what they 
perceive or feel. “Perception is partly a function of prior knowledge” wherein 
presuppositions and theory play a role and result in the reality that observations become 




that served a pivotal role in structuring the research conceptual-theoretical-empirical 
statement research structure (Fawcett, 1999). The major assumptions in this research 
proposal were that HPs play an expert role that via interaction with patients can refer that 
power or empower them, utilizing TFL skills to increase their engagement in health 
behavior modification. This assumption was based on the researcher’s previous 
experience in both a HP and patient role. Additional assumptions will be detailed later.  
Ontologically, positivism and post-positivism support realism, with the latter 
described as taking on a critical realist stance, similar to CST (Guba, 1990). Reality is 
derived from natural laws and is used to predict and control phenomena according to 
positivism; however, as a result the findings are not generalizable as reality is constantly 
changing (Guba, 1990; Monti & Tingen, 1999).  Reality cannot be completely objective 
as many factors and dimensions affect reality from variations between person, time, 
environment, and context. The reality of every patient will be different based on the 
interplay between variables of influence and outcomes; however, a consensus will result, 
representing a modified objectivist view, from multiple perspectives, in this case by 
asking who is influential and what about them or their actions is influential. Both the HPI 
conceptual model and the ITHBC are patient-focused involving human behaviors, 
reactions, and perceptions, also with elements of patient-centered communication and 
care. In this case, the patient was not constructing or defining her own reality, which 
would be consistent with constructivism.  
The post-positivist paradigm was also aligned with the methodology, the means 
used to gather and analyze data to create knowledge, selected for this research. The 




positivistic. This was a quantitative empirical study looking for observations and 
associations, between multiple variables, HP and patient characteristics, patient 
perceptions of HP influence and HP leadership characteristics, delivery and content of 
information, self-efficacy, and patient health behavior modification. Correlations were 
hypothesized to exist between the independent and dependent variables. The nature of 
psychosocial objective measurements of perceptions and behavioral outcomes was 
consistent with post-positivism. Theory testing and application of the ITHBC, and the use 
of valid and reliable measures to examine phenomena of HPI were representative of 
objectivity, present in the positivist and post-positivist paradigms. In this case, the 
objectivity was “modified”, in that knowledge was acquired as objectively as possible 
and according to rules and guidelines for validity, reliability, and use for generalizability. 
Furthermore, the proposition was derived with bias and preconceived notions about the 
association between the variables. These factors all support post-positivism.  
Assumptions of the study 
Ideological 
1. Persons with illness or disease are influenced in their decisions regarding health 
behavior modification by relationships with others, one of whom is their HP. 
2. HPI describes a transformative process by which patients can engage in health 
behavior modification.  
3. Self-efficacy can explain some of the effect of HPI on patient engagement in 
health behavior modification. 
Procedural 




2. TFL characteristics of HP can be assessed by the patients for whom they provide 
care by completion of a survey. 
3. Patient self-efficacy can be assessed by completion of a survey. 
4. Social influence, measured as HPI, is a stable condition and only needs to be 
measured once (Champion, 1994).  
5. Patients can recall and report their healthy eating/diet, PA and glucose monitoring 
behaviors accurately from the past week.  
  The assumptions are based on the review of the literature regarding patient-
centered communication and results of TFL, primarily, in the organizational setting. One 
of the hypotheses for this research, that HPI augments the engagement of patients in 
health behaviors that are positive and beneficial to improve their health status when the 
HP has higher levels of TFL skills/characteristics is based largely on these assumptions.  
Conceptual-Theoretical-Empirical Structure (CTES) 
As soon as a research purpose was identified, and questions formulated, it was 
important to determine what the concepts were, how they were linked together, what they 
were based on, and how the concepts were to be measured (Fawcett, 1999). Concepts 
should be well described and transparency in how they are merged is deemed important 
for those researching and those who intend to understand the theory and findings. Each 
research proposal should be linked to an existing nursing theory to further explain, 
expound on, modify, or refute it (Fawcett, 1999). A means to facilitate this is by 
designing a conceptual-theoretical-empirical structure (CTES) (Figure 1) (Fawcett, 
1992). Although there is a level of clarity intended by developing a CTES, due to the 




not always necessary or possible to describe all the multiple levels of theories for each 
research proposal or determine just one theory that provides the foundation for the 
research. 
Conceptual Framework 
The conceptual framework used for the development of the HPI conceptual model 
and subsequently this research is based on two theories, the ITHBC and the TFL. The 
ITHBC has been described as a descriptive middle-range theory (P. Ryan, 2009). As a 
middle range theory, it is testable and is limited in scope and number of variables, in 
terms of not addressing the full scope of nursing’s concerns; however, it does have a 
broad scope in relation to the types of clinical problems and patient types that could be 
considered, and therefore it is both sufficiently general yet specific enough to be used in 
research (Fawcett, 1999). In addition, it directs and is tested by practice (Fawcett, 1999). 
HPI represents an extraction from the social facilitation-social influence-professional 
influence component of the ITBHC.  
The second theory contributing to the conceptual framework for HPI is TFL. The 
socializing aspect of TFL is conceptually aligned with the social facilitation-social 
influence component of the ITHBC.  TFL serves as the process theory whereby the HP is 
an effective and positive social influencer. The emphasis on intrinsic motivation needed 
for behavior modification is consistent with the motivational aspects of TFL. The 
individualized consideration within TFL is consistent with the patient or person-centered 
approach of the ITHBC. The combination of the two theories of ITHBC and TFL 




specific focus of exploring the correlation between HPI and health behavior modification 
engagement in this and future research.  
Theoretical Framework\ 
Theories are interrelated concepts and statements that are testable, described as 
less abstract, often in the form of middle- range, micro-range, and situation-specific 
theories, and contribute to the intermediate level of the CTES (Fawcett, 1999; Hardy, 
1978; Higgins & Moore, 2000).  The HPI conceptual model represents the theoretical 
level as a practice theory, focusing on a specific population or situation, in this case 
GDMs (Walker & Avant, 2005).  A conceptual model contains a set of relatively abstract 
and general concepts, as well as the propositions that link or describe those concepts and 
is intended to provide the context for theory testing (Fawcett, 1989, 1999). It can be used 
to represent ideas relevant for all healthcare professionals, especially their largest group, 
nursing, HPI describes the components and process of influence involving HPs and 
patients in regard to improved health outcomes via engagement in health behavior 
modification, which was tested for the first time. HPI is a construct of several concepts 
that are operationally defined and represented by several independent variables that were 
tested to verify the correlation between concepts within the model and the links within 
the integrated theory (Walker & Avant, 2005) to determine if the proposed relationship 
among concepts could be validated. While the construct is relatively abstract, selected 
components are being drawn on as they relate to concepts from the two conceptual level 
theories, ITHBC and TFL. Testing these concepts also works simultaneously to test and 





Empirics describe the methods used to collect and analyze the data and represent 
the most concrete level of the statement (Fawcett, 1999). The empirical level represents 
the most concrete level of the structure and contains the measurements of the variables 
representing or providing the operational definition of the concepts interlinked in the 
research statement. A total of nine measures contributed to this empirical level which 





Figure 1: Conceptual-Theoretical-Empirical Structure 
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The HPI model was pulled from and essentially explicates the social influence 
concept, a component of social facilitation from the ITHBC. Social influence is also 
represented from the TFL theory. In this study, social influence was represented by two 
concepts from the HPI model: concordance-logistics and social-communication. 
Concordance-logistics was operationalized as patient and HP characteristics, including 
HP leadership and measured using the Patient Demographic Questionnaire (PDQ), the 
HP Demographic Questionnaire (HPDQ) and the Multifactor Leadership Questionnaire-
5X (MLQ). Social-communication was operationalized as HP social influence measured 
by the Social Influence Questionnaire-GDM (SIQ) and the quality of interaction and the 
informational content received-delivered measured by the Quality of Information-
Interaction-GDM (QOII). Other ITHBC components were linked to the HPI concepts. 
Self-efficacy is a component of knowledge-beliefs, a process construct of the ITHBC as 
well as the primary operational definition of the emotive-cognitive concept of HPI. It was 
measured by the Diabetes Self-Efficacy Scale (DSES). The SIQ and the QOII are also 
linked to the knowledge-beliefs concept on the conceptual level and the emotive-
cognitive concept on the theoretical level. Finally, proximal health outcomes, a 
component of the ITHBC was represented by the behavioral-health behavior modification 
HPI concept and measured by the Eating Breakfast Questionnaire (EBQ) +1, the Physical 
Activity Scale (PAS) and the Glucose Monitoring Questionnaire (GMQ).  
Summary  
A summary of the review of the literature related to the concepts included in the 
research proposal has been presented, as well as a description of theories that provided a 




based on assumptions that HPI increases patient engagement in health behavior 
modification. A gap in the healthcare literature was identified necessitating the need for 
the model due to a lack of an existent one. The post-positivist philosophical paradigm 
that underlies these theories and research and as well as the conceptual-theoretical-
empirical statement has been described including the theories, ITHBC and TFL, and a 
description of the characteristics of the instruments selected for the study variables. 
Assumptions related to the research study have also been reported.  The following 
chapter addresses the design, aims, related hypotheses and research questions, 










The goal of the research was to explore the relationship of healthcare provider 
influence (HPI) and health behavior modification, specifically healthy eating (HE), 
physical activity (PA), and glucose monitoring (GM) in women with GDM. This research 
project was designed and structured as a primary means of testing the relationship 
between components of a newly developed conceptual model for HPI.  The overarching 
research question is “What is the relationship of HPI to health behavior modification of 
healthy eating, physical activity and glucose monitoring behaviors in women with 
GDM?”   
Research Aims, Hypotheses (H) and Questions (RQ) 
The specific research aims with their corresponding hypotheses (H) and a 
question (RQ) were:  
Aim 1) to determine if HPI was associated with patient engagement in health 
behavior modification of HE, PA, and GM in women with GDM. 
H1) HPI, specifically, SIQ and QOII will be positively correlated with an 
improvement in HE, an increase in PA and adherence to GM recommendation behaviors 
in women with GDM. 
Aim 2) to determine if patient characteristics moderated the relationship between 
HPI and patient engagement in health behavior modification of HE, PA, and GM in 
women with GDM. 
H2) Patient factors, specifically, race/ethnicity, primary language, and 




between HPI, specifically, SIQ and QOII and HE, PA, and GM behaviors in women with 
GDM; the relationship will be stronger with race concordance, primary language 
concordance, and a positive personal/family history of GDM/DM (GDMPFH)  
Aim 3) to determine if healthcare provider characteristics moderated the 
relationship between HPI and patient engagement in health behavior modification of HE, 
PA, and GM in women with GDM. 
 H3) HP factors, specifically, gender, HP specialty, HP leadership style (MLQ) 
will have a moderating effect on the relationship between HPI, specifically, SIQ and 
QOII, and HE, PA, GM behaviors in women with GDM; the relationship will be stronger 
with gender concordance, HP transformational leadership style (MLQ) but not differ 
based on HP specialty.  
Aim 4) to determine if self-efficacy mediated the relationship between HPI and 
patient engagement in health behavior modification of HE, PA, and GM in women with 
GDM. 
H4) Patient self-efficacy will have a mediating effect on the relationship between 
HPI specifically, SIQ and QOII and HE, PA, and GM behaviors in women with GDM.  
Aim 5) to determine if there were differences in the pattern of patient engagement 
in HE, PA during pregnancy for women with and without a GDM diagnosis.  
RQ1) Were there differences in patient engagement in health behavior 
modification of HE and PA as a result of time (Phase 1, during high-risk screening and 
Phase 2, near the end of pregnancy) or diagnosis of GDM (control group: non-GDMs and 
GDMs)? and b) were there differences in patient engagement in health behavior 




between 34-36 weeks gestational age) or diagnosis of GDM (control group: non-GDMs 
and study group: GDMs) when adjusting for three covariates: race/ethnicity, primarily 
language and personal/family history of GDM/DM?   
Research Design and Method 
In planning a study to answer the proposed research question and validate the HPI 
conceptual model, it was necessary to select a design, determine sample selection 
including inclusion and exclusion criteria, estimate a sample size, develop a research 
procedure and protocol, including consideration of human subjects protection, select and 
test instruments used to measure variables within the study, and address threats to internal 
and external validity.  Additionally, consideration and relevance to the theoretical and 
philosophical underpinnings was important.  
The primary research design selected was an observational, prospective, 
longitudinal, correlational exploratory design.  A correlational design was determined 
appropriate for inquiry investigating the association between two or more variables 
(Hulley, 2007). This type of design explains if there is and what the association is and 
how strong the relationship is between predictor or independent variables (IVs) and the 
outcome or dependent variables (DVs). In this research, components of HPI, specifically 
HP leadership characteristics, HP specialty, gender, race/ethnicity, and language used and 
patient characteristics, specifically race/ethnicity, primary language, and personal/family 
medical history were explored for their association with patient health behavior 
modification of healthy eating, physical activity and glucose monitoring in women with 
GDM. The association was explored within the natural setting and occurrences without 




exploratory (Hulley, 2007). Elements of timing contributed to the prospective and 
longitudinal nature of the design. Participants were followed from enrollment during 
early to mid- pregnancy through near the end of pregnancy, at approximately 34-36 
weeks gestational age, thus observed prospectively (Hulley, 2007). Longitudinally, an 
effect or change in the outcome variables of HA and PA was assessed over time, at two 
different time frames, with the same sample (Mertler & Vannatta, 2001).  This research 
design was a fitting selection, as it was consistent with theory testing of the proposed 
relationships in the HPI framework and addresses research aims 1 through 4 involving 
the components of cognitive, behavioral and social factors of participants and HPs, as 
well as the outcomes of health behavior modification embedded within the HPI 
conceptual model (Hulley, 2007). 
In addition to the correlational design, a quasi-experimental comparative design 
was used for Aim 5, to explore differences in health behavior modification of HA and PA 
in pregnancy for women at high risk for GDM but were not diagnosed with GDM (non-
GDMs) and those who were diagnosed with GDM (GDMs). A repeated measures 
approach was used to compare changes in HE and PA behaviors during pregnancy at two 
times (Phase 1 occurring at the time of initial high-risk GDM screening test, and Phase 2, 
near the end of pregnancy at approximately 34-36 weeks gestational age) in women with 
GDM and high risk non-GDMs.   
Quantitative methodology is an appropriate fit for this observational, prospective, 
longitudinal, correlational, and explanatory design that proposes to explain phenomena 
and associations, test hypotheses, and explain, in measurable increments, the change in 




instruments/ questionnaires and statistical analyses utilizing correlation and regression 
coefficients to test the recently designed HPI conceptual model and associations between 
variables. This research method was suitable for the post-positivist philosophical 
underpinnings of this research purpose and inquiry as it was intended not only to 
construct knowledge but also to increase the meaning and deepen the understanding 
regarding the process of HPI and its association with patient health behavior 
modification. Analyses included multiple IVs and several DVs, denoting the 
consideration of the complexity of associations influencing multiple outcomes, rather 
than just one, as the population and representative sample participants were likely to be 
affected in more than one way (Guba, 1990). This allowed for a more comprehensive 
inquiry, analyses and interpretation of findings (Stevens, 1992). Quantitative methods are 
commonly used in social science research focusing on findings related to specific health 
behavior outcomes, and used to explain and affect future social change, as future research 
was projected following this discovery (Mujis, 2010; A. B. Ryan, 2006). All these factors 
are consistent with post-positivist philosophy (A. B. Ryan, 2006; Mujis, 2010).  
Population Sample  
The population for this study was pregnant women identified as at high-risk for 
GDM. Sample inclusion criteria for participation were pregnant women, 18 years and 
older, who underwent diagnostic testing for GDM, either in early pregnancy as a result of 
meeting a criterion for higher risk, or as a result of routine mid-pregnancy screening, 
prior to receiving a diagnosis of or counseling for GDM from any type of HP during the 
current pregnancy. All races and ethnicities were included and encouraged for purposes 




both English and Spanish speakers, with sufficient literacy levels to comprehend and 
complete instruments.  
Participants who meet these criteria and were diagnosed with GDM were included 
in the GDM group. Participants who were determined to be at high-risk in early 
pregnancy or had an initial elevated routine mid-pregnancy screening result but were 
subsequently not diagnosed with GDM following diagnostic testing made up the control 
group (non-GDMs) for Aim 5.  Participants were excluded if they had a diagnosis of DM 
prior to pregnancy.  
Setting and Selection of Sample Participants 
Much consideration was given as to the optimal location for study 
implementation, including clinical setting and site, feasibility for quantity and diversity of 
participant recruitment, and timing related to data collection. The sample was obtained 
using a convenience sampling approach from various maternity prenatal clinic settings in 
a Midwestern US city. Seven clinic practice settings were utilized for recruitment of 
participants and data collection, including federally qualified health centers, large 
university hospital-based teaching clinics, and private practice clinics. There are a variety 
of healthcare providers (HPs) that provide maternity care for these patient participants, 
including advanced practice nurses, such as nurse practitioners (NPs) and Certified 
Nurse-Midwives (CNMs), and physicians, such as osteopathic/medical doctors (MDs), 
specializing in Family Practice or Obstetrics/Gynecology. The desire was to have as 
diverse as possible a sample in regard to maternity care provision based on HP specialty 




HP specialties may have or use different leadership skills, affecting HPI and its 
association with patient health behavior modification.   
Sample size estimation 
Accurate sample size estimates were needed to plan for adequate power to obtain 
statistically significant and meaningful results. Factors such as disease prevalence, lack of 
access, and feasibility issues may ultimately affect the sample size to be recruited for the 
study (Munro, 2001).  The sample size estimate is affected by selection of the desired 
power, the effect size, the statistical significance level and the number of IVs tested. A 
power of 0.80 is generally accepted as sufficient and reasonable in behavioral science 
research (Cohen, 1987; Ferguson, 2009; Munro, 2001). A moderate effect size of 0.15 is 
generally desired for correlational research designs (Munro, 2001). The significance level 
(α) expressed as the probability (p) value ranges from 0.00 to 1.0; the generally accepted 
standard for statistical significance has been a p-value of 0.05. It is important to note that 
the statistical significance level is however not equal to the clinical or practical 
significance level especially regarding behavioral research (Thompson, 2002). In cases of 
preliminary research, therefore, when there is no specific recommendation for a desired 
p-value, the p-value should be based on the feasibility of obtaining an adequate sample 
size, which may be restricted when the prevalence rate of disease in the population is 
low, and on the consideration of error type and risk. In these cases, a larger p-value for 
significance may be chosen (Munro, 2001).  Regarding this study, GDM occurs in 
approximately 9.2% of pregnancies in the US (DeSisto et al., 2014; Hartling et al., 2012), 
limiting the accessible patient population. Because the risk of Type 1 error holds less risk 




intervention research (Hulley, 2007) and because the sample is somewhat difficult to 
access, a p-value of .10 was selected for this exploratory, observational study. 
Nonetheless, increasing the error and risk margins of a Type 1 error can pose limitations 
by increasing the threats to validity. Measures to address limitations and threats including 
the selection of analyses were considered. For example, rather than large multivariate 
analytic model, multiple analyses were conducted to explore each hypothesized 
relationship separately with fewer variables to address the limitation of a smaller 
accessible sample that can limit power when large numbers of variables are entered 
(Munro, 2001).   
A power analysis for this research project was conducted using Gpower statistical 
program (Faul, Erdfelder, Lang, & Buchner, 2007, 2009), for a desired power of 0.80, 
moderate effect size ƒ ² of 0.15, and a significance level, p-value of .10.  A power 
analysis for each of the four hypotheses was conducted separately (Table 2). Hypothesis 
1 had a total of two predictor variables (SIQ composite score, QOII total score) for a 
multiple linear regression analysis. Hypothesis 2 has two predictor variables (SIQ 
composite score, and QOII total score and three dichotomous moderating variables (race 
concordance, primary language concordance, and personal or family history of 
GDM/DM).  The two predictor variables, one of the three moderating variables, and the 
interaction between the predictors and the moderating variable will be analyzed for each 
of the moderating variables separately with each of the eight dependent variables lending 
to a total of five tested variables, e.g. SIQ composite score, the QOII total score, race 
concordance, the SIQ composite score X race concordance, and finally, the QOII total 




of GDM/DM will be analyzed in the same manner described above for this multiple 
linear regression analysis. Hypothesis 3 had two predictor variables (SIQ composite 
score, and QOII total score and three dichotomous moderating variables (gender 
concordance, HP specialty, and HP leadership style). The two predictor variables, one of 
the three moderating variables, and the interaction between the predictors and the 
moderating variable will be analyzed for each of the moderating variables separately with 
each of the eight dependent variables lending to a total of five tested variables, e.g.  SIQ 
composite score, the QOII score, gender concordance, the SIQ score X gender 
concordance, and finally, the QOII score X gender concordance. HP specialty, and HP 
leadership style (MLQ) were analyzed in the same manner as described above for this 
multiple linear regression analysis.  Hypothesis 4 contains two predictor variables (SIQ 
composite score and QOII total score), which will be combined separately and together 
with one mediating variable (DSES) for a total of three tested variables for this multiple 
linear regression analyses. The power analysis was based on the selected method of 
analyses that contained the largest number of tested variables, equaling five. 
Based on the results of the power analyses with predetermined power, effect, and 
significance level and the largest number of tested predictor and total tested variables; a 
sample size of 75 participants was estimated to be adequate for the study group: GDMs 
Phase 2 completers and data analyses.  Recruitment continued until fulfilling the 
predetermined sample size, using face-to face data collection and verification of data 
completeness for the Phase 2 data collection and initial analysis has been accomplished. 
This resolved any concerns or threat of insufficient sample size that could have resulted 




withdrawal prior to or during Phase 2, incomplete data collection, and elimination of 
outliers.   
 




A total of nine instruments and questionnaires (Appendix D) were selected or 
developed to empirically measure research concepts and for data collection (Table 1). 
Figure 2 depicts the hypothesized relationships between study variables and measures.  
Measures include: the Multifactor Leadership Questionnaire-5X-Short Form (MLQ); the 
Social Influence Questionnaire-HP-GDM (SIQ), Quality of Information/Interaction-




Breakfast Questionnaire (EBQ) +1, the Physical Activity Scale (PAS), the Glucose 
Monitoring Questionnaire (GMQ), the Participant Demographic Questionnaire (PDQ), 
and finally, the HP Demographic Questionnaire (HPDQ). The PDQ and the HPDQ were 
developed for this study to collect pertinent patient and HP demographics and 
descriptors. Modifications were made to the MLQ, the SIQ, QOII, the DSES and the 
GMQ to address content specific to patients, HPs and GDM, which will be described 
individually in detail below.   
All the instruments are currently available in both English and Spanish language 
following translation for this study or previously translated and used in Spanish speaking 
populations for other research purposes. Those previously translated include the MLQ, 
the PAS, the EBQ, and the DSES. Translations for the other five instruments were 
conducted by certified medical interpreters and underwent both forward and back 




Table 1: Instrument Matrix 
Instrument 
(reference) 





5X (short form) 
(MLQ) 
(Antonakis et al., 
2003; Avolio & 
Bass, 2004; Bass 
& Avolio, 1997; 
Bass & Riggio, 
2006)  
 
Original MLQ:  Test-retest (n=193).52-.82 
MLQ-5X:  α > 0.80 for all scales 
External validity: Tested and used in 
research across large samples 
internationally over > 15 years, with many 
cultures, populations, languages (N > 
15,000) 
Construct validity- Factor analyses 
supports full nine-factor structure FRL 
CFA goodness of fit= .93 
Predictive validity- meta-analyses: 
multiple- support TFL model 
Multiple meta-analyses with strong 
positive correlations with objective and 
subjective measures of performance.  
45 items 
Rated on 0-4 Likert 
scale 
Initial analysis: 
1 final leadership 
style score:  
3 categories, 2 
variables  











(Weiss et al., 
2008; Weiss & 
Lokken, 2009; 
Weiss et al., 
2007) 
Original QDTS tested in multiple 
populations including medical surgical 
(MS) (N=147) postpartum (PP) parents of 
hospital children (PHC) (N=135)  
Reliability coefficient: α > .80 for all 
scales and subscales 
Total content (content received + delivery) 
scale:   α = .87 (PP), .89 -.90 (combined 
samples); .92 (MS).88 (PHC) 
Validity established with large study 
sample 
EFA: 2 factor structure (content and 
delivery) account for 54. 2% of scale 
variance 
Modified for GDM population 
17 items: 6 paired 
(content received and 
needed) and 11 for 
delivery  
Rated on 0-10 Likert 
scale 
1 total score 








Original (social influence scale): tested in 
middle aged women (n=301); α =.83 
Goodness of Fit chi-square p<=.78  
Model chi-square p≤.01 
Modified instrument used in postpartum 
mothers (n=124): α =.84  
Content validity testing  
Modified for GDM population 
3 items  
Item 1: categorical 
Items 2 and 3 
rated on 1-5 Likert 
scale  
Analysis:1 final 
score:  total HP social 
influence score  





González, 2000 ; 
Lorig et al., 
2003 ; Lorig et 
al., 2005 ; Lorig 
et al., 2009)  
Internal consistency,  
α =.83 (English) (N=109, 186)-.85 
(Spanish) (N =147) DMs 
Test-retest validity, r = .80 (n=20 Spanish) 
Face and content validity with multiple 
focus groups (DMs, Diabetic 
Educators/nutritionists) 
Reported item convergent and discriminant 
validity testing but not described 
Forward/back translation for the Spanish 
measures  
8 items  
Range of 1-10 Likert 
scale  
Analysis: 1 total 










Lorig et al., 
2005) 
EBQ: Used with English (n=123) and 
Spanish (N= 315; 317; 109) DMs  
Portion of vegetables (N=109) 
Single items internal consistency and test-
retest were not reported/not applicable 
Face and content validity with multiple 
focus groups (DMs, DEs)  
Forward/back translation for the Spanish 
measures  
3 items  
Analysis: 3 scores 
Item 1: range 0-7 
Item 2: 0 (no) -1 or 
more (yes)  












& Lorig, 1995; 
Lorig et al., 
2003; Lorig et 
al., 2005; Lorig 
et al., 1996; 
Ohlendorf, 2014) 
Used with chronic disease, including DM, 
English and Spanish speaking, and 
postpartum women (PP) (N=124) 
Tested in English (N =1127-1130) Spanish 
(N =270) - retested in English (n=51) and 
Spanish (n=25) for 
strengthening/stretching,  
 r =.56 (English) -.91 (Spanish) and 
aerobic exercise, r =. 72 (English) -.89 
(Spanish) 
Face Validity: items address components 
of physical activity/exercise 
Construct validity testing:  
test-retest .86; 
correlation of .29 was found between Item 
1 and Items 2-6.  
Translation/back translation for the 
Spanish measures 
6 items 
Analysis: 2 scores 
Item 1: range 0-180 






González, 2000 ; 
Lorig et al., 2003 
Lorig et al., 
2005 ; Lorig et 
al., 2009) 
Item 1: English (N=62) and Spanish 
(N=109; 142-speaking DMs 
Psychometric testing reports single-items 
internal consistency reliability; test-retest 
reliability not reported/ not applicable  
Face and content validity with multiple 
focus groups (DMs and Des)  
Forward/back translation for the Spanish 
measures 
4 items 
Analysis: 3 scores +1 
Items 1-2: Range 0-7  
Item 3: Range 0-28 





Instruments Description  
Multifactor Leadership Questionnaire-5X 
The Multifactor Leadership Questionnaire-Short form-5X (MLQ) was used to 
measure the patient’s perception of the leadership characteristics or qualities of their HP 
that could affect self-efficacy and patient engagement in health behavior modifications. 
The MLQ was selected as the measure for Transformational Leadership (TFL) due to its 
strong foundational basis within TFL theory, consistent with one of the central tenets of 




The MLQ was developed to measure the concept of TFL (Bass, 1985; Bass, 
1998). TFL “is the process in which leaders change their associate’s awareness of what is 
important and move them to see themselves and the opportunities and challenges of the 
environment in a new way” (Avolio & Bass, 1995). TFL characterizes leadership wherein 
a leader responds to the follower’s needs, aligns goals and objectives, and though 
empowerment stimulates, inspires and moves followers to meet and exceed performance 
expectations as well as to strive for higher levels of potential (Bass & Riggio, 2006). The 
original MLQ, a 73-item instrument measuring five factors was constructed by Bass 
following a series of interviews with over 70 senior professional and business executives. 
The MLQ has undergone many revisions over the past several decades and has been 
modified following multiple content and factor analyses. It has been tested in many 
settings and with many international populations, numbering well over 15,000 subjects in 
different countries as well as has been translated into several languages (Antonakis et al., 
2003; Bass & Riggio, 2006). The MLQ has been used in multiple industries including 
education, military, healthcare, and politics and “the most widely accepted instrument to 
measure to TFL” (Bass & Riggio, 2006). The most current revision is a reduced version 
named the MLQ-5X (Avolio & Bass, 1995) which will be used for this research. There 
are two forms of the MLQ, the Leader and Rater Forms. For the purposes of this 
research, the Rater form will be utilized and described.  
The MLQ is a 45-item questionnaire, written at a 9th grade level, although used 
previously in less educated populations, and takes approximately 15 minutes to complete 
(Bass & Riggio, 2006).  The Rater Form is most commonly used in research to measure a 




nine factors in the Full Range of Leadership (FRL) model (Bass & Avolio, 1994). The 
FRL model includes characteristics of TFL as well as transactional leadership (TAL) and 
laissez-faire non-leadership (LFNL). TFL is represented and measured by five factors: 
idealized influence/charisma, which divides into two subcategories idealized attributes 
and idealized behaviors; inspirational motivation; intellectual stimulation; and 
individualized consideration. Transactional leadership characterizes leadership through 
social exchange wherein the leader rewards or disciplines based on performance (Bass & 
Riggio, 2006). The two factors that represent transactional leadership are contingent 
reward and management-by-exception-active. Laissez-faire leadership or non-leadership 
is “the avoidance or absence of leadership” (Bass & Riggio, 2006). The two factors that 
represent laissez-faire are passive/avoidant behavior and management-by-exception-
passive. The nine factors are each represented by four items, amounting to 36 items. 
Incorporated into the MLQ are three leadership outcomes: extra effort; effectiveness; and 
satisfaction, represented by nine items amounting to a total of 45 items (Bass & Riggio, 
2006). These outcomes have been found to positively correlate to the five TFL factors 
and contingent reward (Bass & Riggio, 2006). Outcome item data will be collected but 
not used for hypotheses testing in this study.  The items are scored on a 5-point Likert 
scale ranging from “not at all” to “frequently, if not always”. Each of the nine factor 
subscale scores are computed as the mean score of the four item scales. If an item is left 
blank, the mean score is calculated from the answered items. Three leadership composite 
scores are computed as the sum the related factor subscales pertaining to each leadership 
type, divided by the number of factors. The highest of the composite scores, an interval 




or laissez-faire. The three levels of leadership were examined using two variables or 
vectors. Transformational and transactional categories were coded as dichotomous 
variables as the third type, laissez-faire was not determined to be sufficient to analyze 
(n=1) in the regression analysis.  
The MLQ has been widely used in research over a 15-year period and earlier 
versions expand over 25 years. Reliability and validity testing were conducted in earlier 
versions of the MLQ as well as the MLQ-5X. The test-retest reliability of the earliest 
version of the MLQ Rater Form (N=193 ranged from .52-.82 after six months), as 
reported in the unpublished work of Pile (Bass & Riggio, 2006). The MLQ-5X has 
demonstrated high reliability and validity across large samples (Avolio & Bass, 1995). 
Good to excellent internal consistency with α coefficients > 0.80 resulted for all nine 
MLQ-5X factor scales and leadership composite scores (Avolio & Bass, 2004; Bass & 
Avolio, 1997; Bass & Riggio, 2006). The MLQ-5X has undergone numerous validity 
testing including convergent and divergent validity testing and construct validity, 
determined with multi-dimensional confirmatory factor analyses (CFA) of the FRL 
theory and found to support the full nine-factor structure of the MLQ-5X (Antonakis et 
al., 2003; Bass & Avolio, 1997). CFA goodness of fit = .93 (Avolio & Bass, 2004; Bass 
& Riggio, 2006). The average variance extracted from each factor was > .50 and factor 
loadings were found to be satisfactory (Avolio, Bass, & Jung, 1995). 
Predictive validity was determined by multiple meta-analyses using leadership 
type composite scores and found to have strong positive correlations with objective and 
subjective measures of performance to support the TFL model (Bass & Riggio, 2006). 




leadership effectiveness (Bass & Riggio, 2006). A meta-analysis including 20 studies 
separated TFL and transactional leadership into two composites and found that with 
corrected means TFL was correlated at r=.76, .71, and .88 with effectiveness, satisfaction 
and extra effort while transactional leadership correlated at r= .27, .22, and .32 with the 
same three outcomes, respectively in followers (Gasper, 1992). Permission was obtained 
for the use, modification and reproduction of the MLQ-5x following purchase of license 
(Appendix D). The MLQ-5X was minimally altered, not for domain or content, but for 
eight minor stem changes to pertain to patient’s perceptions of HPs rather than use by 
colleagues or subordinates. The results of content validity testing indicated a content 
validity index (CVI) of .67 with 30 of the 45 items deemed relevant. Eight of the 15 items 
determined to be non-relevant items were related to laissez-faire/non-leadership, two 
related to transactional leadership and five to transformational leadership. However, as 
this instrument is intended to assess a continuum of leadership and non-leadership 
characteristics, all items will be retained for use in this research proposal. 
Social Influence Questionnaire-GDM (SIQ) 
The Social Influence Questionnaire-GDM (SIQ) was selected to measure social 
influence of healthcare providers (HPs) from the GDM patient participant perspective. 
This measure addresses the concept of social influence from professionals, in this case 
HPs. The SIQ is a modified version of the Social Influence Questionnaire (Ohlendorf, 
2014) which in turn was adapted from an original social influence scale designed to 
increase mammography utilization (Champion, 1994).  
The social influence measure developed by Champion (1994) is a two part 20-




1994). Six social contacts of the participants which shall be called social influencers were 
specified, two of whom are physicians and nurses. The first part of the scale measures the 
participant’s perceived beliefs of each social influencer about mammography. The second 
part of the scale measures the participant’s perception of the influence that each social 
influencer has on the participant’s behavior (Champion, 1994).  One social influence 
scale score was calculated by summing the computed scored for the two factors of beliefs 
and influence multiplied for each social influencer. A higher social influence score 
indicated greater social influence on the patient’s health behavior modification. Internal 
consistency reliability for the total social influence score was a Cronbach’s α of 0.83 
(Champion, 1994). Validity was tested through factor analysis with other covariates 
wherein social influence was positively correlated to mammogram screening (p=.07) with 
a Goodness of Fit chi-square, p ≤.78, model chi-square, p≤ .01 (Champion, 1994).   
A recent modification and utilization of this social influence scale, called the 
Social Influence Questionnaire (SIQ), was adapted to assess social influence regarding 
weight loss in postpartum women (Ohlendorf, 2014). The SIQ included eight social 
influencers and five beliefs statements. Two of the social influencers are 
physicians/nurse-midwives and hospital nurses. Testing of the SIQ resulted in a 
Cronbach’s α of 0.84 (Ohlendorf, 2014). Content validity of the SIQ was conducted with 
content analysis experts prior to use (Ohlendorf, 2014). Permission was received for 
modification and use of the SIQ.  
The SIQ is a 3-item version, newly modified for use in this study that focuses 
only on healthcare providers (HPs) as sources of social influence and GDM-related health 




(Ohlendorf, 2014), which include a variety of different social influencers including 
family, friends or partners, in addition to HPs, the SIQ only includes different HPs. It has 
been shortened in this publication to SIQ. The HPs that are included are three categories 
that care for women diagnosed with GDM, nurses, nurse-midwives/physicians/nurse 
practitioners, and Diabetic nurse-educators/Registered Dietitians. The first item asked 
which HPs counseled the patient regarding GDM. The first item is categorical level 
measurement that will be used for descriptive purposes only. The second and third items 
inquired about the participant’s perception of the strength of the influence that each of the 
three-social influencer-HP categories have on the patient’s health management behavior 
and the participant’s perception of the strength of nine beliefs that the social influencer-
HP has that the patient can make health behavior modifications. Response options and 
interval level scoring for these items are the same used in the SIQ. Response options for 
the influence factor are on a 5-point Likert scale and ranges from “strongly influences” to 
“no influence”.  Response options for the beliefs factor are on a 5-point Likert scale and a 
range from “strongly agrees” to “strongly disagrees”. Individual social influencer scores 
are computed by multiplying their social influence score by their belief in patient 
behavior score. Scores for each individual social influencer range from 0-225.  Based on 
feedback and to prevent confusion, the research analyses did not proceed with analyses 
involving nurses as their role was too general to assess for professional influence in this 
context. A total social influence score, the sum of all the individual social influencer’s 
score, range from 0-675. This latter score was the one that used for hypothesis testing. 
Content validity was conducted with content experts in a pilot study prior to use in the 




valid. Due to the overall validity of the instrument, although the three items not found to 
be sufficiently relevant they were nonetheless retained as they reflected one belief 
pertaining to three different HP specialties.    
Quality of Information-Interaction-GDM Scale (QOII) 
The Quality of Information-Interaction-Gestational Diabetes Mellitus (QOII) was 
selected and modified to measure the HPI components of GDM-relevant information 
provision, as well as, the interaction and delivery process by pertinent HPs. The QOII is 
adapted from the Quality of Discharge Teaching Scale (QDTS)-New Mother form, which 
is a modification of the original Quality of Discharge Teaching Scale (QDTS) (Weiss & 
Lokken, 2009; Weiss et al., 2007). The QDTS was developed and tested in several 
studies to measure the patient’s perception of the quality of discharge teaching in adult 
medical-surgical patients (N=147), parents of hospitalized children (N =135) and 
postpartum mothers (N =141) (Weiss et al., 2008; Weiss & Lokken, 2009; Weiss et al., 
2007). The QTDS-New Mother form for postpartum mothers is a 19-item scale 
measuring the quality of hospital discharge teaching for postpartum mothers. There are 
seven paired “content received and needed” items and 12 “delivery of information” items 
(Weiss & Lokken, 2009). Permission was obtained from the author for the use and 
modification of the QTDS-New Mother to adapt it for the purposes this study, the 
counseling and delivery of GDM related information to pregnant women diagnosed with 
GDM, thus named QOII-GDM and shortened to QOII for future description herein.  
Although not pertinent to hospital discharge teaching, it is intended to measure content 
and delivery of information for a new diagnosis requiring modification of health 




The QOII- is a 17-item scale modified to include six “content received” items and 
11 “delivery of information-interaction” items. The “content received” domains are 
related to the patients’ perceptions of the amount of informational “content received” 
regarding GDM-related treatment and recommendations for self-management health 
behavior modifications of healthy drinking and eating, PA, and glucose monitoring, 
practice with glucose monitoring, and who and when to call with problems. These items 
are subdivided into content received from two categories of HPs, usually responsible for 
providing this education: a) nurse-midwife/doctor/nurse practitioner and b) diabetic 
nurse-educator/Registered Dietitian. The delivery domains correspond to the interaction 
and approach used by HPs for information delivery and include listening, answering 
specific concerns, showing sensitivity to personal values and beliefs, teaching in 
understandable manner with consistent information and at times that were good for the 
patient and family, evaluating patient understanding, promoting confidence in ability to 
care for self, and decreasing anxiety. One domain eliminated in the QOII-GDM version 
from the original QTDS is “knowing what to do in an emergency,” as GDM is not a 
condition that generally requires hospitalization. The items are scored on an 11-point 
Likert scale, ranging from 0-10, indicating “none” or “not at all” to “always” or “a great 
deal”.  The interval level score that will be used for analyses is the total score, equal to 
the sum of two subscales scores, “content received” score, the sum of the “content 
received” items, and delivery score, the sum of the delivery items (Weiss et al., 2007). 
Higher total scores indicate a greater amount of information received (“content received” 
subscale) and the increased quality of the information-interaction (delivery subscale). 




subscale scores, based on previous research and per the recommendation of the author, 
that the outcome variables can perform differently when the two separate subscale scores 
are used instead of the total score (Weiss et al., 2008; Weiss & Lokken, 2009; Weiss, et 
al., 2007), the decision was to retain the total score instead as the sub-scores did not 
contribute to the analyses, presented multicollinearity concerns and added an additional 
tested predictor variable which would normally require a larger sample size.   
Reliability testing for total and all subscales of the QDTS resulted in a Cronbach’s 
α > .80. Total content scale α = .87-.92 for postpartum mothers, parents of hospitalized 
children and adult medical-surgical patients (Weiss et al., 2008; Weiss & Lokken, 2009; 
Weiss et al., 2007). Validity has been established with an exploratory factor analysis 
found to support a 2-factor structure (content and delivery), which explained 54.2% of 
scale variance (Weiss et al., 2007). Content validity was conducted with content experts 
in a pilot study prior to use in the main study. Results for the QOII found the instrument 
to be valid at .95 with 35 of the 37 items relevant at .83-1.00. Two items that were not 
sufficiently relevant related to contacting HP following diagnosis or counseling if needed. 
These were retained as they involved two different HP specialties had the potential to 
provide insight on expectations for content/delivery of information for different HP 
specialties.  
Diabetes Self-Efficacy Scale (DSES) 
The Diabetes Self-Efficacy (DSE) scale (DSES) measures confidence levels in 
beliefs related to DM and self-management health behaviors, including glucose 
monitoring, healthy eating, and PA (Lorig et al., 2003; Lorig et al., 2009). The DSES was 




2000; Lorig et al., 2003; Lorig et al., 2009), thus content is appropriate and specific for a 
population with GDM. In addition to this, the DSES is a succinct instrument available in 
English and Spanish making it a practical choice for this research.  It is an eight-item 
instrument available in Spanish and English that uses a 10-point Likert scale (1-10) 
format indicating “not at all confident” to “totally confident”. The score is reported as the 
mean of the eight item scores with a range of 0-10.  The scale was modified for the study 
by adding the word “gestational” prior to diabetes in two items. Focus groups including 
patients and their family members, educators and HPs were involved in the design of the 
DSES and the instrument has undergone standard psychometric testing for internal 
consistency, test-retest reliability if indicated, item convergent and discriminate validity 
as well as translation/back translation for the Spanish measures (Lorig & González, 2000; 
Lorig et al., 2005). These results are reported below if provided. The DSES was tested 
with samples of both English (N=186) and Spanish (N=189) speaking DMs resulting in 
findings of strong reliability with internal consistency, α = .83 (English) and α = .85 
(Spanish) and test-retest validity, .80 (Lorig et al., 2003; Lorig et al., 2009). A pre-test/6 
week/3-month post-test study of a community-based, peer-led diabetes self-management 
program resulted in increased self-efficacy for managing diabetes measured by the DSES 
at 6 weeks and 3 months increasing the mean (SD) 1.6 (2.6) at 3 months over the baseline 
of 6 (2.2) (p<0.0001) in a Spanish-speaking DM sample (N=109) (Lorig & González, 
2000). A chronic disease self-management program was evaluated with a longitudinal 
research design in Spanish (N=322) and English (N=123) speaking DMs. Increases 
occurred in self-efficacy, measured by the DSES, from baseline to 4 months/1year in 




2005). Baseline and change in baseline to 4 months self-efficacy was significantly 
associated with improvement in eating breakfast, and aerobic exercise (p <.001 (Lorig et 
al., 2005) measured with the PAS and items in the EBQ+1. 
Eating Breakfast Questionnaire (SEBQ) +1  
The Eating Breakfast Questionnaire (EBQ) +1 was selected to measure the 
healthy behavior of healthy eating/diet. The EBQ+1 includes three items that were 
developed and tested, as was the DSES, for self-management health behavior 
modification research interventions in DMs (Lorig & González, 2000). Two items relate 
to breakfast and a third item to vegetable portion intake, thus naming it the EBQ+1. The 
EBQ+1 assesses the frequency of eating breakfast weekly, the type and number of protein 
foods including the option of adding any not included on the list consumed for breakfast 
that morning, and the number of portions of vegetables consumed daily. Three interval 
level scores result. The response range for the first item is 0-7 while the second and third 
items are open-ended values. This measure will be used in at two different times, Phase 1 
and 2 and compared for differences.  
The search for a healthy eating measure was quite arduous due to the exhaustive 
list available, however many were found to be irrelevant, not disease specific or having 
limitations for research purposes. Counseling related to DM/GDM involves carbohydrate 
reduction and replacement with or increasing protein intake. A strong emphasis is placed 
on the intake of adequate, but not excessive carbohydrates, low glycemic versus high 
glycemic index carbohydrates, and those containing high versus low fiber. The learning 
curve regarding these characteristics of carbohydrates is difficult for most patients to 




reliable data in asking about these dietary patterns would be cumbersome. Research has 
found that healthy eating behaviors conducive for DM/GDM include eating breakfast 
following the self-evaluation of fasting blood sugar, eating frequent meals starting with 
breakfast, increasing overall protein intake which increases insulin sensitivity, and 
increasing fiber intake by way of increased vegetable intake (Mekary, Giovannucci, 
Willett, van Dam, & Hu, 2012). Eating breakfast has also been found to decrease the risk 
of DM by 30% (Mekary et al., 2012). Insulin resistance is greatest in the morning for 
most women with GDM and therefore fewer carbohydrates should be eaten in the 
morning (Gutierrez & Reader, 2005).  There are associations between excessive dietary 
fat intake and increased insulin resistance and elevated risk of GDM and DM 
(Hernandez, Anderson, Charter-Logan, Friedman, & Barbour, 2013).  
Several factors contributed to the selection of the EBQ+1. GDM/DM related 
counseling and research evidence supports the relevance of the three items. The measure 
is easy to use and score, thus increasing accuracy in completion and analysis, and is brief, 
thus decreasing participant burden. Additionally, it addresses HP recommended GDM 
treatment/prevention strategies of nutritional counseling and health behaviors involving 
the timing and type of food intake, thus supporting the positive rather than the negative 
aspects of dietary carbohydrate and high fat restriction. Multiple focus groups with 
content experts, specifically diabetic nurse-educators, nutritionists, and persons with DM, 
met to discuss necessary content for inclusion in DM self-management health behavior 
modification peer education intervention studies and participated in the development of 
the EBQ+1 item (Lorig & González, 2000). As the healthy eating recommendations are 




in research, along with the DSES, with English and Spanish speakers (Lorig & González, 
2000; Lorig et al., 2005).  
Development and content validity testing of the items included in the EBQ+1 was 
conducted with multiple focus groups and content experts, Diabetic Educators, 
nutritionists, and persons with DM and their family members (Lorig & González, 2000). 
Translation, back translation, and translator consensus agreement for the Spanish 
measures was undertaken (Lorig et al., 2005). Standard psychometric testing of the items 
in the EBQ+1 for reliability and validity was reported as having been undertaken with 
internal consistency and test-retest reliability and item convergent and discriminant 
validity in English (N=123) and Spanish- (N=315/317; 109) speakers but limited 
description was provided (Lorig & González, 2000; Lorig et al., 2005). Repeated 
measures testing in a pre-test/6 week/3-month post-test study of a community-based, 
peer-led diabetes self-management program in a Spanish-speaking DM sample (N=109) 
measured by the items included in the EBQ+1 found improvement at 6 weeks in eating 
breakfast, eating protein at breakfast, and number of portions of vegetables eaten daily 
(p<.05) (Lorig & González, 2000).  In the same study at 3 months, improvement in eating 
breakfast, the mean (SD) increased .24 (2.4) over the 5.9 (2.1) baseline (p =.31), eating 
protein at breakfast increased 12% over baseline 79% (p ≤ .01), and number of portions 
of vegetables eaten daily increased .31 (1.3) over 1.3 (1.0) (p ≤.01) (Lorig & González, 
2000).  Validity testing of self-efficacy and the EBQ items was conducted in a 
longitudinal study of a chronic disease self-management program with repeated measures 
at pre-test, 4-months and 1 year in Spanish (N=322) and English (N=123) speaking DMs. 




Spanish-speakers (p<.001) and 4 months in English speakers (p=.006) (Lorig et al., 
2005).  
Physical Activity Scale (PAS) 
The Physical Activity Scale (PAS) was selected to measure the health behavior of 
physical activity (PA). This measure will be used at two different times, Phase 1 and 
Phase 2, and compared for within GDM group and between control and GDM group 
differences. As with the previous outcome measure, a number of other instruments and 
applications used to measure exercise and PA were evaluated for use in this study; 
however the major impetus for selecting this measure was due to its development for and 
use in prior research focused on health behavior self-management modification in chronic 
illness including DMs (González et al., 1995; Lorig & González, 2000; Lorig et al., 2003; 
Lorig et al., 2005; Lorig et al., 1996) and in research involving postpartum women (N 
=124) (Ohlendorf, 2014). An additional benefit of the PAS is that it has been tested and 
re-tested in Spanish and English-speaking populations and is thus available in Spanish 
language.  It is a six-item instrument addressing the total minutes of 
stretching/strengthening (Item 1) and aerobic exercise (Items 2-6) weekly, resulting in 
two scores. Each item receives a self-reported 5 point ordinal level scale response. These 
five options range from “none” to “greater than three hours per week”. Each option 
assigns a value from 0 to 180 representing “minutes spent”. One score is derived from 
item 1 with a possible range of 0-180. The second score is the sum of items 2-6, with a 
possible range of 0-900. The authors described this selection of an ordinal to interval 
conversion approach to prevent data skewing on both ends of reporting, to correspond to 




non-zero categories, to lead to scoring rules, and for correlation analyses (Lorig et al., 
1996).  
Focus groups led to the development of the measure items prior to reliability and 
validity testing. Test-retest reliability estimates have been reported as r = .56 for item 1 
and .72 for items 2-6 in studies of English-speakers (test, N =1127, 1130; retest, n=51) 
(Lorig et al., 1996), and r =.91 for item 1 and .89 for items 2-6 in Spanish-speakers (test, 
N =270; retest, n=25) (González et al., 1995). Construct validity and item-convergent and 
discriminant validity testing was conducted (Lorig et al., 1996). A correlation, r = .29 
was found between Item 1 and Items 2-6, thus considered independent of one another. 
Internal consistency was found to be .83; test-retest .86 and range of item-scale 
correlations .68-.71.  Item-convergent and discriminant validity testing were conducted as 
part of the multi-trait scaling analyses to evaluate the correlation of self-efficacy to 
perform self-management exercise to PAS. Correlations between self-efficacy exercise 
scale and PAS Item 1 was .26 and Items 2-6, .37 indicating greater convergence with 
aerobic exercise than with stretching/strengthening (Lorig et al., 1996). 
Several longitudinal studies evaluating community-based, peer-led DM self-
management program with repeated measures were conducted (Lorig & González, 2000; 
Lorig et al., 2003; Lorig et al., 2005). Based on pre-test/6-week/3-month post-test, 
improvement in exercise (p <0.05) at 6 weeks and at 3 months with an increase in mean 
(SD) of 50 (121) minutes/week over a baseline of 88 (103), p ≤ .0001) was found in a 
Spanish-speaking DM sample (n=109) (Lorig & González, 2000). In a randomized 
control study, Spanish-speaking participants (N=327) involved in a 6-week program 




months (n=224) and 1 year (n=271) (p≤.0001) (Lorig et al., 2003). Interventions resulted 
in improvements in aerobic exercise, measured by the PAS at 4 months/ 1 year 
(p<.001/p<.001) in Spanish (n=322) and 4 months (p=.005) in English (n=123) speaking 
DMs (Lorig et al., 2005).  
Glucose Monitoring Questionnaire (GMQ) 
The Glucose Monitoring Questionnaire (GMQ) is a 4-item measure developed for 
this research. The Glucose Testing Questionnaire (GTQ), a 2-item questionnaire provided 
the basis for the development of the GMQ as well as one of its four items. The GTQ was 
developed for and used in self-management health behaviors modification and self-
efficacy research with DMs (Lorig & González, 2000; Lorig et al., 2003; Lorig et al., 
2005; Lorig et al., 2009).  Other glucose monitoring measures including daily logs have 
been utilized with DM/GDM, but these are not practical and feasible for outcome 
measurement. Item 1 of the GTQ was not included in the GMQ because it was inquired 
as to the availability of monitoring equipment which is generally provided to GDMs at 
the first counselling session for the short-term duration of the pregnancy, whereas those 
with long-term DM have life-long requirements for access to equipment and supplies. 
Item 2 of the GTQ is the first item of the GMQ, as it is pertinent to GDM and assesses 
the frequency of glucose monitoring behaviors weekly. The following items (Items 2 and 
3) of the GMQ relate to GDM counseling recommendations and use the format of the 
GTQ to inquire as to: Item 2) the frequency of glucose monitoring behaviors four times 
daily and Item 3) a weekly recall regarding number of abnormal glucose results above the 
recommendations. Items 1, 2, and 3 of the GMQ are interval level scores that range from 




perception of causes of glucose elevations if occurred and results in an open-ended 
response that may be used for narrative purposes only. This item is intended to prompt 
participant’s thinking regarding elevations for their own self-awareness.  
A general statement about reliability and validity testing using standard 
psychometric studies was reported for all measures. Testing relevant to Item 1 of the 
GMQ, adopted from the GTQ was conducted with English-speaking (N=62), mean (SD) 
of 4.85 (2.57) and Spanish-speaking (N=142), mean (SD) 4.23 (2.73) participants (Lorig 
et al., 2003; Lorig et al., 2005). A pre-test/6-week/3-month post-test study of a 
community-based, peer-led diabetes self-management program in Spanish-speaking 
(N=109) found improvement in frequency of glucose monitoring at 6 weeks (p <0.05) 
and an increase in mean (SD) days of monitoring of .67 (2.34) over baseline 4.4 (2.7) (p ≤ 
.05) (Lorig & González, 2000).  
The DSES and the PAS, as well as items included in the EBQ +1 and the GMQ 
are all instruments that has been used in chronic illnesses self-management health 
behavior modification and self-efficacy research. These have been described in the theory 
development of the Integrated Theory of Health Behavior Change (ITHBC) and the 
Individual and Family Self-management Theory (IFSMT) (P. Ryan, 2009; P. Ryan & 
Sawin, 2009). 
Participant Demographic Questionnaire (PDQ) and the HP Demographic 
Questionnaire (HPDQ)  
The participant demographic questionnaire (PDQ) and the HP demographic 
questionnaire (HPDQ) collected patient and their maternity HP characteristics, to 




These two questionnaires were completed, primarily by the patient participant, and 
finalized by the researcher or assistants.  
The PDQ is an 11-item instrument that includes three categorical study variables 
used for analysis:  race/ethnicity, previous or family history of GDM/DM, and primary 
language. Race/ethnicity and primary language were selected as they have been found to 
correlate with health behavior modification in previous studies (Anderson, 1999; Street, 
2003; Verlinde, De Laender, De Maesschalck, Deveugele, & Willems, 2012). The 
additional categorical and interval level items were used for descriptive purposes only. 
These include the language that the teaching was conducted in, inquiry into whether the 
patient’s HP is one they preferred for care, age, completed years of education, years in 
the United States, parity, pre-pregnancy and Phase 2 body mass index (BMI), and number 
of HP clinic visits since screening and/or diagnosis.  
The HPDQ, a 9-item questionnaire includes three categorical level items that used 
for correlational analyses and six items that will be used for descriptive purposes. 
Race/ethnicity, gender, and professional specialty were three variables selected for 
analyses. These have been studied previously in health behavior correlational research 
(Anderson, 1999; Street, 2003) as well as have been found to mediate and moderate the 
effects of TFL (Bass & Riggio, 2006). The remaining items include the name of clinic 
and the HP, the language used in conversation/counseling with the patient participant, 
including the use of interpreter services for the interaction, years in practice, and age.  
Pilot Study 
A pilot study was conducted following the approval of Marquette University’s 




instruments modified for use in the study: the MLQ-5X; the SIQ-HP-GDM; and the 
QOII-GDM, in both English and Spanish languages, prior to use in the research project. 
As mentioned previously, the MLQ was modified for use with patients to elicit their 
perception of their HP’s leadership characteristics. The SIQ was modified to eliminate all 
categories of influencers except HPs and to increase the number of subcategories to 
include relevant HP types as well as adapting the perceived beliefs to relate to GDM. The 
QOII was modified to include item language relevant to GDM counseling and HP types.  
Content validity refers to the extent to which an instrument measures what it was 
developed to measure (Lynn, 1986). Content validity for the modified instruments was 
used to assess the relevance and adequacy of the content area sampled (Lynn, 1986), 
ensure appropriateness of use, feasibility, and language proficiency. A pilot study sample 
of five content experts was determined appropriate for establishing content validity 
(Lynn, 1986). A convenience sample of six patient participants were recruited as content 
experts from the primary researcher’s clinical setting. Inclusion criteria were English 
and/or Spanish speaking and literate, and a current or recent diagnosis of GDM within the 
past 12 months. Recruitment of Spanish speakers in addition to English was intended to 
gain insight and establish validity from and for use in populations more vulnerable to 
GDM, such as Latina populations.  Participants were approached following a prenatal or 
postpartum clinic appointment. They were informed of the purpose of the pilot study and 
assured that participation was voluntary. If interested, participants were given a written 
description of the pilot study that included instructions about how to complete the forms 
and language that stated that completion of them, implies consent. Participants were 




GDM, and the QOII-GDM by completing a content validity questionnaire. Their 
suggestions for item modification were also solicited. The content validity questionnaire 
was developed, based on guidelines for the validation of new or modified instruments, as 
described by Lynn (1986). The foci of the content validity questionnaire were on the 
clarity and importance of the instrument items and the appropriateness of content 
regarding GDM counseling and leadership characteristics of their HPs. Content validity 
was conducted and results of the CVI for the MLQ = .67, the SIQ = .90, and the QOII = 
.95.  
Protection of Human Subjects  
Prior to initiating the study, the research proposal detailing procedure from 
recruitment to consenting, to data collection through analyses, was sent to the 
Institutional Review Board (IRB) at Marquette University. Approval was sought 
subsequently from each clinic and participating hospital IRB.  For clinic settings that do 
not have a specific IRB committee or process, the University IRB process and approval 
was reviewed, and permission secured prior to recruiting eligible participants at those 
sites. The University IRB served as the IRB of record for all of the clinic sites. 
Recruitment and data collection were initiated only after permission was granted to 
proceed and IRB approval had been obtained.   
After receiving IRB approval or administrative permission as appropriate to the 
setting, a meeting was arranged with a designated contact person at each site to describe 
the research project purpose and process, including voluntary consent, data collection and 
handling, and the importance of maintaining confidentiality throughout all the stages of 




clinic staff and participants to answer any questions, concerns, or to report any adverse 
risks or effects of recruitment, participation, and involvement.  
As potential participants were identified in the various clinic settings as meeting 
inclusion criteria by clinic staff, their permission to be approached to elicit interest and 
permission to participate in the research study by research staff was solicited. The clinic 
staff notified the research staff of the potential participant’s name and the research staff 
then proceeded with recruitment at the appointment time designated for laboratory 
testing. The recruitment occurred predominantly with permission in an examination room 
or in the laboratory setting prior to or following specimen collection. Introductions were 
made between potential participants and the PI or trained research assistants. The 
recruitment process then involved providing a description of the study and provision of 
consent forms. Health Insurance Portability and Accountability Act (HIPAA) 
authorization for use and disclosure of Personal Health Information was obtained as part 
of the consent process. No data were collected prior to recruitment and consenting.  
Timing and Procedure of Participant Recruitment  
Each potential participant was approached individually by the PI or trained 
research assistants regarding participation in the study when identified as meeting the 
inclusion criteria by clinic staff. The two times that recruitment occurred predominantly 
were correlated to routine GDM screening times during routine prenatal visits based on 
recommendations of the NIH Consensus Guidelines (Vandorsten et al., 2013) and 
generally accepted by ACOG (2013) and the ADA (2014) and which were consistent in 
across the sites. The first time, early gestational GDM testing usually occurs in the first 




prenatal intake appointment, at which time screening for GDM is based on high risk 
indicators for pre-existing DM or early GDM. These factors include obesity with Body 
Mass Index (BMI) > 30, patient personal history of GDM or first degree relative family 
history of DM, or other factors such as BMI > 25 coexistent with other risk factors such 
as history of infant birth weight greater than nine pounds, history of unexplained 
stillbirth, high-risk ethnicity (African-American, Asian-American, Hispanic/Latina, 
Native American, East Indian), history of polycystic ovarian syndrome (PCOS) or 
medical comorbidities, such as hypertension or heart disease. This initial screening 
occurred via laboratory testing of patient blood samples for either a fasting blood sugar, a 
hemoglobin A1c, or a one-hour glucose challenge test (GCT) otherwise called glucose 
load test (GLT) or a glucose tolerance test (GTT) of 50 grams of carbohydrates. Elevated 
results indicating early GDM (often referred to as pre-diabetes) include a fasting blood 
serum level greater than 95 mg/dl, a hemoglobin A1c of greater than or equal to 5.7 or a 
one-hour GLT greater than 200 mg/ dl.  Results from a one-hour GLT greater than or 
equal to 140 mg/ dl, but below 200 mg/ dl, lend to a follow-up diagnostic testing 
recommendation of a series of four blood specimens tested for glucose levels, fasting, 
and in one-hour intervals for three hours following a 100-gm carbohydrate GLT. If two 
of the four results are elevated, the patient is diagnosed as having GDM. Results of a 
fasting blood serum greater than 125 mg/ dl or hemoglobin A1c greater than 6.4 is 
diagnostic for DM.  The second time for routine screening for those pregnant women 
who have not been previously screened nor determined to have high risk factors 
indicating need for earlier screening occurred usually between 24- and 28-weeks 




with a one hour 50 gm GLT and adhere to the same laboratory result recommendations 
previously mentioned. With the diagnosis of GDM or DM, appropriate counseling, 
treatment recommendations, and/or blood sugar monitoring should be discussed either by 
the obstetrical HP and/or the Diabetic Educator/Registered Dietitian team.  
Consent 
 All participants were informed of the study verbally and were then given a 
written informed consent form (Appendix C) to read and sign. The written consent form 
was given in Phase 1 and was intended to cover two phases of data collection, Phase 1 
and 2.  Consent included permission for the researcher or trained research assistants to 
retrieve a minimal amount of information from the patient or staff to complete the PDQ 
and HPDQ only. Verbal confirmation of intention and willingness to participate in Phase 
2 and agreement to be contacted or to coordinate contact with the clinic staff for Phase 2 
participation during a clinic appointment time was solicited during Phase 1. Prior to 
Phase 2 data collection, verbal confirmation in-person was again solicited and obtained. 
Assurance of the voluntary nature of consent was provided at both times of participation, 
as well as permission to withdraw if at any time a participant expressed a desire to do so. 
The patient would have been assured that, whether consenting to or declining to 
participate, there would have been no effect or impact on the patient’s care or relationship 
with the HP or clinic and also reassured that any future involvement was voluntary and 
that if she does not desire to be further involved, there will be no penalty or repercussions 
related to clinic care or otherwise. Appreciation will be expressed for their involvement, 
and confidentiality reassured. Contact information for the PI was provided to the 




occur due to being involved in the study. There were no participants who desired to stop 
the study for any reason 
Data Collection Procedure 
The initial period of recruitment occurred at the time the participant was identified 
as high-risk for GDM, either early gestational age, or at the routine gestational age, but 
prior to receiving diagnosis and counseling by any HP regarding GDM and potential 
health outcomes. The timing of early or routine screening coincided as intended with the 
potential participant presenting to the clinic for lab work, which takes from several 
minutes to over three hours to complete. For many potential participants requiring 
extensive laboratory testing time, this was determined and found to be an ideal and 
appropriate time to recruit participants. The study was described to the potential 
participant. If expressing interest in participating, the participant was asked to sign a 
written consent form. The study data was collected in the prenatal clinic during the office 
visit or laboratory testing appointment for Phase1. Following the consenting process, the 
PDQ, the EBQ+1 and the PAS were given to the participant to complete. These 
documents were available in English and Spanish. The coded instruments and 
questionnaires were assigned a study ID number (coded). A separate document is being 
kept by the PI that links the study ID number to identifying information, specifically 
name, date of birth and phone number. Once the instruments were completed by the 
participant, they were placed in a sealed envelope with the matching study ID number on 
the outside. The participants were notified that would be contacted for a second round of 
data collection, Phase 2, in the third trimester of pregnancy and asked their preferred 




assigned to a control group (non-GDMs) while those who are diagnosed with GDM will 
be assigned to the study group (GDMs). This diagnosis was determined by the HP based 
on the blood glucose results. Blood glucose results were obtained from clinic staff 
responsible for laboratory result follow-up as well confirmation of diagnosis, who then 
contacted and relayed the information to the PI for control versus study group 
assignment.  
Phase 2 data collection occurred at approximately 34-36 weeks gestational age. 
For the GDM group, this occurred minimally, 8-10 weeks following GDM diagnosis, 
counseling, and a series of repeated visits with maternity HP and/or diabetic nurse-
educator/Registered Dietitian team. The participant preferred contact information was be 
used to schedule Phase 2 data collection. Data collection for Phase 2 for the GDM group 
occurred in-person at the prenatal clinic during the routine office visit that takes place at 
that time. Contact with the participant or permission to contact the clinic staff to 
determine appointment time was obtained. Control group (non-GDMs) participants were 
given the option of being contacted for Phase 2 data collection by phone or completing in 
the clinic at a routinely schedule prenatal appointment. The majority completed during 
their routinely schedule appointment.  
During Phase 2, the GDM group participants completed the HPDQ, the MLQ the 
SIQ, the QOII, the DSES, the GMQ as well as repeated the EBQ+1, and the PAS (Figure 
1). Appreciation was expressed and at the conclusion of this second phase, participants 
received a compensation gift in the form of a gift card to area department or grocery store 




the HPDQ, the PI or trained research assistants collected the additional information from 
the medical staff, thus completing the data collection.  
Data Protection and Anonymity 
Vigilance to data protection and maintaining confidentiality was initiated at 
recruitment and throughout data collection and analysis. Consent forms and completed 
data collection forms were sealed immediately in an envelope coded with a study 
identification (ID) number and transferred to the PI by trained research assistants as soon 
as possible. The Study ID code was linked to each participant’s contact information, 
name, and date of birth using a master file, both in the form of a secured password-
protected flash drive and a hardcopy spreadsheet. The Study ID code was placed on all 
data collection forms needing completion for Phase 2. As was the case for Phase 1, once 
the data forms have been completed by the participant, verified for thoroughness by the 
research assistant or PI and additional data recorded, the forms were placed in a coded 
envelope and transferred to the PI. All data entry occurred in a private office at the PI’s 
home. The data is stored on a password-protected flash drive, along with the hard-copy 
master file and all forms are kept in a locked file cabinet in a locked office in the PI’s 
home at all times except during data entry. Data is retained in a de-identified format after 
the completion of the study. All identifiers on hard copy and electronic files were 
destroyed or erased.  
Data Analyses 
 Data Preparation  
Data was entered, and analyses conducted using Statistical Package for Social 




evaluated for missing or incomplete values as well as for distributions and outliers. Plans 
were in place to replace with substitution of means of scale items if there was less than 
20% of the responses missing on an individual questionnaire which had responses and if 
greater to use listwise deletion, however there were no cases of data missing on any 
questionnaire except for the MLQ and not greater than 20%.  
Data Analyses 
Due to the purpose and correlational exploratory design of this research, the 
overall focus of analyses was to explore for relationships among the study variables using 
correlation models. In addition to correlations models, comparative difference models of 
analysis between GDM and non-GDM over two time periods during the pregnancy 
addressed whether health behavior modification of healthy eating and PA occurred in 
pregnancy with and without a GDM diagnosis. It is important to note that because of the 
exploratory nature of the analysis and the small sample size, several considerations were 
necessary. Multiple analyses were conducted with limited number of variables per 
analytic model as the sample size would not support larger more complex multivariate 
modeling such as structural equation modeling. The level of significance criterion was 
relaxed to p≤ .10 to preserve analytic power and to provide the opportunity for 
relationships to emerge as significant, that could be studied and with larger samples in the 
future. The limitations of this approach are discussed in the “strengths and limitations” 
section.  
Descriptive and inferential statistics were used for analytic purposes to address 
the aims of this research project. As an initial step, descriptive statistics, primarily 




tendency, such as means and standard deviations, were used for interval variables to 
describe the sample demographic characteristics of the participant such as race/ethnicity, 
primary language, age, history of GDM/DM as well as the HP characteristics such as 
gender, race/ethnicity, age, and HP specialty.  
The methods used for inferential analyses for each of the study aims included 
include both univariate and multivariate analyses using multiple linear regression and 
analyses of covariance (ANCOVA) to analyze paths identified in Figure 2 and listed in 
Table 2. Multiple regression analyses are useful to explain the interrelationships among 
multiple variables, to examine the contribution of each independent variable (IV to the 
dependent outcome variable (DV) (Mertler & Vannatta, 2002; Munro, 2001). The 
purpose of ANCOVA was to determine group differences while controlling for the effect 
of one or more variables (Mertler & Vannatta, 2002). Repeated measures were integrated 
into the ANCOVA analyses to measure group mean differences over time (Munro, 2001).  
The first step following data collection and prior to analyses was to employ data 
screening methods to detect potential data problems, such as data entry errors, missing 
values, possible outliers, and non-normal distributions (Odom & Henson, 2002).  
Depending on the type of analysis, assumptions were examined to ensure there were no 
violations of linearity, normality, homogeneity of variance, homoscedasticity, and 
multicollinearity (Mertler & Vannatta, 2002; Munro, 2001).  Examination of residential 
scatterplots, correlation coefficients among IVs, or variance inflation factor (VIF) were 
conducted for multiple linear regressions (Tabachnick & Fidell, 1996; Mertler & 
Vannatta, 2002). For repeated measures ANCOVAs, this can be accomplished with 




and the Levene’s test for homogeneity of variances (Mertler & Vannatta, 2002; Munro, 
2001). The variables and predetermined analysis are described for each hypothesis to be 





 Table 2: Research Analyses 
Hypothesis (H)/ 
Research Question (RQ)  
Level of 
Measure 
Method of Analyses Gpower Sample Size Estimate 
H1) HPI, specifically, SIQ 
and QOII will be positively 
correlated with an 
improvement in HE, an 
increase in PA, and 
adherence to GM 
recommendation behaviors 




Multiple Linear Regressions: 
8 separate regression models for 
each of the 8 DVs: health 
behaviors (3 HE, 2 PA, and 3 
GM)  
2 IVs: HPI (SIQ composite 
score, QOII total score)  
F tests – Linear multiple regression: 
Fixed model, R² deviation from zero  
Analysis: A priori: Compute required 
sample size  
Input: 
Effect size f² = 0.15 
α err prob = 0.1 
Power (1-β err prob) = 0.8 
Tested predictors = 2 
Output:   
Noncentrality parameter λ = 8.1000000 
Critical F = 2.4097449 
Numerator df = 2 
Denominator df = 51 
Total sample size = 54 
Actual power = 0.8014124 
H2) Patient factors, 
specifically, race and 
language concordance and 
a personal/family history 
GDM/DM (GDMPFH) 
will have a moderating 
effect on the relationship 
between HPI, specifically, 
SIQ and QOII, and HE, 
PA, and GM monitoring 
behaviors in women with 







Multiple Linear Regressions  
In each step: Separate 
regressions for each of the 8 
DVs: health behaviors (3 HE, 2 
PA, and 3 GM) 
Step 1: on 2 IVs: HPI (SIQ 
composite score, QOII total 
score) 
Step 2: separately on each of 3 
Moderating Variables: patient 
factors (race concordance, 
F tests – Linear multiple regression: 
Fixed model, R² deviation from zero 
Analysis: A priori: Compute required 
sample size  
Input: 
Effect size f² = 0.15 
α err prob = 0.1 
Power (1-β err prob) = 0.8 
Tested predictors = 5 
Output: 





be stronger with race 
concordance, primary 
language concordance and 
with a positive GDMPFH 
language concordance, and 
GDMPFH)  
Step 3: separately on the 
interaction term between each of 
the 3 Moderating Variables: 
patient factors (race 
concordance, language 
concordance and GDMPFH) and 
the 2 IVs: HPI (SIQ composite 
score, QOII total score) 
Critical F =1.9325887 
Numerator df =5 
Denominator df = 69 
Total sample size=75 
Actual power = 
0.8031994 
H3) HP factors, 
specifically, gender 
concordance, HP specialty 
and HP leadership style 
(MLQ) will have a 
moderating effect on the 
relationship between HPI, 
specifically, SIQ and QOII, 
and HE, PA, and GM 
behaviors in women with 
GDM; the relationship will 
be stronger with gender 
concordance, and HP 
transformational leadership 
style (MLQ) but not differ 
based on HP specialty. 







Multiple Linear Regressions  
In each step: Separate regression 
for each of the 8 DVs: health 
behaviors (3 HE, 2 PA, and 3 
GM)  
Step 1: on 2 IVs: HPI (SIQ 
composite score, QOII total 
score)  
Step 2: Separately on each of the 
3 Moderating Variables: HP 
factors (gender concordance, HP 
specialty; HP leadership style 
(MLQ)   
Step 3: separately on the 
interaction term between each of 
the 3 Moderating Variables: HP 
factors (gender concordance, HP 
specialty; MLQ) and   the 2 IVs: 
HPI (SIQ composite score, QOII 
total score)  
F tests – Linear multiple regression: 
Fixed model, R² deviation from zero 
Analysis: A priori: Compute required 
sample size  
Input: 
Effect size f² = 0.15 
α err prob = 0.1 
Power (1-β err prob) = 0.8 
Tested predictors = 5  
Output: 
Noncentrality parameter λ= 
11.2500000 
Critical F =1.9325887 
Numerator df =5 
Denominator df = 69 
Total sample size=75 





H4) Patient self-efficacy 
will have a mediating 
effect on the relationship 
between HPI specifically, 
SIQ and QOII) and HE, 
PA, and GM behaviors in 





 Multiple Linear Regressions 
Primary analysis (Baron & 
Kenny, 1986) 
1. Regressing the Mediating 
Variable: DSES on each of 
the 2 IVs: HPI (SIQ 
composite score and QOII 
total score  
2. Separately regressing the 8 
DVs: health behaviors (3HE, 
2 PA, and 3 GM) on 2 IVs: 
HPI (SIQ composite score 
and QOII total score  
3. Separately regressing 8 DVs: 
health behaviors (3 HE, 2 
PA, and 3 GM) on 2 IVs: 
HPI (SIQ composite score 
and QOII total score and the 
Mediating Variable: DSES  
Secondary analysis: (Preacher 
& Hayes, 2008)  
Estimate the relative total and 
indirect effects of IV: HPI (SIQ 
and QOII total score) in 
separate equations on 8 DVs 
(health behaviors: 3 HE, 2 PA, 
and 3 GM) through the 
Mediating Variable: DSES  
Generates bootstrap percentile 
or Monte Carlo confidence 
intervals for indirect effects 
F tests – Linear multiple regression: 
Fixed model, R² deviation from zero 
Analysis: A priori: Compute required 
sample size  
Input: 
Effect size f² = 0.15 
α err prob = 0.1 
Power (1-β err prob) = 0.8 
Tested predictors =3 
Output: 
Noncentrality parameter λ=9.3000000 
Critical F=2.1807273 
Numerator df =3 
Denominator df = 58                
Total sample size= 62 





MEDIATE Y= health 
behavior/X=HPI (SIQ 
composite score and 
QOII/M=DSES   
RQ1a)  
Were there differences in 
patient engagement in 
health behavior 
modification of HE and PA 
as a result of time (Phase 1, 
during screening and Phase 
2, near the end of 
pregnancy) or diagnosis of 
GDM: control group: non-
GDMs and study group: 
GDMs?    
 
RQ1b) Were there 
differences in patient 
engagement in health 
behavior modification of 
HE and PA as a result of 
time (Phase 1, during 
screening and Phase 2, near 
the end of pregnancy) or 
diagnosis of GDM: control 
group: non-GDMs and 
study group: GDMs when 







Comparative Model:  
One-way repeated measures 
ANCOVA  
Separate analyses for each of  
5 DVs: health behaviors (3 HE 
and 2 PA) 
Two different times (Phase 1 and 
2) 
IV: 2 Groups: study: GDMs and 
control group: Non-GDMs 
Covariates: patient factors  
(race/ethnicity, primary 
language, personal/family 
history of GDM/DM)  
 
F tests – ANOVA: Repeated measures, 
within-between interaction  
Analysis: A priori: Compute required 
sample size  
Input: 
Effect size f² = 0.25 
α err prob = 0.1 
Power (1-β err prob) = 0.8 
Number of groups = 2 
Number of measurements = 2 
Correlations among rep measures = 0.5 
Nonsphericity correction = 1 
Output: 
Noncentrality parameter λ=7.0000000 
Critical F=2.9091325 
Numerator df =1.0000000 
Denominator df = 26.0000000                
Total sample size= 28 










Research Aim 1/Hypothesis 1 
Research aim 1 was to determine if HPI was associated with patient engagement in health 
behavior modification of HE, PA and GM monitoring in women with GDM. To test the 
hypothesis that HPI will be positively correlated with an improvement in HE, an 
increased in PA, and adherence to GM recommendation behaviors in women with GDM, 
a multiple linear regression model was selected (Mertler & Vannatta, 2002). All measures 
were interval level. A separate multiple linear regression equation was analyzed for each 
of the eight DVs, health behaviors. Three DVs relate to HE measured by the EBQ+1. 
Two related to PA, measured by the PAS. Three related to GM, measured by the GMQ. 
The IVs, HPI, measured by the SIQ composite score and the QOII total score were 
entered simultaneously into the analysis for each of eight DVs. A secondary analysis 
followed the same steps with three IVs, including the SIQ composite score and a two 
QOII-GDM “content received” and “delivery” subscale scores instead of the one QOII 
total score.  The decision was made to retain analyses with the QOII total score as there 
were some concerns including multicollinearity issues with the subscale scores. 
Research Aim 2/Hypothesis 2 
Research aim 2 was is to determine if patient characteristics moderated the 
relationship between HPI and patient engagement in health behavior modification of HE, 
PA, and GM in women with GDM. The hypothesis states that patient factors, 
specifically, race concordance, primarily language concordance and a personal/family 
history GDM/DM (GDMPFH) will have a moderating effect on the relationship between 
HPI, specifically, SIQ and QOII, and HE, PA, and GM behaviors in women with GDM; 




and with a positive personal/family history of GDM/DM (GDMPFH). A moderating 
variable is generally accepted to be a descriptive characteristic that can affect the strength 
or direction of the relationship between the IV and the DV (Baron & Kenny, 1986). For 
this analysis, the IV, HPI was measured by the SIQ composite score and the QOII total 
score, both, interval level. The moderating variables include three patient factors (race 
concordance, language concordance and GDMPFH) contained in the PDQ and are all 
categorical level. The eight DV health behaviors (three relate to HE, two related to PA 
and three relate to GM) measured by the EBQ+1, the PAS, and the GMQ, respectively, 
are all interval level.  
Using a multiple regression model, separate regressions were run on each step of 
the three-step process for each of the eight DVs.  In the first two steps, the eight DV 
health behaviors were regressed separately on the two IVs of HPI and on the three 
moderating variables, patient factors for a total of 40 regressions equations. Each of the 
patient factors are categorical level dichotomous variables: race concordance 
(Concordance/Discordant), primary language concordance (Concordance/Discordant), 
and personal/family history of GDM/DM (Yes/No). In the third step, the eight DVs, 
health behaviors were separately regressed on an interaction term between each patient 
factors and each of the two IVs of HPI to determine if there is a moderating effect, for a 
total of 48 additional regressions. In this latter step, if the regression results were 
significant, the moderating hypothesis would be supported. A secondary analysis using 
the same steps above included all the same variables listed however, using three IVs, the 
SIQ score and two QOII “content received” and “delivery” subscales instead of the QOII-




website (Preacher, Curran, & Bauer, 2006). The decision was made to retain analyses 
with the QOII total score only as there were some concerns including multicollinearity 
issues with the subscale scores. 
Research Aim 3/Hypothesis 3 
Research aim three was to determine if healthcare provider characteristics 
moderate the relationship between HPI and patient engagement in health behavior 
modification of HE, PA, and GM in women with GDM. The hypothesis states that HP 
factors will have a moderating effect on the relationship between HPI and HE, PA, and 
GM behaviors in women with GDM; the relationship will be stronger with gender 
concordance and HP transformational leadership style (MLQ) but not differ based on HP 
specialty. The IV, HPI, measured by the SIQ composite score and the QOII total score, 
were both at interval level. The moderating variables include three HP factors (gender 
concordance, HP specialty) measured by the HPQ and the leadership characteristic 
measured by the MLQ, all categorical levels.  The eight DV health behaviors (three relate 
to HE, two relate to PA, and three relate to GM) are measured by the EBQ+1, the PAS, 
and the GMQ, respectively and all are interval levels.  
Using a multiple regression model, separate regressions were run in each step of 
the three-step process for each of the eight DVs. In the first two steps, calculating main 
effects, each of the eight DVs, health behaviors were regressed separately on the two IVs 
of HPI and on each of the three moderating variables, HP factors for a total of 48 
regressions. Each of the HP factors are categorical dichotomous variables: gender 
concordance (Yes/No), HP specialty (nurse-midwife/physician) and leadership 




effect, the eight DV health behaviors were separately regressed on an interaction term 
between each of the four HP factors and each of the IVs of HPI to determine if there is a 
moderating effect for an additional 48 regressions. If in this latter step, the regression 
results were significant, the moderating hypothesis would be supported. A secondary 
analysis using the same steps includes all the same variables but with three IVs, the SIQ 
score and two QOII “content received” and “delivery” subscales instead of the QOII 
score. To explore interaction patterns, simple slope tests were conducted with the use of 
Preacher’s website (Preacher, Curran, & Bauer, 2006). The decision was made to retain 
analyses with the QOII total score only as there were some concerns including 
multicollinearity issues with the subscale scores. 
Research Aim 4/Hypothesis 4 
In addition to the exploration of the moderating effects of patient and HP factors 
on the relationship between HPI and health behavior modification, it was important to 
explore the mediating effect of patient self-efficacy on that same relationship as well. The 
fourth research aim was to determine if self-efficacy mediated the relationship between 
HPI and patient engagement in health behavior modification of HE, PA, and GM in 
women with GDM. This addressed whether the degree of self-efficacy (either higher or 
lower) affects the relationship between HPI and health behavior modification differently.  
In general, a mediating variable reflects a transformative process within a 
participant that intervenes between the IV and the DVs and is said to account for the 
relation between the IV and the DVs (Baron & Kenny, 1986). To test the hypothesis that 
there will be a mediating effect of patient self-efficacy on the relationship between HPI 




level of measurement and address several conditions to conduct multiple linear 
regressions. All the levels of measurement were interval for this analysis. Assumptions 
when doing multiple regressions with mediating variables are that there is no 
measurement error in the mediator, although this is virtually impossible as mediators are 
often, as in this case, an internal psychological variable, likely to be measured with error 
(Baron & Kenny, 1986). Another assumption is that the DVs do not cause the mediator 
(Baron & Kenny, 1986). Conditions that must be met are that variations in HPI 
significantly account for variations in self-efficacy, variations in self-efficacy 
significantly account for variations in health behavior modifications and when variations 
in HPI on self-efficacy and variation in self-efficacy on health behavior modifications are 
controlled, a previously significant relation between HPI and health behavior 
modification is no longer significant (Baron & Kenny, 1986). 
This multiple regression model involved a three-step process testing separate 
coefficients for each regression equation. The first step involved regressing the mediating 
variable, self-efficacy, measured by DSES on the IVs, HPI, measured by the SIQ and the 
QOII total score, entered separately.  For self-efficacy to function as a mediator, HPI 
must be shown to correlate with self-efficacy. The second step involves eight separate 
regressions equations for each of the eight DV health behaviors, three HE, two PA, and 
three GM, measured by the EBQ+1, the PAS, and the GMQ on HPI. A prerequisite to 
mediation by self-efficacy was that HPI must affect the health behaviors. The third step 
involves regressing each of the eight DV health behaviors on the combined IVs, HPI and 
the mediating variable, self-efficacy, wherein self-efficacy must affect the health 




steps and include all the same variables but with three IVs, the SIQ score, and two QOII 
“content received” and “delivery” subscales instead of the QOII-GDM total score. The 
decision was made to retain analyses with the QOII total score only as there were some 
concerns including multicollinearity issues with the subscale scores as well as increased 
risk for error with an added variable.  
A further analysis was conducted to estimate the relative total and indirect effects 
of the IVs: HPI (SIQ and QOII total score) in separate equations on 8 DVs (health 
behaviors: 3 HE, 2 PA, and 3 GM) through the mediating variable: self-efficacy (DSES).  
This analysis generated bootstrap percentile or Monte Carlo confidence intervals for 
indirect effects using the equation: MEDIATE Y= health behavior/X=HPI (SIQ-HP-
GDM composite score and QOII-GDM)/M=DSES (Preacher & Hayes, 2008).  
Research Aim 5/Research Questions 1a/1b 
The fifth aim was to determine if there were differences in the pattern of patient 
engagement in HE and PA during pregnancy for women with and without a GDM 
diagnosis. 
To address this aim, the research question asks, “were there differences in patient 
engagement in health behavior modification of HE and PA over time (Phase 1, during 
screening and Phase 2, near the end of pregnancy) or diagnosis of GDM (control group: 
non-GDMs and GDMs)?” A mixed design, repeated measures ANCOVA addressed this 
two-part question inquiring into the between two groups and within each group 
differences at two times in the pregnancy. ANCOVA combines analysis of variance 
(ANOVA) with regression to measure differences among group means (Munro, 2001). 




groups, the control group (non-GDMs) and the GDM group, five DV health behaviors 
(three HE and two PA), measured by the EBQ+1 and the PAS, all interval level, and 
three covariates, patient factors (race/ethnicity, primary language, personal/family history 
of GDM/DM), measured by the PDQ, all categorical level. Separate equations were run   
for each of the five DVs, and include the IV and the three covariates, for mean 
differences between the GDM and non-GDM groups over time (Phase 1 and Phase 1). 
The third health behavior outcome, glucose monitoring was only measured in Phase 2 as 
it is not relevant to Phase 1 and thus was not be included in this analysis.  
Methodological Rigor 
 To strive for methodological rigor, it was imperative to carefully design and 
describe a research protocol and policies that addressed the many elements of a research 
project with integrity, legitimacy, soundness, validity and feasibility. To confirm 
methodological rigor, it was imperative to evaluate the appropriateness of the research 
design and selection of method in answering the research question, address internal and 
external validity threats, and provide an overall assessment of the strengths and 
limitations of the research design and methods, instruments, and analyses. 
The research design was appropriate for research inquiries involving cognitive, 
behavioral and social factors of participants and HPs and the outcomes of health behavior 
modification. The correlational design has been used in similar research inquiries 
involving one or multiple concepts of social influence, self-efficacy, and health behavior 
modification. It was designed as an initial exploration into the concept of HPI, testing of 
a recently developed conceptual model, and the association of HPI with patient health 




legitimizing the need for the inquiry. The design provided a solid approach to initiating 
the understanding of how HPs influence patient health behavior modification and thus 
how to increase this process toward overall improved health status. Quantitative 
methodology supported this research designed to describe associations between HPI and 
health behavior modification as well as exploring additional potential patient and HP 
factors that modifying that relationship. A non-experimental correlational design is 
appropriate for the exploration of associations, prior to implementation of any future 
intervention studies. However, this design also carried with it, potential threats to internal 
and external validity.  
Strengths and Limitations of the Research Design, Methods, and Measures 
Several measures were taken to increase the strength and reduce threats to 
external and internal validity. External validity relates to the how well the research design 
reflects the research question whereby research findings can be generalized to the 
populations and settings (Hulley, 2007; Polit & Beck, 2008). Internal validity is related to 
how well the implementation of the study reflects the research plan and whether the 
results are attributable to the IVs or other unrelated factors (Polit & Beck, 2008).  
Design 
This correlational exploratory research design was appropriate to conduct initial 
validity testing of the newly developed HPI conceptual model. It was a first step in a 
process to collect data and information to contribute to the understanding of the process 
wherein HPs influence patient health behavior modification, describe more fully the HP 




eventual development of future exploratory and intervention studies.  The sample, 
measures and analyses are described separately following the discussion of the design.  
Using a control group provided strength to the design, as it allowed for the 
comparison between those who were diagnosed versus those who were not diagnosed 
with GDM. It considered that health behavior modification might occur because of 
pregnancy alone. There are several possible design limitations. The first was the use of 
quantitative methods as the sole methodology. Although this method is pertinent to post-
positivist philosophy, the use of qualitative methods could enrich the values-component 
included in this paradigm. Following initial exploration of the relationships among 
variables in this quantitative study, future studies should include a more robust mixed 
methods approach to increase the depth and richness of data that leads to a better 
understanding of the association between the concept of HPI and health behavior 
modification. Another possible limitation impacting the results and reflecting a threat to 
internal validity come from a threat of maturation, the effect that the naturally occurring 
process of time has on participants and outcomes (Polit & Beck, 2008). There is some 
concern that time, or time-related factors present a threat to validity. The longer a 
participant is enrolled in the study, such as in the case of early pregnancy versus mid-
pregnancy diagnosis of GDM, the more it could impact health behavior modification. In 
addition, greater time could have allowed influences for behavior modification, apart 
from HPI.  However, it is important to remark that time, including the duration and 
frequency of contact with the HP, is contributory to the relationship and included in the 





There are several strengths related to the sample. Participants were recruited 
based on predetermined inclusion and exclusion criteria. They were recruited from 
various healthcare clinical settings and institutions, with various types and specialties of 
HPs and includes both English and Spanish-speakers. This was intended to provide for a 
clinically and demographically diverse participant sample, to represent the target 
population well (Hulley, 2007), and to explore diverse HP-patient relationships with 
different HP specialties. The intentions with these sample considerations were to increase 
accuracy of estimations, decrease bias and homogeneity, and thus add to the design 
strength. A limitation related to sample selection includes the use of convenience 
sampling. This could also contribute to the opposite effect listed previously, wherein the 
sample was not representative of the population demographics. 
Adequacy of sample size estimation is an important criterion for internal validity. 
Power analysis was used to determine a samples size a priori. An acceptable power 
criterion of .80 was selected. A moderate effect size was predetermined, which is one of 
the most important elements of the power analysis and may contribute more to the 
clinical and practical significance of the results than could be achieved by the statistical 
significance. Additionally, adding to the precision of the estimate was the decision to 
recruit and collect and review data until it is determined that the sample size estimate was 
achieved for analyses purposes, even if data collection resulted in greater than the sample 
size calculation (Hulley, 2007), albeit overall recognizably small in relation to the 
number of variables to be explored.  
A limitation that could result in an increased risk of type 1 error related to the 




a family wise error rate resulting from conducting multiple linear regressions for several 
hypotheses. Statistical significance alone is insufficient as a criterion for behavioral 
research and was selected based on the feasibility of recruiting participants in a timely 
manner, albeit a lower level which inherently may limit the findings (Thompson, 2002). 
This decision was based on the relatively infrequent occurrence of GDM among 





Measures to ensure validity included standardized and consistent training of 
research assistants in recruitment criteria and procedures, consenting, and procedures for 
data collection and ensuring quality and completeness of data based on the understanding 
that the results of the analyses are only as good as the reported data (Hulley, 2007; 
Mertler & Vannatta, 2002). The decision to thoroughly train research assistants in 
recruitment as well as in consistent face-to-face data collection methods while providing 
continuous access to the PI occurred and contributed to design strength on several levels 
as well as decreasing random measurement or systemic error. These include an increase 
in the accuracy, thoroughness, and usefulness of the data responses for analyses both by 
decreasing potential response bias in the event the PI is the exclusive recruiter and data 
collector but also by increasing the ability to review forms following completion, return 
immediately for missing data or to assist with instruction or clarification (Hulley, 2007). 




missing data, increased adherence to maintaining confidentiality, and provided for 
assurance to participants and subsequently retention and participation in Phase 2 of the 
study. Missing data and retention did not present as concerns. There was an overall lost to 
follow-up in both the control and the study group of 7%. Involving clinic staff in 
identifying potential participants was beneficial as it increased staff interested and their 
willingness to recommend participants. Likewise, it did appear to increase the trust of the 
participants and increase their willingness to participate, while preventing attrition and 
loss to follow-up, which often present as threats in longitudinal studies.  Additional 
strengths relate to the timing of data collection which eliminated any inconvenience 
related to financial or transportation burden was facilitating recruitment and participation 
at times the participant participated in routine receiving prenatal care. Burdens and 
possible limitations related to data collection involving multiple clinic settings did require 
an increased need for organization, training, and persistence on the part of the PI for 
adequate and appropriate participant recruitment and reimbursement however it also 
increased the diversity of the sample. An additional limitation is possible due to the 
option of a different data collection method, via phone, for Phase 2 for the control group 
participants. This was a seldom selected option.  
Measures 
To increase precision and accuracy of findings and to reduce measurement 
systematic error, several factors to strengthen the design were considered. Each 
instrument was scrutinized prior to selection for relevance to content, fit with study 
purposes, prior use in similar research projects, level of measurement, and strong 




previous self-management health behavior modification research with DMs. All the 
variables are measured with interval level of measurement except the moderating 
variables. Reliability and validity have been reported for the instruments overall and 
many have been tested and used with similar and diverse populations, except for those 
modified for this research. However, the three instruments that were modified underwent 
a pilot study testing for content validity prior to implementation in the study to determine 
relevance, clarity and comprehensiveness by content experts. Content validity was 
evaluated by both English and Spanish speakers to gain insight and establish validity for 
the study population. All the instruments are available in English and Spanish, including 
those that were translated and back translated by certified medical interpreters for the 
purposes of this study. Competent translation reduces random measurement and systemic 
error that occurs with response variation and results in accurate results when item 
confusion or lack of clarity in wording or content is addressed (Hulley, 2007).  
Most of the instruments impose little participant burden as they were brief and 
easy to understand. Instrument options that were disregarded included multiple day food 
diaries or logs that would have been relevant but bear the risk of reporting errors or recall 
regarding portion sizes, types of foods, forgotten foods or beverages which could be 
significant, and thus deemed unsuitable. In addition to potential inaccuracies, they are 
cumbersome for the participant and time-consuming for analyses for the researcher. 
Those types of instruments might be better used in the clinic setting for counseling 





Several possible limitations are measure-related. Most of the instruments are 
completed by the participants, and all the health behavior modification outcomes 
measures are self-reported. While there are limitations to using self-report measures, they 
can also be the useful and provide an insight to the self-perception of a participant’s 
behaviors, which is an overall facet to this research (P. Ryan, 2009). Habitual responding 
might also occur wherein the participant may get into a pattern of responding without 
considering the questions, especially when they are somewhat repetitive. One instrument, 
the MLQ did lacks brevity, although it is shorter that previous versions, and has been 
used reliably with large samples, in multiple languages and cultures and with populations 
having literacy levels below its designated level.  Regarding instrument modifications, 
the MLQ, it had never been used in the clinical setting for patient evaluation of HP 
characteristics. As a result, it may not be the most appropriate instrument for this 
purpose. However, a review of the literature fails to result in any other option for this 
specific purpose of patient evaluation of HP influence. Future replication and uses with 
this modified instrument will be necessary to establish reliability and validity.  
Analyses  
There are several strengths of the selected analyses. One is the use of repeated 
measures ANCOVA which removes added sources of variance before comparing group 
means, thus decreasing error, increasing power, and requiring a smaller sample (Munro, 
2001). Multivariate analysis in final regression pathways adds strength to the analyses. 
Multiple variables increase the amount of variance accounted for in the DV, which will 
increase the accuracy of a prediction (Munro, 2001). Multiple regression is described as 




variables, as well as numerous independent and dependent variables simultaneously 
(Munro, 2001). This allows for a more holistic and comprehensive understanding, and 
possible identification of interconnected relationships between variables. The exploration 
into the relationships between variables may result in findings that reflect the complexity 
of the human mind or a set of behaviors that often do not exist in isolation but rather may 
affect or be affected by several variables that even with the increased potential for errors 
might not have been considered prior to analyses (Mertler & Vannatta, 2002).  Secondary 
analyses are planned to test several of the hypotheses using additional IVs, which may 
provide relevant information for future research.  
Due to the limited availability of participants and feasibility for this study, the 
sample size was small overall. One of the major limitations of analyses with a smaller 
sample is the need to run multiple linear regression models for several of the hypotheses, 
one for each of the moderating variables and for each of the DVs for each research 
hypotheses instead of an alternative, for example, structural equation modeling. These 
multiple analyses of the same sample data increase the risk of Type 1 error, with 
possibility for a robust family size error, thus finding a significant effect in one or more 
of the multiple analyses that can be in fact a spurious finding. In this exploratory study, 
no correction for multiple comparisons is included. Another limitation involves 
categorical levels of measurement when conducting multiple regression models. As much 
as was possible, instruments with higher level interval measurement were selected for 
analyses purposes as well as to increase precision, accuracy and resultant generalizability 
of inferences (Hulley, 2007). Another possible limitation is that the p value criterion is 




and additionally, this is intended to allow for possible associations to emerge for future 
more in-depth analyses with larger samples.  
Summary 
Identifying gaps in the healthcare research literature regarding the process of how 
HPs influence patient self-management of health behavior modification in women 
diagnosed with GDM resulted in formulating a research purpose and proposal to begin 
addressing this health promotion concern.  The research purpose, five aims and related 
hypotheses or question were all described. The predictor and outcome variables were 
delineated as well as the instruments used to measure the variables and their levels of 
measurement. The instruments were described in detail, including the rationale for the 
selection of these instruments and reported reliability and validity. Modifications made to 
the original instruments for use in this study were pilot tested to establish content validity 
to determine if the modified content was appropriate for the study population. The plan 
and process for implementing the research project including estimating the sample size, 
recruitment of the sample, protection of the participants and data, seeking IRB approval, 
participant consenting, and procedure for data collection were detailed.  Data analyses, 
including the selection of the appropriate test, adherence to methodological rigor and 
minimizing error or bias were described. The research design and methodology were 
thoroughly planned to address the study aims with the intention of understanding the 
process and components of how HPs influence patient health behavior modification in 




Chapter 4: Results 
 
 
The majority of the results of this research study is presented in a manuscript 
titled “Healthcare Provider Influence on Health Behavior Modification in Gestational 
Diabetics (“Appendix E). The manuscript includes the details of the descriptive statistics 
and characteristics for the research study participants as well as the psychometric 
properties of the study instruments used. Additionally, a description and discussion of the 
analyses of four research aims including Hypotheses 1-3 and an additional research 
question are reported, clinical practice implications, future research recommendations, 
and a conclusion.  One hypothesis and two research questions not reported in the 
manuscript are presented in this chapter.  
Hypothesis 4 and Research Questions 
1) Hypothesis 4 states that patient self-efficacy will have a mediating effect on the 
relationship between HPI specifically, SIQ and QOII and healthy eating, physical activity 
and glucose monitoring behaviors in women with GDM. 
2) The research questions were: a) Are there differences in patient engagement in 
health behavior modification of healthy eating and physical activity as a result of time 
(Phase 1, during screening and Phase 2, between 34-36 weeks gestational age) or 
diagnosis of GDM (control group: non-GDMs and study group: GDMs) and b) are there 
differences in patient engagement in health behavior modification of healthy eating and 
physical activity as a result of time (Phase 1, during screening and Phase 2, between 34-
36 weeks gestational age) or diagnosis of GDM (control group: non-GDMs and study 
group: GDMs)when adjusting for three covariates: race/ethnicity, primarily language and 






Following data collection and prior to analyses, data cleaning was conducted to 
detect and resolve data problems, such as data entry errors, missing values, possible 
outliers, and non-normal distributions (Odom & Henson, 2002). Correlation analyses 
were computed using Pearson’s r for interval level data, point biserial for categorical to 
interval level and chi-square for categorical to categorical level data.   
To address Hypothesis 4, regression analyses were conducted separately for two 
healthcare provider types: the maternity healthcare provider (HP) and the diabetic nurse-
educator (DE). Separately, each of the eight health behavior outcomes: three healthy 
eating (HE1, HE2, and HE3), two physical activity (PA1 and PA2 and three glucose 
monitoring (GM1, GM2, and GM3) were regressed onto the HPI measures, SIQ and 
QOII for the HP. Second, self-efficacy (DSES) score was regressed onto the same HPI 
measures. The eight health behavior outcomes were regressed onto DSES score and 
lastly, the eight health behavior outcome scores were regressed onto the HPI measures 
and DSES score. This process was repeated for the HPI measures for the DE.  
Paired t-tests were used to measure the within group differences at two different 
times, Phase 1 to Phase 2 for control (non-GDM) and the study (GDM) group. One-way 
repeated measure analysis of variance (ANOVAs) compared the control and the study 
groups outcome change scores for the three HE and two PA outcomes at Phase 1 and 
Phase 2 for group differences. Analysis of covariance (ANCOVAs) analyzed the variance 




language, referred to as language, and personal/family history of GDM/DM, referred to 
as GDMPFH) in the outcome scores for the same five outcomes.  
Prior to regressions and ANCOVA analyses, violations of the assumptions of 
linearity, normality, homogeneity of variance, homoscedasticity, and multicollinearity via 
scatterplots, histograms, correlation coefficients, Variance Inflation Factor, Kolmogorov-
Smirov test of normality, F tests for independent and covariate interactions, Box’s and 
Levene’s tests were examined. (Tabachnick & Fidell, 1996; Munro, 2001; Mertler & 
Vannatta, 2002).  
Instrument Description and Psychometrics 
Instrument description and psychometric test results for all measures except the 
DSES are described in the manuscript in Appendix E.  
The Diabetes Self-Efficacy Scale (DSES), modified to add “gestational” is an 8-
item instrument which is scored from 0-10 and results in one mean score. Self-efficacy 
has been studied often in patients with DM (Lorig & González, 2000; Lorig, Ritter, & 
Jacquez, 2005; Lorig, Ritter, Villa, & Armas, 2009). The DSES measures confidence 
levels in beliefs related to DM and self-management health behaviors, including healthy 
eating, physical activity and glucose monitoring. Prior reliability testing found internal 
consistency, α = .83 (Lorig et al., 2009), similar to this study’s results, α =.86. The inter-
item mean correlations = .44 with the actual range from 2.13-10 with a mean (SD) of 
7.9(1.56).  
Results 




 The description of the total sample is presented in Table 1. The total sample 
recruited (n=210) for this study were divided into a control group (n=126) and a study 
group (n=84). At Phase 2, 93% from each group, 117 of 126 (control group) and 78 of 84 
(study group), completed the study. Statistically significant differences between the Phase 
1, control (n=126) and study group (n=84) participants included age, primary language, 
GDM screening, early versus routine (all p ≤ .01), personal history of GDM (p ≤ .01), 
and personal/family history of GDM/DM (GDMPFH) (p ≤ .05). Early screening for 
GDM based on risk factors versus routine screening at approximately 24 weeks GA 
occurred 75.4% in the control versus 51.2% in the study groups. The control group 
reported a 12.7% personal history of GDM and a 63.5% GDMPFH versus a 28.6% 
personal history of GDM and a 77.4% GDMPFH in the study group.  
Correlations  
Correlations for all the study variables were analyzed to determine associations 
and to assess for multicollinearity concerns among the variables. Table 2 reports 
correlation results between study variables. Significant correlations were found between 
∆HE1 and ∆HE2 (r = .38) and glucose monitoring days/weekly (GM1) and 4 times/daily 
(GM2), (r = .63), both p ≤ .001 and GM1 and abnormal glucose results/weekly (GM3) (r 
= .25) and ∆PA1 and GM2 (r = .27), both p ≤ .05.  
Among the HPI conceptual model measures, both professional influence scores 
(SIQHP and SIQDE) were significantly associated (p ≤ .001), both quality of information 
and interaction (QOII) scores (QOIIHP and QOIIDE) were significantly associated (p ≤ 
.001) and each professional influence score for the HP and DE were associated with its 




QOIIDE) (p ≤.001). Point serial and chi-square correlations were used for the following 
analyses. Race and language concordance were negatively correlated with QOIIHP, 
QOIIDE, and only the former with self-efficacy. Transformational leadership style was 
associated with glucose monitoring daily, race and language concordance and SIQHP and 
SIQDE.  
 
Hypothesis 4: Self-efficacy as a mediator of HPI and health behavior 
outcomes 
As previously described (Appendix E), models including HPI measures for the 
HP, with SIQHP and QOIIHP as independent predictors and the DE, with QOIIDE as an 
independent predictor were predictive of one healthy eating outcome, breakfast 
frequency/weekly (HE1). HPI measures for the HP further explained 10% of the total 
variance, F (1,77) =4.153, p = .02 with QOIIHP as the only independent predictor (ß=.31, 
p=.01) for self-efficacy. Similarly, HPI measures for the DE explained 8% of the total 
variance, F (1,77) = 3.162, p = .05 with QOIIDE as the only independent predictor 
(ß=.33, p=.02) for self-efficacy. Self-efficacy was found to be a significant positive 
independent predictor for eating protein for breakfast (HE2) (ß = .22, p ≤ .05) and a 
significant negative predictor for increased abnormal glucose results (GM3) (ß = -.22, p ≤ 
.05) but was not a mediator for HPI measures on HE1, nor predictive of any other 
outcomes.  





Tables 3 and 4 presents the descriptive frequencies and results of paired t-tests for 
outcome changes for the control (non-GDM) and the study (GDM) group. Over time 
(Phase 1 to 2) significant increases in HE1 was found for both groups, control (p =.003) 
and study (p =.03). While approximately 56-58% in each group made no changes, 23-
29% increased and 12.8-15.4% decreased their breakfast frequency in both groups.  
Significant increases in HE2 occurred in the control group (p <.001) with 23.1 % more 
and 3.4% less eating protein for breakfast and in the study group 15.4 % more 9 % less 
eating protein and 74-76% in both groups not changing their behavior either way. In the 
study group, significant increases were evident for HE3, 51.3% increased vegetable 
portions and PA1, 50% increased stretching/strengthening exercise duration (p<.001) 
Table 5 presents the one-way repeated ANOVA results for within and between 
group differences over time in healthy eating and physical activity. Over time, there were 
significant improvements in HE1, HE2, HE3 (p≤ .001) and PA1 (p=.02) for the total 
group. Between group significant differences over time were HE2 (p =.06) with more 
improvements in the control and in HE3 (p <.003) and PA1 (p <.01) more improvements 
in the study groups. Significant between group differences were found in vegetable 
portions/daily HE3 (p≤ .01) improvement in the study group and aerobic exercise 
duration (PA2) (p≤ .1) improvement in the control group.  
Table 6 present the ANCOVA results for within and between group differences 
over time in healthy eating and physical activity while controlling for race (white), 
language (English-speaking), and personal/family history of GDM/DM (GDMPFH) 
(positive history). Kolmogorov-Smirov testing for ANCOVA covariates were significant 




The increase in breakfast frequency (HE1) over time was accounted for by white 
race (p=.04) and for vegetables portions/daily (HE3) by positive GDMPFH (p=.06). The 
difference over time between groups for eating protein for breakfast (HE2), vegetables 
portions/daily (HE3) and for stretching and strengthening exercise (PA1) were all 
accounted for by white race, English language and positive GDMPFH. For HE2: race 
(p=.06), language (p=.06) and GDMPFH (p=.04); for HE3, race (p=.003), language 
(p=.004) and GDMPFH (p=.01); and for PA1: race and language (p= .01) and GDMPFH 
(p=.02).  
The difference between the groups in HE1 were explained by white race (p=.003), 
English language (=.07) and positive GDMPFH (p=.02). The difference between the 
groups in HE2 were explained by white race (p=.06). The difference between the groups 
in HE3 were explained by white race and English language (p≤ .001). All the significant 
effect sizes reported from the ANCOVA analyses were small ranging from 2-9%. 
 





Chapter 5: Discussion 
 
 
Discussion, Implications, and Conclusions  
 
The manuscript titled “Healthcare Provider Influence on Health Behavior 
Modification in Gestational Diabetics” (Appendix E) includes a discussion of the study 
results as well as limitations, implications for practice and a conclusion.  
This chapter includes additional discussion regarding the findings related to the 
comparison of a control: non-GDM and a study: GDM group, as well as additional 
discussion of threats to validity, limitations and strengths, and implications for vulnerable 
populations and nursing education, research, and policy.   
Discussion of Findings 
In consideration of the hypotheses and findings reported here and, in the 
manuscript, (Appendix E), HPI measures (patients’ perception of their healthcare 
providers’ influence, quality of information and interaction in teaching encounters), 
leadership style, and patient-healthcare provider concordance factors influence GDM 
patients’ engagement in health behavior modifications of healthy eating, physical activity 
and glucose monitoring outcomes. Self-efficacy was not a mediator but an independent 
predictor of one healthy eating and one glucose monitoring outcomes, findings consistent 
with previous studies (Lorig & González, 2000; Lorig, Ritter, & Jacquez, 2005; Lorig, 
Ritter, Villa, & Armas, 2009). Although social influence was not predictive of self-
efficacy, quality of information and interaction from HPs and DEs was. Self-efficacy 
appears to play a role in influencing and has a place in the HPI conceptual model.  
Significant improvements in three healthy eating (HE1, HE2, HE3) and one 




that pregnant women make positive changes whether or not they have GDM and receive 
counseling. While both groups increased breakfast frequency (HE1), an important dietary 
modification for GDM, the control group as well increased consumption of protein for 
breakfast (HE2) more than the study group and the study group increased vegetable 
portions/daily and stretching and strengthening exercise minutes/weekly (PA1) resulting 
in between group differences over time.  
Emphasis should be placed on counseling GDM patients of the benefits of eating 
fewer carbohydrates at the first meal in the morning due to increased insulin resistance 
and instead adding or increasing protein which increases insulin sensitivity.(Gutierrez & 
Reader, 2005, Mekary, Giobannucci, Willett, van Dam, & Hu, 2012) It is important to 
consider whether the control group, although at high risk for GDM was able to maintain 
stable glucose results, in part related to this change. The study group did however 
increase their vegetable portions/daily significantly whereas the control group did not. 
While in pregnancy, vegetables would benefit both groups with increased vitamin and 
mineral content to counter the loss to fetal development needs and the benefits of 
increased fiber to counter gastrointestinal slowing in pregnancy, they are also the optimal 
choice for acquiring this carbohydrate sourced nutrient without increasing the risk for 
higher glucose results from other less optimal and higher glycemic index carbohydrate-
fiber sources, such as grains (Mekary, et al, 2012).  
The benefits of stretching/strengthening exercises, found to be increased in the 
study group, should be consistently a focus of GDM counseling. Strengthening exercises 
potentially increase muscle mass which increased insulin sensitivity and decreases need 




stable glucose levels and, in the study group, 77% of participants reported achieving 
recommended normal levels of ≤ 2 abnormal results/weekly. The are other pregnancy-
related benefits of stretching and strengthening, such as treating advancing gestational 
age aches and discomforts that both groups would have benefitted from. Although 
aerobic exercise change was not found to be significant, 44-48% of participants in both 
groups did increase their duration weekly, a commendable change in pregnancy when 
considering the increasing physical discomforts and fatigue that can occur as the 
gestational age increases which may have thus led to 29-33% decreasing aerobic exercise 
duration in both groups. There is some evidence that GDM counseling may be was 
effective in influencing the study group engagement in more healthy eating and physical 
activity behavior conducive to achieving glycemic control.  
In considering variables accounting for differences in outcomes, all three 
covariates: white race, English language, and positive GDMPFH played small significant 
effects on change over time and between the control and the study groups. English-
speaking, white women, and those with a previous experience or exposure to GDM or 
DM and the study group improved breakfast frequency, vegetable portion intake and 
increased stretching and strengthening exercises, more than those in the control group.  
Although the effects were small, a focus on understanding how women of different races, 
languages and health history modify their behaviors more or less than others and may 
respond to professional influence differently is an area worthy of further exploration. In 
the context of influencing health behavior modification, patient and HP characteristics 
should remain an area of focus and may help to redirect counseling content, delivery, and 




The increase in breakfast frequency (HE1) over time was accounted for by race 
(p=.04) and for vegetables portions/daily (HE3) by GDMPFH (p=.06). The difference 
over time between groups for eating protein for breakfast (HE2), vegetable portions/daily 
(HE3) and for stretching and strengthening exercise (PA1) were all accounted for by race, 
language and GDMPFH. For HE2: race (p=.06), language (p=.06) and GDMPFH 
(p=.04); for HE3, race (p=.003), language (p=.004) and GDMPFH (p=.01); and for PA1: 
race and language (p= .01) and GDMPFH (p=.02).  
Threats to Internal and External Validity 
 Threats to validity of results were considered. There were time variations 
between Phase 1 and Phase 2 depending on whether involvement in the control or study 
group began at early versus routine screening time. This time variation may have affected 
the ability and amount of behavior change that could occur an thus affect the between 
group difference results.  
During the data collection process, feedback was received from one Asian 
participant that providing perceptions related to someone in a position of power, such as 
HPs, (referring to completion of the MLQ) especially if it contained any negative content, 
or was not culturally appropriate; however she understood the confidential nature of the 
responses and did not feel this would change her answers but felt it was important to 
bring light to this issue for the researchers in case other participants were impeded in 
responding accurately. As this study is based on patient perceptions of their HPs 
influence, interaction, and leadership style, objective measures would arguably diminish 
the intention, purpose and value of including the patient view.  




Limitations regarding instruments were considered. Although the QOII and the 
DSES address glucose monitoring, the SIQ did not specifically inquire as to HP influence 
and beliefs of patient ability and barriers for engagement in glucose monitoring for GDM 
control and prevention of DM.  
 Strengths incorporated into the research design include counseling regarding 
and use of anonymous reporting, use of trained research assistants (RAs) to collect data, 
and the longitudinal nature of the design using the change score for five of the health 
behaviors as the outcome measure decreased concern for inflating responses. Outcome 
measure surveys are easy to complete with very few questions, which decrease 
participant burden. Additional strengths included the certified medical translators 
completed two-way forward-backward translation for Spanish language forms. Not only 
did this increase the accuracy but also allowed for the recruitment and inclusion of a 
more diverse sample which represents a vulnerable population at higher risk for GDM 
and DM. All revised and translated forms were able to be pilot testing for content validity 
prior to their use in this study.  
Unanticipated benefits included the opportunity for multiple participants to 
express their positive and negative feedback, although unsolicited, by verbalizing to 
researcher or RAs or written expressions of gratitude or frustrations regarding counseling 
experiences or content, pertinence to their individual needs and healthcare system 
concerns in regard to approaching management for GDM. One participant requested to be 
contacted and participate in public presentations where the research results might be 
presented as well as reported her personal motivation to become a DE because of what 




Implications for Vulnerable Populations 
Ethnic minority populations have the greatest prevalence and are at greatest risk 
for GDM/DM and, if current trends continue, the latter is projected to affect 50% of 
minority versus 33% of all U.S. children born after 2000 (DeSisto, Kim, & Sharma, 
2014; Fujimoto, Samoa, & Wotring, 2013; Guariguata, Linnenkamp, Beagley, Whiting, 
& Cho, 2014; Narayan, Boyle, Thompson, Sorensen, & Williamson, 2003). Barriers that 
pose increased risks to developing GDM/DM and the inability to modify diet/eating and 
increase physical activity health behaviors recommended for the prevention and treatment 
of GDM/DM are the lack of awareness prevention knowledge and awareness as well as 
decreased access to quality healthy and sufficient foods and safe communities (Gucciardi, 
Vahabi, Norris, Del Monte, & Farnum, 2014; Hasan-Ghomi, Ejtahed, Mirmiran, 
Hosseini-Esfahani, Sarbazi, Azizi, et al., 2015; Laraia, Siega-Riz, Gundersen, 2010; 
López, & Seligman, 2012). Recognizing the increased prevalence and seriousness of DM, 
the diagnosis, prevention and formal DM education became a major focus of the Healthy 
People 2020 objectives on (DHHS, 2013). Extending this objective to include formal 
education with GDM management during pregnancy could address the more remote goal 
for prevention, delay of onset or earlier treatment of DM in females. Multiple approaches 
are necessary that are tailored to the specific target population group and its environment. 
Healthcare providers should assess the knowledge, awareness, and vulnerabilities of their 
individual patients in relation to GDM/DM treatment knowledge and their community 
and environmental resources to determine actions that can help to improve knowledge 
and eliminate health disparities within these and other vulnerable populations (Gonzalez, 




awareness of cultural differences in staple foods, attitudes to physical activity, and access 
to safe areas, while eliciting family support when often there are few or few willing to 
help can be difficult (Laraia, Siega-Riz, Gundersen, 2010; López, & Seligman, 2012).   
A specific focus on GDM/DM involves not only providing correct, consistent, 
culturally and linguistically appropriate counseling but also trialing different strategies to 
interact, communicate, and even solicit information that can lead to more confidence and 
subsequently more influencing potential. In collaboration with patients and families, 
finding out what is available, appetizing, adequate, and quality resources that would 
additionally meet optimal health eating recommendations is important. HPs who take 
responsibility to be as educated and informed regarding their resources on every level of 
their patients can increase their potential to best influence health behavior modification 
and improve outcomes. 
Education Implications 
While the counseling and education of patients specific to the treatment and 
prevention of health problems and diseases is imperative, the initial education and 
training of HPs on how to counsel, interview, motivate, and interact with patients is 
equally important. In addition to encouraging self-reflective clinical practice and 
stimulating individual or group change to approaching patient health behavior 
modification, these research findings can be used to contribute to strategies and models of 
learning in education programs for all, including new and experienced, clinical, 
academic, and research focused HPs. Professional influence from HPs can positively 
impact all areas of practice which can stimulate a trickle-down effect of improved health 




perceptions of influence, information, interaction, leadership styles, and concordance 
factors affect the overall influencing capacity and potential of a HP can be not only 
individually transformative but also organizationally and nationally. Using different 
leadership skills can potentially affect both short and long-term outcomes. While 
transactional skills may focus on behavior modification for obvious proximal benefits, 
transformational skills involve exploring individual’s values, goals, experiences, and 
vision, and uses these to impact longer term behavior change.  
Policy Implications  
To address the rapidly increasing rise in GDM and the number of potential 
deleterious effects to the mother and fetus, a bill was passed in 2012 mandating screening 
for GDM in order to lead to earlier diagnosis and treatment with the objective to reverse 
or prevent these complications. While screening is critical to identify those at risk, the 
follow-up diagnostic testing and management of GDM is even more vital. First line 
treatment considerations for GDM include optimal eating/drinking, physical activity and 
glucose monitoring. Health behavior modification minimally requires access to 
appropriate counseling and support from trained, culturally sensitive, and language 
concordant HPs and DEs via medical interpreters, if indicated, as well as, access to 
appropriate foods and safe places for physical activity. Treating GDM appropriately is 
one early and direct pathway to DM prevention, delay and treatment (Ruchat & Mottola, 
2013). These considerations as well as the national objective calling for formal DM 
counseling (DHHS, 2013) are beginning steps to awareness for future policy changes.  
Legislative initiatives and policy modifications are essential and must 




appropriate foods, resolve food resource and scarcity concerns, ensure safe places for 
physical activity, and access to glucose monitoring supplies for those with GDM/DM 
(Gonzalez, 2012). A current focus could include government assistant programs, such as 
the Supplemental Nutrition Program for Women Infants and Children Program (WIC) 
which currently addresses food scarcity concerns and already focuses on anemia as one 
area of eating related malnutrition. Expanding the scope of nutrition awareness and 
resources for GDM treatment is a potential objective for this program. Providing diligent 
and accurate education and awareness regarding dietary and healthy eating GDM 
recommendations from this program is a first step. Additionally, reviewing foods that are 
approved, recommended and available for those with GDM, such as increased promotion 
of proteins and vegetables/vegetable juices and fewer but higher fiber carbohydrates, 
decreased fruit juices and other high carbohydrate nutrient poor processed foods/drinks 
could be effective. This is only one of many potential areas to focus efforts for change.  
Research Implications and Future Directions 
 Addressing a gap in the research literature by conducting this pilot study has 
provided an initial understanding of the process of HPI and an additional layer of 
comprehension regarding patient-centered healthcare communication and counseling. In 
addition, it has stimulated the emergence of many new questions and served to guide 
education efforts for HPs in addressing GDM in order to prevent DM. Replicating testing 
of the current and additional testing of new components of the HPI conceptual model is 
highly recommended in order to lend a more comprehensive understanding and trajectory 
into utilizing this patient-centered model to improve influencing HBM, potentially 




cardiovascular diseases. A specific direction using this model in the context of 
prevention/treatment of DM is measuring continued health behavior modification with a 
more distal focus in the postpartum period, such as at the 6-week routine and annually 
when glucose tolerance screening is recommended. A greater understanding how HP use 
of leadership styles is associated with short and long-term health behavior modification 
outcomes could lead to new approaches for health promotion and disease prevention. An 
awareness of how transformational leadership skills consider, inspire, motivate and 
transform individual patient’s decision-making/goal setting and behavior modification 
should be sought after. This process of social/professional influence should be compared 
to the use of specific protocol reinforced recommendations for health outcome 
achievement in terms of satisfaction, quality of life and other variables. 
Additional considerations for future research include the following: 1) adding 
research variables from the HPI conceptual model such as time, number and duration of 
visits by HP/DE, previously established personal or family relationship and interaction 
with HP prior to this pregnancy, and additional concordance factors, such as personal 
similarity and HP communication/patient learning styles; 2) further inquiry into how 
quality of information and interaction but not social influence was associated with self-
efficacy, while both predicted different outcomes, 3) other factors of HPI that could 
increase self-efficacy and further exploration of its role as a mediator and moderator in 
outcome behavior modification; 4) deepening the inquiry into the leadership style of DEs 
may provide additional information and guidance for their improved influencing.; and 5) 




professional influence via family, community, peer, media or technological sources is 
another area of future research.   
Finally, more comprehensive outcome measures for healthy eating, physical 
activity, and glucose monitoring behaviors and modifications to the SIQ would increase 
the strength of this design. Minor changes include modifying the HE2, protein for 
breakfast measure to include the number of protein portions at breakfast daily or weekly 
or overall daily portions. Another direction would be the development and use of an 
application that would assemble, analyze and report out what is entered into them 
including timing of meals, amount, type and nutrient-content of foods, such as protein, 
carbohydrates, fats, total calories in and used, BMI, physical activity tracker for time 
spent in exercise, and glucose results would provide invaluable information, but of course 
is sensitive to accurate input. The modification of the SIQ measure would include glucose 
monitoring items with a focus on inclusion of transformative leadership language 
throughout the instrument.   
Summary 
This chapter provides additional discussion regarding results for research findings 
not previously discussed in the manuscript, “Healthcare Provider Influence on Health 
Behavior Modification in Gestational Diabetics (Appendix E). It adds policy and 
educational implications and additional future research recommendations for 
consideration.  
Conclusion  
This pilot study’s exploratory findings provide initial glimpses into the 




Patients’ perception of their healthcare providers’ influence, the quality of information 
and interaction in teaching encounters, their leadership style, their specialty, and patient-
healthcare provider concordance factors provide initial insight and awareness of what and 
how influence works for improving GDM patients’ engagement in health behavior 
modifications. Healthcare provider self-reflection on practice, communication, interaction 
and leadership style could motivate the desire for professional transformation and play a 
role in influencing increased patient engagement in health behaviors.  Every healthcare 
provider and every patient have the potential to become or do more. While some factors 
such as race, language, personal or family history, and concordance factors may increase 
or decrease this influencing potential, an awareness of these relationships can guide 
personal or organizations strategies for growth and improvement. There are numerous 
future directions for professional influence research.  
 
Results Tables and Figures 
 
 
Table 1: Total Sample Demographics and Descriptors 
 Range Mean (SD) 
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(Notes: Chi-square difference in P1 control and study groups: [*p ≤.1, **p ≤.05, ***p≤.01, ****p≤.001; DM: Diabetes Mellitus;  



























































(Notes: Significant findings bolded [*p ≤.1, **p ≤.05, ***p≤.01, ****p≤.001,), ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score,  
∆PA1: Physical Activity 1 Change Score; ∆PA2: Physical Activity 2 Change Score. RC: race concordance. LC: language concordance, GC: gender concordance, GDMPFH: personal/family history of GDM/DM. HP SPec:  
Healthcare provider specialty, MLQ: Leadership style, DSES: Self-efficacy 
Table 2 Correlation Matrix  
Variable 
 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) 
∆HE1 
 (1) 
 .38**** .15 .02 .14 -.06 -.03 
 


















.2* .06 .02 
∆HE3 
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         .59**** .38**** .27** .06 .02 -.05 .11 .09 -.01 .26** 
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           .79**** .31*** -.19* -.27** .15 
 
.06 .14 .01 
QOIIDE 
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HP Spec 
(18) 
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MLQ 
(19) 




 Table 3: Outcome Changes Over Time  
(Phase 1 to Phase 2) 









65 (55.6)  
34 (29.1)  
18 (15.4)  
 
45 (57.7)  
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12 (15.4)  


















53 (45.3)  
34 (29.1)  
30 (25.6)  
 
31 (39.7)  
39 (50)  







56 (47.9)  
34 (29.1)  
 
18 (23.2)  
34 (43.6)  








41 (52.6)  
GM3  
(≤ 2 abnormal 
results week) 
  
60 (76.9)  
        Notes: HE1: Healthy Eating 1, HE2: Healthy Eating, HE3: Healthy Eating 3, PA1: Physical Activity 1,  
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                       Notes: HE1: Healthy Eating 1, HE2: Healthy Eating 2, HE3: Healthy Eating, PA1: Physical Activity 1; PA2: Physical Activity 2.  
 
  
Table 5: One-way repeated measures ANOVA within and between groups 
 Within Group (1,191) ANOVA  
F, p, partial ɳ2 within/ 
*group F between group diff 
Between group  
HE1   F=13.317, p ≤.001, ɳ2 = .07 
*Grp F = .000, p =.99, ɳ2 =.00 
F = .016, p =.9, ɳ2 =.00 
HE2  F=13.592, p ≤.001, ɳ2 =.07 
*Grp F= 3.51, p =.06, ɳ2 =.02 
F = .802, p =.37, ɳ2 = .004 
HE3 
 
F = 13.61, p ≤.001, ɳ2 =.07 
*Grp F=8.837 p =.003, ɳ2 =.04 
F = 6.443, p = .01, ɳ2 = .03 
PA1  
 
F=.5845, p =.02, ɳ2 = .03 
* Grp F= 6.51, p ≤.01, ɳ2 = .03 
F = .309, p=.58, ɳ2 =.002 
PA2  
 
F=.289, p =.59 partial ɳ2 =.001 
*Grp F=.217, p = .64, ɳ2 =.001 

































                     
Notes: 
HE1: Healthy Eating 1, HE2: Healthy Eating 2, HE3: Healthy Eating, PA1: Physical  ctivity 1;  
                     PA2: Physical Activity 2, p<0.1 
  
Table 6: One-way repeated measures ANCOVA 
 Within Group 
Covariate/Group Interaction effect 
(1,192); BMI 
F, p, partial ɳ2 
Between Group 
Covariate interactions (1, 191) 
F, p, partial ɳ2 
 
HE1 *Race F=4.494, p=.04, ɳ2 = .02 
*Grp F= .001, p=.98, ɳ2 =.00 
*Lang F=.808, p= .37, ɳ2 =.004 
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*Race F=1.806 p=.18, ɳ2 = .01 
*Grp F=6.569, p=.01, ɳ2 =.03 
*Lang F= .585, p=.45, ɳ2 = .03 
*Grp F = 6.935, p=.01, ɳ2 = .04 
* GDM F = 1.01, p=.32, ɳ2 =.01 
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*Race F=.784, p=.38, ɳ2 =.004 
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*Lang F= .616, p= .43, ɳ2 =.003 
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*GDM F=2.965, p=.09, ɳ2 =.02 
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Race F=1.585, p=.21, ɳ2 = .01 
Lang F =1.201, p=.27, ɳ2 = .01 
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Table 1: Abbreviations 
BMI: Body Mass Index  
DSES: Diabetes Self-Efficacy Scale 
EBQ+1: Eating Breakfast Questionnaire +1 
GC: Gender Concordance  
GDMPFH: Personal/Family History of Gestational Diabetes Mellitus/ Diabetes 
Mellitus  
GM1: Glucose Monitoring Question 1: Glucose Monitoring days/week 
GM2: Glucose Monitoring Question 2: Glucose Monitoring 4 times/day 
GM3: Glucose Monitoring Question 3: Abnormal blood glucose results/weekly 
GMQ: Glucose Monitoring Questionnaire 
∆HE1: Healthy Eating 1 Change Score: Frequency of Eating Breakfast/Weekly 
∆HE2: Healthy Eating 2 Change Score: Eating Protein for Breakfast  
∆HE3: Healthy Eating 3 Change Score: Vegetable Portions/Daily 
HP specialty: Healthcare Provider Specialty 
LC: Language Concordance 
MLQ: Multifactor Leadership Questionnaire- Healthcare Provider Leadership Type  
P1: Phase 1  
P2: Phase 2  
PAS: Physical Activity Scale 
∆PA1: Physical Activity Change Score 1: Stretch/Strengthen Exercise Minutes/Weekly 
∆PA2: Physical Activity Change Score 2: Aerobic Exercise Minutes/Weekly  
QOII: Quality of Information and Interaction GDM 
QOIIDE: Quality of Information and Interaction GDM-Diabetes Nurse- Educator Total 
Score 
QOIIHP: Quality of Information and Interaction GDM-Healthcare Provider Total 
Score 
RC: Race Concordance  
SIQ: Social Influence Questionnaire-GDM 
SIQDE: Social Influence Questionnaire-GDM-Diabetic Nurse-Educator  
SIQHP: Social Influence Questionnaire-GDM-Healthcare Provider  
TAL: Transactional Leadership 















Integrative Review and Development of a Model of Healthcare Provider Influence 
 
 
Denise K. FRYZELKA, MS, CNM 





Background: Effective communication impacts several patient and healthcare measures, 
including patient satisfaction, health status, and treatment adherence. Influence, 
frequently associated with communication, is used ubiquitously and primarily to describe 
an action or effect between persons, however the concept of healthcare provider influence 
has not been explicitly described in nursing or health sciences literature 
Aim: To understand the process of healthcare provider influence on patient health 
behavior modification.  
Design: Integrative review of the healthcare literature  
Data Sources: PubMed and CINAHL 1992-2013 
Review Methods: The research questions and recommendations by Whittemore and 
Knafl (2005) guided the methods used for retrieval and analysis of relevant publications 
and synthesis of the literature.  
Results: Synthesis of the relevant publications (n=8) resulted in the development of a 
model and definition of healthcare provider influence. Healthcare provider influence is 
defined as a process wherein a purposeful interpersonal interactive, collaborative, and 
transformative relationship develops between a patient and healthcare provider working 
together toward a specific focus of health behavior modification. Components include 
social, communicative, emotive, cognitive, concordant, and logistic factors. Conditions 
include a healthcare need, mental capacity for decision-making, and potential for 
interaction. Outcomes include health behavior modifications and cognitive and emotive 
enhancement. Relevance to populations wherein values and beliefs vary significantly 
from the interpersonal collaborative perspective that underpins this healthcare provider 
influence model may not be possible.  
Conclusion: A definition and model of Healthcare Provider Influence can be utilized to 
understand and research the influence providers can exert on health behavior 
modification.  
 







Why is this review needed? 
• Extensive research has explored patient-centered communication by healthcare 
providers and its relationship to patient outcomes, including patient satisfaction, 
preventive health practices, adherence to treatment plans, and improved patient 
health.  
• Patient-centered communication is foundational to healthcare provider influence, 
but it is only part of the process.  
• Understanding the healthcare provider role in influencing patients can provide a 
new perspective or approach for modifying health behaviors, improving health 
outcomes, and decreasing costs associated with poor health behaviors. 
What are the key findings? 
• An integrative review of the literature unearthed very few references to healthcare 
provider influence and found it to be a form of social influence. There was no 
description, definition, or model to explain the process.  
• HPI is the name given to a concept that is used to describe the process of how and 
what HPs do that contribute to patients envisioning, desiring, and activating steps 
to make modifications in their thinking, desires, motivation, goals for health 
behavior modification. 
• Healthcare provider influence is a process wherein a purposeful interpersonal 
interactive, collaborative, and transformative relationship develops between a 
patient and a healthcare provider working together toward a specific focus of 
health behavior modification.  
How should the findings be used to influence policy/practice/research/education? 
• The definition and conceptual model of healthcare provider influence should 
facilitate the complex process of influence that can affect transformative health 
behavior changes in a patient through interaction and collaboration. 
• Healthcare policy, practice and research should incorporate the concept of 
healthcare provider influence which places the onus of responsibility on the 
healthcare provider to stimulate patient health behavior changes in a manner that 









Healthcare literature is replete with communication research that describes effective 
patterns and characteristics of patient-provider relationships, barriers to and factors to improve 
communication among individuals, groups and systems within the health care professions, and 
how communication impacts health behaviors and outcomes. Multiple variables affect patients 
and their modification of health behaviors and health outcomes. However, a noticeable gap in the 
literature revealed lack of a comprehensive description regarding the intricate process or essential 
components of the relationship between healthcare providers (HPs) and patients that are 
necessary to influence patient adaptation and modification of health behaviors and ultimately 
health outcomes. This comprehension of how patients prioritize and modify health behaviors in 
interaction and collaboration with their HP, what HPs do or do not do, and how HPs do or do not 
influence these changes is important for HP educational preparation and for planned 
implementation of health promotion strategies. HP-patient communication is ubiquitous to all 
areas of healthcare. The term “healthcare provider” (HP) will be hereafter used to include all 
terms for or categories of trained health professionals that designate provision of care to a patient, 
including but not limited to providers, professionals, healthcare professionals, healthcare 
providers, advanced practice nurses or advanced nurse practitioners, nurses, clinicians, 




The aim of this integrative review was to gain a greater understanding of the 
interpersonal process of influence and the role that HPs have on patients’ decisions and goals, and 
in facilitating, initiating, and supporting implementation of health behavior modifications in order 
to address chronic or acute healthcare concerns, problems, or diagnoses and improve health 
outcomes. Understanding this influence from the perspective of the patients and how this 





Two specific questions provided the direction for this review: (1), “What is known in the 
health care research literature about the influence of HPs on the patients’ adaptation and 
modification of health behaviors related to treating or preventing acute and chronic illness and 
diseases? and (2), “What are the most influential elements that HPs contribute to patient 
understanding, motivation, adaptation and modification of health behaviors related to acute and 
chronic health problems?” 
Design 
The integrative review of the healthcare literature was undertaken to understand the published 
literature related to the concept of influence specific to HPs. The search methods, analyses, and 
synthesis for this review were guided by the recommendations of Whittemore and Knafl (2005).    
Search Methods 
Searches were conducted utilizing PubMed and Cumulative Index of Nursing and Allied 
Health Literature (CINAHL) electronic databases to provide a comprehensive perspective from 
nursing, socio-psychology, medicine, and allied health care professions research. To include an 
international perspective and current relevant research findings, criteria included national and 
international research and scholarly publications, in English from 1992-2013. The search term 
“influence” was linked with “healthcare”, “health care”, “provider”, “professional”, and 
“clinician” in seven different search combinations to retrieve the largest number of references 
possible for review.  
Due to the scarcity of publications and to expound the complex concept of healthcare 
provider influence, hereafter named HPI, it was necessary to further explore patient-centered 
communication (PCC), one of its main tenets. Several principal research publications regarding 







  The final number of publications referencing “influence” obtained and reviewed after 
elimination of duplicates totaled 26. After a review of these publications for relevance, however, 
the total number included in the analysis was reduced to eight. The search strategy, terms, and 
total retrieved for each combination are presented (Table 1). Additional theory and PCC 
references were also included in the final analysis. 
Quality Appraisal 
 After relevance was determined, ancestral searching was conducted, and publication 
reference lists were scrutinized for additional relevant references. References were retained if 
they were retrieved from peer-reviewed publications or scholarly commentaries and included a 
description or reference to HPI, theoretical or experimental, even if related to a specific disease or 
population.  
Data Abstraction 
 The publications were analyzed for type of research, population, research query or 
theoretical basis, relation to HP or patient, health behaviors, outcomes, as well as descriptors, 
definition, process or characteristics of influence. A matrix was used to organize the references 
and findings (Table 1) to facilitate synthesis.   
Synthesis 
Requiring an iterative and reflective process, all references were reviewed for conditions, 
components or descriptors, and outcomes that were then classified and named. Several 
classifications serve as categories of components as well as conditions or outcomes of the process 
of influence. For example, cognitive knowledge and awareness serve as both a category of 




functions as both a category of condition as well as an outcome (Figure 1). A synthesis of the data 
ensued, and a conceptual model was developed to clarify and describe the characteristics and 
components of HPI. 
RESULTS 
Throughout the literature, the term ‘influence’ has been utilized as an action or result 
between factors or individuals or as a description of an individual or a system, including 
references to the influence that HPs have on patients. It has not been well described or analyzed 
as a concept, which embodies a process of impacting or affecting a change or modification. It has 
however been used frequently as a verb in association with other terms such as when discussing 
or describing outcomes or behaviors. Surrogate terms for influence include affect, effect, and 
impact. Due to the lack of description and definition of HP influence, the process selected to 
clarify HPI was the development of a conceptual model from the integrative synthesis of the 
literature. 
Influence cannot occur without communication, one of its main components. It could not 
therefore be well isolated from the patient-provider and effective communication (EC) literature.  
When EC is described, it is almost always in relation to the EC results, its effects, or influences. 
Therefore, multiple references related to aspects and emerging trends in the healthcare 
communication research literature are included as they provided vital foundational elements for 
the development of the HPI model.  
Development of the HPI Definition and Conceptual Model 
After synthesizing the results from the integrated review of the healthcare literature, the 
necessary components for describing HPI became apparent and within the context of health care, 
a description, definition, and conceptual model of HPI were developed (see Figure 1). HPI is the 
name given to a concept that is used to describe the process of how and what HPs do that 
contribute to patients envisioning, desiring, and activating steps to make modifications in their 




wherein a purposeful interpersonal interactive, collaborative, and transformative relationship 
develops between a patient and a HP working together toward a specific focus of health behavior 
modification. The conditions, components and outcomes of the concept are described.  
Conditions 
For HPI to occur, there are necessary conditions that must be in place. These are patient-
related and categorized as mental-physical and resources. Mental-physical includes an existent or 
elevated risk for an impending health problem or need, the mental and physical capacity for 
decision-making and health behavior modification, and finally, an awareness of how to access 
and initiate a relationship. Access may include navigation of the infrastructure established by 
healthcare policy, insurance, and organizations and there must be an opportunity for interaction. 
Resources include time and means, such as finances, insurance, and transportation to access or 
seek care whether in a physical or virtual space (Jucks et al., 2012).  Some patients lack the 
ability to interact or process and understand basic health information they need to make decisions 
due to cognitive, mental or speech disorders (Travaline et al., 2005, Tarkan, 2008), creating 
barriers to HPI. Events of illness, pain or stress, prolonged wait or access times, time constraints, 
physical space or ambiance as well as lack of income or resources, such as, insurance, 
transportation or technology may also impede or influence the HP-patient interaction and 
adherence to recommendations (Sheppard et al., 2004, Travaline et al., 2005, Verlinde et al., 
2012).  
Components 
Fundamental to HPI is a relationship that is interpersonal between a patient and HP 
within a healthcare context and purposeful due to the designated roles of each. The central and 
essential dimension upon which the concept of HPI is based is social-communication. The HPI 
model describes a process that evolves because of this relationship that includes three primary 
components: interaction, collaboration, and transformation. Four additional categories are 




unquestionably a relationship across components. The categories are logistics and concordance, 
linked to interaction, and cognitive and emotive, linked to transformation.  
Social-Communication  
Pivotal to HPI and all its components and categories is social-communication, and more 
specifically, PCC. Effective interpersonal communication (EC) is described as a dynamic and 
ongoing process between patients and providers leading to understanding of each other’s 
perspectives, cooperation, and coordination (Stewart, 1995, Epstein & Street, 2007). EC becomes 
PCC when the patient is viewed and approached as a whole person with a unique personal history 
and having individual needs from a bio-psycho-social or holistic perspective (Charlton et al., 
2008, Hartog, 2009, Verlinde et al., 2012). PCC skills and care are based in human respect, 
central to culturally competent care, used in verbal, non-verbal and virtual communication, and 
involve patient-value guided clinical decisions (DiMatteo, 1995, National Research Council, 
2001, Verlinde et al., 2012). Examples of PCC skills include; (a) understanding patient’s 
perspective of illness, causes, treatment options, and ability to adhere to recommended treatment; 
(b) active and careful listening; (c) asking non-judgmental questions about concerns and 
expectations for treatment; (d) empathetic understanding; (e) providing clear and thorough 
information, explanations, and recommendations; (f) not avoiding discussion of sensitive topics: 
and (g) engaging in negotiation by involving and working with patient to problem-solve and set 
realistic and achievable health lifestyle goals for behavior change as well as coaching and 
empowerment (Koster et al., 2005). Both EC and PCC have been described as important 
components for clinical management of chronic diseases, patient compliance and adherence to 
treatment recommendation, self-management, influence on patient health behavior modification, 
alteration of patient perception of health-damaging effects and as well as reduction in preventable 
adverse events (Jerant et al., 2005, Durant et al., 2009, Jensen et al., 2010).  An analysis of seven 
studies of nurse practitioners’ communication styles demonstrated that use of PCC influences 




control, symptom resolution, overall health status and satisfaction as well as diagnostic 
expediency and accuracy by the HPs (Charlton et al., 2008). Multiple research efforts have 
demonstrated that the overall quality and consistency in communication as well as specific 
characteristics of the HP-patient interaction utilizing PCC positively impacts these same 
outcomes (Street, 2002, Duberstein et al., 2007, Jensen et al., 2010).  When communication is not 
effective or PC, the opposite outcomes have been demonstrated (DiMatteo, 1995, Koster et al., 
2005, Durant et al., 2009).  
PCC training models teach HPs the process of EC with patients as well as behaviors to 
avoid in order to improve the HP-patient interaction. One such model, AGENDA, stands for 
Agenda and health Goal setting; Expressing concerns, questions, and negotiations; Navigating 
health literacy issues; Disclosing detailed information; and Active types of listening (Arnold et 
al., 2012). Patient communication training has improved interaction and increased patient health 
knowledge, organization, and positive attitudes during visits (Talen et al., 2011).  
Non-verbal communication behaviors, such as eye gaze, tone of voice, and proximity of 
the patient and HP to each other affect outcomes, such as patient satisfaction (Mast, 2007). In 
written HP-patient communication interactions, such as email, the importance of awareness, 
anticipation, and continuous vigilance to elements of PCC by the HP were deemed to be 
necessary to identify discrepancies in patient self-reports of knowledge and understanding of 
medical conditions that indicated lack of full comprehension (Jucks et al., 2012). 
When “influence” is used in the health communication literature, PCC is frequently 
referenced. Not only the HP’s communication style but also the HP’s personal qualities have been 
identified as sources of potential influence (Verlinde et al., 2012). HPI is considered a form of 
social influence wherein a social process occurs between the HP, the social influencer and the 
patient, the influenced. “Social influence is the attempt of one or more individuals to alter, modify 
or change the attitudes, reactions or behaviors of another individual or group (Gabel, 2012).  The 




of social influence, under social facilitation, and describes a knowledgeable person in a position 
of perceived authority who sways the thinking and motivation of another, leading to engagement 
in behavior (Ryan, 2009). In a study based on ITBHC, social influence was associated with 
postpartum weight self-regulation, but the influencers included family, friends, and/or providers 
(Ryan et al., 2011).  
Interactive  
HPI is a process, which may occur within a single patient encounter but is more 
successful if it is continuous, evolving, and builds on previous steps or events. It is an 
interpersonal interactive process, thus involving and between at least two persons or individuals, 
in this case, a patient and a HP, and denoting an intended productive action and a positive 
outcome. It is not a unidirectional HP to patient instruction, characterized by passive receptivity 
on the part of the patient that is more representative of an oppressive relationship between the 
individuals wherein the HP is significantly more dominant and controlling or demanding. The 
process does not have to be person to person within the same space but there must be an 
interaction. This means that HPI can occur in virtual as well as physically shared space settings 
(Jucks et al., 2012).  While the work of the process may be predominantly social-communicative, 
the external portrayal of that action may be presented as behavior or behavior modification 
outcome. 
Logistics 
Time and physical and virtual environment have an impact on patient behaviors and 
perspectives. Measures of influence in published research frequently focused on logistical aspects 
of time, such as time spent in interaction or counseling, length of the HP-patient relationship, and 
timing of interaction correlating to increased patient disclosure and seeking of health care 
(Morrison, 1996, Scholle & Kelleher, 2003, Orford et al., 2006). Increased time spent or 
continuity of care over time in the HP-patient relationship increased trust, access to and quality of 




perception of the quality of interactions between themselves and their HP (Sheppard et al., 2004, 
Wallace et al., 2009, Verlinde et al., 2012). HPs who interacted and spent adequate time inside 
and outside of the exam room were perceived by patients to be more competent (Shay et al., 
2012).  
Concordance  
Concordant factors refer to the similarity of characteristics that the HP and the patient 
share such as race, culture, age, gender, socioeconomic status, language, literacy, religion, and 
personality (Cooper-Patrick et al., 1999, Travaline et al., 2005). HP-patient concordance in 
demographics, language, culture, values and beliefs, experiences, and patient characteristics are 
important sources of potential influence and have been shown to impact patient expectations, 
health behaviors and status (Anderson, 1999, DeVoe et al., 2009, Verlinde et al., 2012). 
Discordance can negatively affect a patient’s perceptions of the relationship and interaction with 
their HP, the content of the consultation, and healthcare delivery (Bertakis, 2009, Verlinde et al., 
2012).  Less time and explanation regarding treatment and diagnoses and less patient participation 
were reported when socioeconomic discordant factors, such as low income, limited education or 
health literacy were present (Verlinde et al., 2012). Discordance in culture and native language, as 
well as failure to provide or correct these via interpretive services, for example, have been found 
to correlate with increases in health care use and costs, hospitalizations, misdiagnoses, infection 
transmission rates, sicker patients, missed appointments, as well as, decreases in patient trust, 
satisfaction, willingness to follow advice, compliance with medical or treatment 
recommendations, continuation of care, health status, preventative behaviors, and provider 
satisfaction (Smith & Pietrzyk, 2012). 
Significant practice style behavior and foci differences, such as emphasis on preventive 
services and psychosocial counseling, and higher satisfaction ratings and empathy were found in 
female compared to male HPs with increased rates for both found for female HPs, even after 




other variables such as age, ethnicity, and personal experience were examined (Bylund & 
Makoul, 2002, Bertakis, 2009).  These differences and discordant variables can alter the structure 
of the communication and affect goals, skills, perceptions, emotions and overall influence the HP- 
patient interaction (Street, 2002, Markova & Broome, 2007, Bertakis, 2009). 
Corrections to or modification of discordant factors or use of collaborative PCC in 
discordant relationship interactions positively influenced patient perception of communication 
quality, increased emotive factors such as faith and trust, and other outcome measures (Anderson, 
1999, Schoenthaler et al., 2012, Verlinde et al., 2012). Provision of language access services for 
improved language concordance increased EC, trust, access to and quality of health care, more 
preventive services, higher patient satisfaction and improved patient’s perception of the quality of 
interactions between themselves and their HP (Gregg & Saha, 2007; Wallace et al., 2009). 
Collaborative 
The process of HPI is also collaborative, with a patient and HP working together on a 
mutual understanding of information, agenda setting, goal congruence and decision-making. 
Collaboration requires interaction via EC between a patient and HP within a relationship that is 
therapeutic, balanced, and reciprocal with shared power and responsibility and equal participation 
(Mead & Bower, 2000, Talen et al., 2011, Verlinde et al., 2012). Sharing information, 
appreciating the other’s strengths and differences, establishing mutually agreed upon priorities 
and goals, and sharing decision-making are all aspects of collaboration and found to be essential 
for improved health status (Cegala et al., 2000, Street & Millay, 2001, Bylund et al., 2010).   
The primary purpose of collaboration is decision-making. Patients have different 
perspectives, priorities, needs, preferences and approaches to decision-making. HPs have been 
described as influential in both autonomous and shared decisions with patients. They are 
encouraged to be cognizant of their own professional influence in this process (Rempel et al., 
2004). Awareness of communication differences, understanding the different values and beliefs 




influential in optimizing PC decision making (Anderson, 1999, Rempel et al., 2004). Tailoring 
information, eliciting perspectives, asking questions, determining outcomes, ensuring 
collaboration and assessing other HP-patient characteristics are also imperative to this process 
(Tinetti & Basch, 2013, Verlinde et al., 2012).  
When shared decision-making was emphasized, self-reports of greater adherence to 
treatment recommendations and improved health outcomes in patients with chronic diseases 
resulted (Stewart, 1995, Stewart et al., 2000). Shared decision making with HPs is the preference 
of more than 70% of patients, although this is not consistent across all patient populations as 
certain subsets prefer HP-delegated decision-making (Chewning et al., 2012).   
Transformative 
The process of HPI is also transformative. Cognitive and emotive transformation can 
begin as soon as HP-patient interaction is initiated and continues as the relationship evolves. It 
can occur with HP provision of health information, skills, and recommendations that lead to 
increased patient knowledge, awareness, motivation, desire, trust, respect, rapport and 
confidence, if received and acted upon for health behavior modification. 
Power and leadership are required for this transformative component of HPI, a type of 
social influence (Gabel, 2012). The Transformational Leadership Model developed by Gabel 
(2012), social psychologist, provides a strong foundation upon which HPI is constructed. It 
describes a relationship between power and leadership, the types of power that play a potential 
role, and the appropriate exertion of power and leadership that is necessary to foster PC goals 
(Gabel, 2012). Expert power is that which comes from the HP as the “health problem expert” in 
the relationship and referent power is that which is derived from being respected or trusted, 
increasing as the relationship builds (Raven, 2008, Gabel, 2012). “Leadership involves working 
in socially appropriate ways to influence others in subordinate or follower positions to achieve 
principle-driven goals or objectives that these individuals may not have wanted to reach, may not 




(Gabel, 2001) whereas, power is described as the strategies used by leaders to influence those in 
subordinate or follower positions to achieve important goals (Gabel, 2012). HPI adopts these two 
concepts, placing the onus of responsibility on HPs as experts and leaders to potentiate patient 
health behavior modification.   
The idea of power and leadership may appear to be in contrast with negotiation, sharing 
information, “power sharing” and reciprocity, essential components of PC communication (PCC), 
however a power differential does not negate these components but rather reinforces them via 
referent power, resulting in empowerment. Empowerment of patients promotes patient 
engagement in decision-making and consequently improves health outcomes (Stoddart & Bugge, 
2012, Verlinde et al., 2012). 
Cognitive 
The cognitive component should continuously evolve as awareness, understanding, and 
knowledge about one’s health problem or needs, and involvement in treatment choice is 
enhanced. Cognitive transformation requires HP use of PCC during interaction and collaboration 
to modify information, strategies, or recommendations to address alterations in patient goals, 
values, lifestyle factors, motivation, intention and desire for decision-making. In many of the 
references specific to HPs, influence was described or measured as a transformative component. 
Inquiries, discussion, and provision of information by HPs via teaching and demonstration 
increases knowledge, understanding, and adoption of healthy practices (Morrison, 1996, Rempel 
et al., 2004, Orford et al., 2006, Farmer et al., 2007, Binns et al., 2009). In a study of predictors of 
breast self-examination (BSE), personal HP-to-patient teaching and HP inquiries about BSE 
practices were described as provider influence, categorized as enabling and reinforcing factors, 
and were associated with the proficiency and frequency of patient BSE practice (Morrison, 1996).  
Similarly, when the HP discussed colorectal cancer screening, odds of patient screening 
significantly increased (Farmer et al., 2007).  Delivery of new or different information than 




pursuing previously determined procedures (Gilliam et al., 2008). Discussion of treatment 
availability and provision of timely referrals for health problems by HPs was categorized as an 
external influence measure (Orford, et al., 2006). Counseling influenced the patient’s perception 
of HP’s role or status as expert, as well as the HP’s awareness of own professional and personal 
values and beliefs and assessment of patient’s personal values and beliefs (Anderson, 1999, 
Rempel et al., 2004). Decreased patient understanding of information was related to decreased 
questioning about a medical condition, treatment plans, or advice and options, and subsequently 
less adherence and compliance to treatment recommendations (Arnold et al., 2012).  
Emotive 
The emotive component includes rapport building with increasing mutual respect, trust, 
caring, confidence, support, and encouragement. Patient perception of the relationship with their 
HP, the HP’s competence, and faith and trust in their HP were found to be influenced by a 
number of provider, patient, and visit factors (Shay et al., 2012). Poor HP perceptions and past 
unfortunate patient experiences can adversely impact trust in HPs and contribute to decreased 
adherence to treatment recommendations for some patients (Ciechanowski et al., 2001, Sheppard 
et al., 2004). Conversely, HP use of PCC skills, such as understanding patient’s and own values, 
preferences and emotions while listening and discussing diagnosis and treatment options, 
allowing control and choice, and expressing concerns stimulated increased trust and positively 
predicted increased patient perception of HP competence and subsequent adherence to certain 
protective health behaviors (Epstein & Street, 2007, Sheppard et al., 2004, Verlinde, et al., 2012, 
Wallace et al., 2009,). Empathy, truthfulness, and hopefulness in HP-patient communication are 
more effective when compared to purely information-based medical consults (Hartog, 2009; 
Travaline et al., 2005). Influence has been described as faith and trust in the HP (Anderson, 1999, 





Patient-related outcomes of HPI can be categorized as cognitive, psychological, 
behavioral, and physical. Cognitively and psychologically, positive outcomes include an 
increased awareness, understanding, and knowledge of a personal health problem or need, a 
heightened perception of self and ability for change, increased desire, intention, and resolution for 
behavior modification, improved personal health outcomes, and increased satisfaction. 
Behaviorally and physically, positive outcomes include behavior modification activation, distal 
and proximal health goal(s) achievement, and improved health status and outcomes. The process 
of HPI is intended to stimulate patient activation (PA), a concept in the health literature that 
describes patient’s acquiring the understanding, knowledge, skills, beliefs, and confidence and 
then assuming a primary role in the care process by adapting health behaviors that result in better 
outcomes and satisfaction with care experiences (Hibbard et al., 2004, Hibbard & Greene, 2013).  
Related Models  
Two models contain similar constructs to those included in the HPI. Health Behavior 
Framework (HBF) (Bastani et al., 2010) identifies two categories: (1) physician and health care 
system factors, under which HP characteristics, health care settings and environment are listed 
and (2) individual factors:  knowledge, communication with provider, health beliefs, social norms 
and support, past health behaviors, barriers and supports, cultural factors and beliefs. In this 
patient-centric model, the HBF does not address the HP leadership and expert role or HP 
communication, only that of the individual patient and HP characteristics. The second model, the 
Ecological Model of Communication (Street, 2002) describes the social and reciprocal nature and 
PCC aspects for decision- making and how HP and patient characteristic concordance is 
influential but lacks other components of influence, health behavior modification outcomes, and 
the leadership and expert role of the HP. 
DISCUSSION 
Components of communication, such as different styles, demographic and language 




but neither a definition nor a model describing the process of HPI on patient health behavior 
modification and outcomes has previously been fully described in healthcare research.   
HPI Model 
A diagrammatic representation of the HP concepts (Figure 1) depicts the components 
intentionally situated to demonstrate their relationship to one another. Social-communication is 
centrally located, placed under and extends across the three components (interaction, 
collaboration, and transformation) as it represents the primary process for the work of these 
components. The concordance and logistics factors are located under interaction as these 
primarily relate to space, time, and positive or negative aspects of the interaction. Emotive and 
cognitive are located under transformation as these are the transformation foci that result from 
interaction and collaboration. The left to right ordering of interaction, collaboration, and 
transformation is intended to denote a primarily left to right direction of action although a spiral 
would illustrate the circular nature of this process ideally. 
The HPI model will likely have utility and applicability to a variety of populations, health 
behaviors, problems, and diseases as health behavior modification is first and foremost an 
individual issue and this model emphasizes an individual rather than a collective approach, 
focusing on individual HP-patient characteristics and relationship. The conditions within this 
model however may not be conducive for use in settings, communities, cultures, or countries in 
which social or cultural values do not support interaction and collaboration between HP and 
patient or in which reciprocity in the relationship, mutual respect and trust are not valued.  
There are several limitations to this integrative review of the literature and analysis. The 
HPI model is newly developed and has not yet been utilized or tested in practice or research. 
Limiting the literature review to PubMed and CINAHL and utilizing quotations around search 
terms to extract references with conceptual descriptions of influence rather than an action may 
have limited exposure to other relevant descriptions of the concept HPI or another closely termed 




selected for publications but restricting to English language may have limited finding 
international research or descriptions about HPI.  
CONCLUSION 
The development of the HPI model derived from a synthesis of relevant literature serves 
to fill a gap regarding the multifaceted process of HPI by providing an expansive and methodical 
depiction of the role the HP plays in the interaction with patients in transforming the patient’s 
adoption or modification of health behaviors. This model extends the conceptualization of PCC, 
an essential and well-researched component, to include multiple other variables that collectively 
correlate to distal or short term as well as proximal or long-term health improvement and 
outcomes. Clarifying how influence has been described and measured along with this current 
conceptualization contributes to knowledge development and understanding by HPs about how 
their demeanor, actions, understanding, communication and interaction with patients contribute to 
health status.  
HPI model research could contribute to the definition, description and measurement of 
the social facilitation construct in Ryan’s Integrated Theory of Health Behavior Change (2009), 
which serves as an ideal theoretical framework to support the HPI model. Using the HPI model in 
conjunction with TFL model concepts (Gabel, 2012) provides the framework for the development 
of new or modifications of existing PCC education and training models and interventions for HPs 
that have the potential to optimize their interactions during healthcare consultations to assist in 
achieving optimal patient health outcomes.  
The new HPI model provides a foundation for the development of future knowledge, 
research, interventions, and tailored instruments to measure the influence of nurses and other 
health care providers across a broad spectrum of patient populations and practice settings, on 
health behaviors with the long-range goals of improved health care status, decreased healthcare 
costs, and reduction in the myriad of burdens that accompany health problems. Individual health 












Anderson, G. (1999). Nondirectiveness in prenatal genetics: Patients read between the 
lines.  Nursing Ethics, 6 (2), 126-36.  
doi: 10.1177/09697330990060020510.1191/096973399671284106 
Arnold C.L., Coran, J.J., & Hagen, M.G. (2012). Revisiting patient communication 
training: An updated needs assessment and the AGENDA model. Patient 
 Education and Counseling, 88(3), 399-405. doi: 10.1016/j.pec.2012.06.026 
Bastani, R., Glenn, B.A., Taylor, B.A., Chen. M.S., Nguyen, T.T., Stewart, S.L., & 
Maxwell, A.E. (2010). Integrating theory into community interventions to reduce 
liver cancer disparities: The Health Behavior Framework. Preventative Medicine, 
 50, 63-76. doi: 10.1016/j.ypmed.2009.08.010 
Bertakis K.D. (2009). The influence of gender on the doctor-patient interaction. Patient  
Education and Counseling, 76(3), 356-60. doi: 10.1016/j.pec.2009.07.022 
 Binns, H.J., O’Neil, J., Benuck, I., & Ariza, A.J. (2009). Influence on parent’s decisions 
            for home and automobile smoking bans in households with smokers. Patient 
            Education & Counseling, 74(2), 272-6. doi: 10.1016/j.pec.2008.09.00 
Bylund, C.L., & Makoul, G. (2002). Empathic communication and gender in 
physician- patient encounter. Patient Education and Counseling 48 (2002) 207–216.  
Bylund, C.L., D’ Agostino, T.A., Ho, E.Y., & Chewning, B.A. (2010). Improving clinical 
communication and promoting health through concordance-based patient 
education. Community Education, 59, 294-311.  
Cegala, D.J., Martinelli, T.M., & Post, D.M. (2000). The effects of patient 
communication skills training on compliance. Archives of Family Medicine, 9, 







Charlton, C.R., Dearing, K.S., Berry, J.A., & Johnson, M.J. (2008). Nurse practitioners'  
communication styles and their impact on patient outcomes: an integrated 
literature review. Journal of American Academy of Nurse Practitioners, 20(7), 382-8. 
doi: 10.1111/j.1745-7599.2008. 00336.x 
Chewning, B., Bylund, C.L., Shah, B., Arora, N.K., Gueguen, J.A., & Makoul, G. (2012). 
Patient preferences for shared decisions: A systematic review. Patient Education 
and Counseling, 86(1), 9-18. doi: 10.1016/j. pec2011.02.004 
Ciechanowski, P.S., Katon, W.J., Russo, J.E., & Walker, E.A. (2001). The patient- 
provider relationship: Attachment theory and adherence to treatment in 
diabetes. American Journal of Psychiatry, 158 (1), 29-35. PMID: 11136630 
Cooper-Patrick, L., Gallo, J.J., Gonzalez, J.J., Vu, H.T., Powe, N.R., Nelson, C. et al., 
(1999). Race, gender, and partnership in the patient-physician relationship. Journal of the 
American Medical Association, 282, 583-9. 
DeVoe, J.E., Wallace, L.S., & Fryer, G.E. (2009). Measuring patient’s perceptions of 
communication with healthcare providers: Do differences in demographic  
and socioeconomic characteristics matter? Health Expectations, 12, 70-80.  doi: 
10.111/j.1369-7625.2008.00516.x 
DiMatteo, M.R. (1995). Patient adherence to pharmacotherapy: The importance of  
             effective communication. Formulary, 30, 596-8, 601-2, 605. 
Duberstein, P., Meldrim, S., Fiscella, K., Shields, C.G., & Epstein, R.M. (2007).  
Influences on patients’ ratings of physicians: Physicians demographics and 
 personality. Patient Education and Counseling, 65, 270-74. PMID: 17125958 
Durant, N. H., Bartman, B., Person, S.D., Collins, F., & Austin, S.B. (2009). Patient 
provider communication about the health effects of obesity. Patient Education 






Epstein, R.M., & Street, R.L. Jr. (2007). Patient-centered communication in cancer 
care: Promoting healing and reducing suffering. National Cancer Institute, 
 Report No: NIH Publication No. 07-6225.  
Farmer, M, Bastani, R., Kwan, L., Belman, M., & Ganz, P.A. (2007). Predictors of  
colorectal cancer screening from patients enrolled in a managed care health plan.  
Cancer, 112(6), 1230-1238. doi: 10.1002/cncr.23290 
Gabel, S. (2001). Leaders and healthcare organizational change: Art, politics and 
process. Kluwer Academic/Plenum Publishers: New York. 
Gabel, S. (2012). Power, leadership and transformation: the doctor's potential for 
influence. Medical Education, 46(12), 1152-1160. doi:10.1111/medu.12036 
Gilliam, M., Davis, S.D., Berlin, A., & Zite, N.B. (2008). A qualitative study of barriers 
to postpartum sterilization and women’s attitudes toward unfulfilled sterilization 
requests. Contraception, 78(1), 44-9. doi: 10.1016/j.contraception.2007.09.011 
Hartog, C. (2009). Elements of effective communication: Rediscoveries from 
homeopathy. Patient Education and Counseling, 77, 172-178. doi:  
10.1016/j.pec.2009.03.021 
Hibbard, J.H. Stockard, J., Mahoney, E.R., & Tusler, M. (2004). Development of the 
Patient Activation Measure (PAM): Conceptualizing and measuring activation in 
patients and consumers. Health Services Research, 39(4, part 1), 1005-26. PMID:  
15230939 
Hibbard, J.H., & Greene, J. (2013). What the evidence shows about patient activation: 
Better health outcomes and care experiences; fewer data on costs. Health Affairs, 
32(2), 207-214. doi: 10.1377/hlthaff.2012.1061 




communication and low-income adults: Age, race, literacy, and optimism 
predict communication satisfaction. Patient Education and Counseling, 79: 30- 
35. dx.doi.org/10.1016/j.pec.2009.09.041 
Jerant, A.F., von Friederichs-Fitzwater, M.M., & Moore, M. (2005). Patients’  
perceived barriers to active self-management of chronic conditions. Patient 
 Education and Counseling, 57, 300-7. PMID: 5893212 
Jucks, R., Paus E., & Bromme, R. (2012). Patients' medical knowledge and health 
counseling: What kind of information helps to make communication patient- 
centered? Patient Education and Counseling, 88(2), 177-83. Epub 2012 Feb 23. doi: 
10.1016/j.pec.2012.01.011 
Koster, F. R. T., Verheijden, M. W., & Baartmans, J. A. (2005). The power of  
communication. Modifying behaviour: Effectively influencing nutrition patterns  
of patients. European Journal of Clinical Nutrition, 59, 17-21; discussion S22-3.doi: 
10.1038/sj.ejcn.1602169 
Markova T, & Broome B. (2007). Effective communication and delivery of culturally 
            competent health care. Urologic Nursing, 27(3), 239-42. PMID: 17674601 
Mast, M.S. (2007). On the importance of nonverbal communication in the physician- 
patient interaction. Patient Education and Counseling, 67, 315-318.  
doi.10.1016/j.pec.2007.03.005 
Mead, N., & Bower, P. (2000). Patient-centeredness: A conceptual framework and 
review of the empirical literature. Social Sciences Medicine, 51, 1087-1110.  
PMID: 11005395 
Morrison. C. (1996). Determining crucial correlates of breast self-examination in older 
women with low incomes. Oncology Nursing Forum, 23 (1), 83-93.  
PMID: 8628714 








Orford, J., Kerr, C., Copello, A., Hodgson, R., Alwyn, T., Black* et al., (2006). Why 
 people enter treatment for alcohol problems: findings from UK Alcohol 
 Treatment Trial pre-treatment interviews [corrected] [published erratum appears in 
Journal of Substance Use, 11(5), 363-4. doi: 10.1080/14659890500246540 
Raven, B.H. (2008). The bases of power and the power / interaction model of interpersonal  
influence. Analyses of Social Issues & Public Policy. 8, 1-22.  
NLM: 101183751 
Rempel, G.R., Cender, L.M., Lynam, M.J., Sandor, G.G., & Farquharson, D. (2004). 
Parents' perspectives on decision making after antenatal diagnosis of congenital 
heart disease.  Journal of Obstetric, Gynecologic & Neonatal Nursing, 33 (1), 64- 
70. doi: 10.1177/084217503261092 
Ryan, P. (2009). Integrated theory of health behavior change: Background and 
intervention development. Clinical Nurse Specialist: The Journal of Advanced Nursing 
Practice,23(3), 161-72. Dx.doi.org/10.1097/NUR.0b013e3181a42373  
Ryan, P., Weiss, M., Traxel, N., & Brondino, M. (2011). Testing the Integrated Theory 
of Health Behavior Change for postpartum weight management. Journal of 
 Advanced Nursing, 67(9), 2047-2059. doi: 10.111.j.1365-2648.2011. 05648.x 
Schoenthaler, A., Allegrante, J.P., Chaplin, W., & Ogedegbe, G. (2012). The effect of 
patient-provider communication on medication adherence in hypertensive 
black patients: Does race concordance matter? Annals of Behavioral Medicine, 
43, 372-382. doi 10.1007/s12160-011-9342-5 




income women. Maternal & Child Health Journal, 7 (2), 95-102.  
doi: 1092-7875/03/0600-0095/0 
Shay, L.A., Dumenci, L., Siminoff, L.A., Flocke, S.A., & Lafata, J.E. (2012). Factors 
associated with patient reports of positive physician relational communication. Patient 
Education and Counseling, 89, 96-101. doi10.1016/j. pec2012.04.003 
Sheppard, V.B., Zambrana, R.E., & O’Malley, A.S. (2004). Providing health care to 
low-income women: A matter of trust, Family Practice, 21(5), 484-490. 
doi:10.1093/fampra/cmh503 
Smith, H., & Pietrzyk, A. (2012, August 23). Annotated bibliography on patient- 
 Provider communication. www.patientprovidercommunication.org.  
Stewart, M.A. (1995). Effective physician-patient communication and health outcomes: 
A review. Canadian Medical Association Journal, 152, 1423-33.    
Stewart, M., Brown, J.B., Donner, A., McWhinney, I.R., Oates, J., Weston, W.W. et al., 
 (2000). The impact of patient-centered care on outcomes. Journal of Family 
 Practice, 49, 796-804). 
Street, R.L. Jr. (2002). Gender difference in the health care provider-patient 
communication: Are they due to style, stereotypes, or accommodation? Patient 
 Education and Counseling, 48, 201-206. PMID: 12477604 
Street, R.L. Jr., & Millay, B. (2001). Analyzing patient participation in medical 
encounters. Health Communications, 13, 61-73.  
Stoddart, K., & Bugge, C. (2012). Uncovering the features of negotiation in developing 
the patient-nurse relationship. British Journal of Community Nursing, 17(2), 77-84. 
PMID: 22306600 
Talen, M.R., Muller-Held, C.F., Eshleman, K.G., & Stephens, L. (2011). Patients’ 
communication with doctors: A randomized control study of a brief patient 





Tarkan, L. (2008, September 15). E.R. Patients Often Left Confused After Visits,  
The New York Times, p. F1. 
Tinneti, M.E. & Basch, E. (2013). Patients’ responsibility to participate in decision 
making and research. Journal of American Medical Association, 309(22), 2331- 
2332.  
Travaline, J.M., Ruchinskas, R., & D’Alonzo, G.E. (2005). Patient-physician 
communication: Why and how. Journal of the American Osteopathic Association of 
Clinical Practice 105(1), 13-18. PMID: 15710660 
Verlinde, E., De Laender, N., De Maesschalck, S., Deveugele, M., & Willems, S. (2012). 
The social gradient in doctor-patient communication. International Journal for 
 Equity in Health,11(12), 1-14. doi:10.1186/1475-9276-11-12 
Wallace, L.S., DeVoe, J.E., Rogers, E.S., Protheroe. J., Rowlands, G., & Fryer, G.E. Jr.   
 (2009). Digging deeper: Quality of patient-provider communication across 
Hispanic subgroups. BioMed Central Health Services Research, 9(240), 1-8. 
doi:10.1186/1472-6963-9-240.  
Whittemore, R. & Knafl, K. (2005). The integrative review: Updated methodology.  











Table 1: Search Strategy and Summary of Articles on Healthcare Provider Influence 
Database: CINAHL and PubMed, Years 1992-2013 
Combined search terms and results: “influence” linked with each of the following:  
healthcare provider (1); health care provider (2); healthcare professional (0); health care professional (0); provider (18); professional (21); 
and clinician (3).  
Cumulative Results: Total 42- duplications (13) = 29 - Dissertations (3, unable to obtain) = 26 - irrelevant (18) = Final (8). 































sharing (genetic counseling) 
*HP behavior 
*Pt perception of HP as 
expert authority and behavior 
*HPs professional and personal 
biases, values and morals affect 
medical knowledge presentation 
and clinical decisions.  
*listened/heard/understood by 
HP: “knowing the pt.”  
and faith/trust in HP help pts 
make informed and autonomous 
decisions about screening and 
diagnostic tests 









smoking bans in 
homes of 
children living 










sharing (query / counseling 
about smoking)  
 
*Perception of harm was 
strongly associated with having 
bans 
*Recall of child’s doctor query 
about smoking status were less 
likely to have a home smoking 
ban - possible inadequate/too 





















sharing (CRC) with HP 
1 (of 2) strongest determinants 
of obtaining CRC screening: HP 
influence- discussion 

























sharing with HP 
*interactions with HP 
1 (of 5) last-minute themes for 
not undergoing postpartum 
sterilization. 
HPI: new/different information 
than given previously nervous 
and “leery”; convincing to opt 
for reversible options. 
Negative interactions- neglected 




















sharing (personal 1:1 pt.-HP) 
BSE demo/instruction)  
1 (of 10) variables found to 
predict BSE behavior in this 
population: HP influence- 
influential teaching, exposure to 
clinician messages – timing and 
frequency 





























External Influence  seeking 
professional help for drinking 
problems: pressure / referral – 




























*HP behavior, understanding 
of pt. perspective, timing, and 
support 
*Pt perception of HP role and 
input from expert 
 
 
Parent perception of HP role and 
expert authority varied.  
Some sought HP opinion if 
greater deliberation about 
decision 
Some offended by information – 
even if option not decision based  
Recommendations for HPs: 
Aware of parents’ perspective, 


























Greater HP-pt. familiarity 
influences women’s disclosure / 
solicitation of depression advice 














Conflict of interest  
No conflict of interest has been declared by the author(s). 
 
Funding 
This research received no specific grant from any funding agency in the public, commercial, or 






Appendix C:  
 







April 14, 2015  
Ms. Denise Fryzelka Nursing  
Dear Ms. Fryzelka: 
Your protocol number HR-2942, titled, “Healthcare Provider Influence on Health Behavior 
Modifications in Gestational Diabetics” was expedited on April 14, 2015, by a member of the 
Marquette University Institutional Review Board.  
Your IRB approved informed consent form and Authorization to Use and Disclose Protected 
Health Information in Research is enclosed with this letter. Use the stamped copies of this form 
when recruiting research participants. Each research participant should receive a copy of the 
stamped consent form for their records.  
Subjects who go through the consent process are considered enrolled participants and are counted 
toward the total number of subjects, even if they have no further participation in the study. Please 
keep this in mind when conducting your research. This study is currently approved for 66 
subjects.  
If you need to increase the number of subjects, add research personnel, or make any other 
changes to your protocol you must submit an IRB Protocol Amendment Form, which can be 
found on the Office of Research Compliance web site: 
http://www.marquette.edu/researchcompliance/research/irbforms.shtml. All changes must be 
reviewed and approved by the IRB before being initiated, except when necessary to eliminate 
apparent immediate hazards to the human subjects. Any public advertising of this project requires 
prior IRB approval. If there are any adverse events, please notify the Marquette University IRB 
immediately.  
Your approval is valid until April 13, 2016. Prior to this date, you will be contacted regarding 
continuing IRB review.  
An IRB Final Report Form must be submitted once this research project is complete. The form 
should be submitted in a timely fashion and must be received no later than the protocol expiration 
date.  
Contact the IRB office if you have any further questions. Thank you for your cooperation and 













December 7, 2015  
Ms. Denise Fryzelka Nursing  
Dear Ms. Fryzelka:  
The amendment you submitted for your protocol number HR-2942, titled, “Healthcare 
Provider Influence on Health Behavior Modifications in Gestational Diabetics,” received 
expedited approval on December 7, 2015, from a member of the Marquette University 
Institutional Review Board.  
This amendment:  
• Adds Christine Kern Steffan to research personnel;  
• Adds a control group;  
• Increases sample size to 200;  
• Modifies data collection instruments; and  
• Adds a $10 incentive to GDM participants.  
Your protocol is valid until April 13, 2016. Prior to this date, you will be 
contacted regarding continuing IRB review. Any public advertising of this project 
requires prior IRB approval. If there are any changes in your protocol or adverse 
events, please notify the IRB immediately.  
Contact the IRB office if you have any further questions. Thank you for your 
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April 7, 2016  
Ms. Denise Fryzelka Nursing  
Dear Ms. Fryzelka:  
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health Behavior 
Modifications in Gestational Diabetics” received expedited continuing approval on April 7, 
2016, from a member of the Marquette University Institutional Review Board.  
You are approved to recruit a total of 200 subjects, of which you have already recruited 7.  
You are also approved to add Stephanie Conley, Julie Hillard, Kandra Barb, Keeley Johnson 
Crosby and Alexandra Ramirez to your research personnel.  
Any changes to your protocol must be requested in writing by submitting an IRB Protocol 
Amendment Form. All changes must be reviewed and approved by the IRB before being initiated, 
except when necessary to eliminate apparent immediate hazards to the human subjects. Any 
public advertising of this project requires prior IRB approval. If there are any adverse events, 
please notify the Marquette University IRB immediately.  
Your approval is valid until April 17, 2017. Prior to this date, you will be contacted regarding 
continuing IRB review.  
An IRB Final Report Form must be submitted once this research project is complete. The form 
should be submitted in a timely fashion and must be received no later than the protocol expiration 
date.  
Contact the IRB office if you have any further questions. Thank you for your cooperation and 
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March 21, 2017  
Ms. Denise Fryzelka College of Nursing  
Dear Ms. Fryzelka:  
The amendment you submitted for your protocol number HR-2942, titled, “Healthcare 
Provider Influence on Health Behavior Modifications in Gestational Diabetics,” received 
expedited approval on March 20, 2017, from a member of the Marquette University 
Institutional Review Board.  
This amendment approves the following: 
• addition of Associate Physicians of Madison, WI as a recruitment site  
Your protocol is valid until April 17, 2017. Prior to this date, you will be contacted 
regarding continuing IRB review. Any public advertising of this project requires prior 
IRB approval. If there are any changes in your protocol or adverse events, please notify 
the IRB immediately.  
Contact the IRB office if you have any further questions. Thank you for your cooperation 
and best wishes for a successful project.  
Sincerely,  
 
Jessica Rice, MPH, CIP 
IRB Manager 










March 30, 2017  
Ms. Denise Fryzelka College of Nursing  
Dear Ms. Fryselka:  
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health 
Behavior Modifications in Gestational Diabetics” received expedited continuing 
approval on March 30, 2017, from a member of the Marquette University Institutional 
Review Board.  
You are approved to recruit a total of 200 subjects, of which you have already recruited 
162.  
Any changes to your protocol must be requested in writing by submitting an IRB 
Protocol Amendment Form. All changes must be reviewed and approved by the IRB 
before being initiated, except when necessary to eliminate apparent immediate hazards to 
the human subjects. Any public advertising of this project requires prior IRB approval. If 
there are any adverse events, please notify the Marquette University IRB immediately.  
Your approval is valid until April 17, 2018. Prior to this date, you will be contacted 
regarding continuing IRB review. Please note that it is the PI’s responsibility to be aware 
of the study’s expiration date and submit continuing review materials as needed. 
Continuing review materials submitted less than two weeks before the expiration date 
may lead to a lapse in study approval.  
An IRB Final Report Form must be submitted once this research project is complete. The 
form should be submitted in a timely fashion and must be received no later than the 
protocol expiration date.  
Contact the IRB office if you have any further questions. Thank you for your cooperation 






Jessica Rice, MPH, CIP 
IRB Manager 
Office of Research Compliance 
 
April 6, 2018  
Ms. Denise Fryzelka College of Nursing  
Dear Ms. Fryselka:  
Your protocol number HR-2942, titled “Healthcare Provider Influence on Health Behavior 
Modifications in Gestational Diabetics” received expedited continuing approval on April 5, 
2018, from a member of the Marquette University Institutional Review Board.  
You are approved to recruit a total of 200 subjects, of which you have already recruited 162.  
Any changes to your protocol must be requested in writing by submitting an IRB Protocol 
Amendment Form. All changes must be reviewed and approved by the IRB before being 
initiated, except when necessary to eliminate apparent immediate hazards to the human 
subjects. Any public advertising of this project requires prior IRB approval. If there are any 
adverse events, please notify the Marquette University IRB immediately.  
Your approval is valid until April 17, 2019. Prior to this date, you will be contacted 
regarding continuing IRB review. Please note that it is the PI’s responsibility to be aware of 
the study’s expiration date and submit continuing review materials as needed. Continuing 
review materials submitted less than two weeks before the expiration date may lead to a lapse 
in study approval.  
An IRB Final Report Form must be submitted once this research project is complete. The 
form should be submitted in a timely fashion and must be received no later than the protocol 
expiration date.  
Contact the IRB office if you have any further questions. Thank you for your cooperation and 













Are you interested in participating in research to gain further 
knowledge regarding Gestational Diabetes Mellitus? 
DO YOU QUALIFY?  
If you are 18 years or older, pregnant, speak and write English or Spanish, and have been 
told that you will be tested for Gestational Diabetes Mellitus because you are at higher 
risk or have an elevated blood sugar result from your one-hour glucose test, you may 
qualify.  
WHY IS IT IMPORTANT?  
Acquiring more knowledge about how to better treat Gestational Diabetes Mellitus 
during pregnancy is important to help prevent complications in pregnancy and following 
pregnancy for mothers and babies and reduce the risks of Diabetes Mellitus later in life.  
BENEFITS:  
Participating in this research study allows you to help us learn more about how healthcare 
providers can help women with Gestational Diabetes Mellitus engage in healthy 
behaviors, in order to treat themselves to reduce the complications for themselves and 
their babies during pregnancy and prevent Diabetes Mellitus in the future.  
TIME COMMITMENT:  
It will only take 5 minutes to complete questionnaires for Phase 1. It will take an 
additional 2‐3 minutes to complete questionnaires for Phase 2 if you do not have 
Gestational Diabetes Mellitus and approximately 25 minutes to complete 
questionnaires if you do have Gestational Diabetes Mellitus.  
It will not require any additional laboratory testing or extra visits. 
You can complete it during a clinic visit before or after you see your healthcare provider. 
If you are interested, please contact *** 
Conducted by Denise Fryzelka, PhD student, Marquette University  
If you have any questions about this research project, you can contact Denise Fryzelka by phone at 
816‐716‐ 9901 or by email at dfryzelkacnm@hotmail.com.    
        




¿Ud. interesa participar en la investigación para adquirir más conocimientos 
sobre Diabetes Mellitus Gestacional? 
¿CALIFICA USTED?  
Si Ud. tiene 18 años o más, está embarazada, habla y escribir inglés o español y le han 
dicho que le harán la prueba para Diabetes gestacional porque Ud. Corre un mayor riesgo 
o ya tiene un resultado de azúcar en la sangre elevada en su prueba de glucosa de una 
hora, usted puede calificar.  
¿POR QUÉ ES IMPORTANTE?  
Adquirir más conocimientos sobre cómo tratar mejor la Diabetes gestacional durante el 
embarazo es importante para ayudar a prevenir complicaciones en el presente embarazo y 
el siguiente embarazo para las madres y los bebés y reducir los riesgos diabetes más 
adelante en vida.  
BENEFICIOS:  
Participar en este estudio de investigación permite que nos ayuden a aprender más sobre 
cómo los prestadores de servicios pueden ayudar a las mujeres con Diabetes gestacional 
involucrarse en comportamientos saludables, para tratar ellos mismos para reducir las 
complicaciones para ellas y sus bebés durante el embarazo y prevenir la Diabetes más 
adelante en la vida.  
CUANTO TIEMPO TOMA:  
Solo tardará 5 minutos para completar cuestionarios de fase 1. Tomará unos 2 a 3 
minutos más para completar la segunda fase si Ud. no tiene diabetes gestacional y 25 
minutos completar la segunda fase si Ud. tiene diabetes gestacional.  
No requerirá visitas adicionales o pruebas de laboratorio adicionales. 
Usted puede completar durante una visita a la clínica antes o después de ver su proveedor 
de atención médica. Si usted está interesado, póngase en contacto con: 
Realizado por Denise Fryzelka, CNM, PhDc, estudiante de doctorado, Universidad de 
Marquette. Si usted tiene alguna pregunta acerca de este proyecto de investigación, 
puede comunicarse con Denise Fryzelka por teléfono al 816‐716‐9901 o por correo 
electrónico a dfryzelkacnm@hotmail.com. 






AGREEMENT OF CONSENT FOR RESEARCH PARTICIPANTS 
HEALTHCARE PROVIDER INFLUENCE ON HEALTH BEHAVIOR 
MODIFICATIONS IN GESTATIONAL DIABETICS 
Denise K. Fryzelka, CNM, MS 
College of Nursing 
You have been invited to participate in this research study. Before you agree to 
participate, it is important that you read and understand the following information. 
Participation is completely voluntary. Please ask questions about anything you do not 
understand before deciding whether or not to participate.  
PURPOSE: The purpose of this research study is ask questions about eating and physical 
activity practices you engage in and who and how pregnant women with gestational 
diabetes are influenced to make changes in their diet and physical activity levels. You 
will be one of a minimum of 66 participants in this research study.  
PROCEDURES: You will be asked to complete a set of questionnaires. Following your 
laboratory testing, if you are diagnosed with gestational diabetes you will be invited to 
participate in a second phase, wherein you will be asked to complete another set of 
questionnaire and surveys when you return for one of your prenatal visits at 
approximately 34-36 weeks gestational age. After completion of the questionnaires, your 
participation in the study is fulfilled  
DURATION: Your participation may take approximately 5 minutes to complete 
questionnaires for the first phase today and 25 minutes for the second phase to complete 
questionnaires.  
RISKS: There are no risks associated with participation in this study or at least none 
greater than you would experience in everyday life.  
BENEFITS: The benefits associated with participation in this study include assisting 
research efforts in understanding how healthcare providers can improve their care and 
counseling for pregnant women with gestational diabetes. Additionally, your 
participation may provide you with a better understanding and an increased awareness of 
the educational components that are involved in caring for and treating gestational 







CONFIDENTIALITY: All information you reveal in this study will be kept 
confidential. All your data will be assigned an arbitrary code number rather than using 
your name or other personal information that could identify you as an individual. When 
the results of the study are published, you will not be identified by name at any time and 
results will be reported grouped together with others. The data will be destroyed by 
shredding paper documents and deleting electronic files three years after the completion 
of the study. All data in hard copy or electronic copy will be stored in a locked and secure 
location and all computer files will be password protected.  
VOLUNTARY NATURE OF PARTICIPATION: Participating in this study is 
completely voluntary and you may withdraw from the study and stop participating at any 
time without penalty or loss of benefits.  
COMPENSATION: Due to the additional length of time to complete the questionnaires 
in Phase 2 of the study if you do have gestational diabetes; you will be compensated with 
a $10.00 gift card to a local department or grocery store (e.g. Target, Walmart, 
Woodmans, or other) following completion of Phase 2.  
CONTACT INFORMATION: If you have any questions about this research project, 
you can contact Denise Fryzelka by phone at 816-716-9901 or by email at 
dfryzelkacnm@hotmail.com. If you have questions or concerns about your rights as a 
research participant, you can contact Marquette University’s Office of Research 
Compliance at (414) 288-7570 or orc@mu.edu.  
I HAVE HAD THE OPPORTUNITY TO READ THIS CONSENT FORM, ASK 
QUESTIONS ABOUT THE RESEARCH PROJECT AND AM PREPARED TO 
PARTICIPATE IN THIS PROJECT.  
_________________________________________ 
(Printed Name of Participant)  
_________________________________________ 




(Printed Name of Individual Obtaining Consent)  
__________________________________________ 







AGREEMENT OF CONSENT FOR RESEARCH PARTICIPANTS  
HEALTHCARE PROVIDER INFLUENCE ON HEALTH BEHAVIOR 
MODIFICATIONS IN GESTATIONAL DIABETICS 
Denise K. Fryzelka, CNM, MS 
College of Nursing 
You have been invited to participate in this research study. Before you agree to 
participate, it is important that you read and understand the following information. 
Participation is completely voluntary. Please ask questions about anything you do not 
understand before deciding whether or not to participate.  
PURPOSE: The purpose of this research study is ask questions about eating and physical 
activity practices you engage in and who and how pregnant women with gestational 
diabetes are influenced to make changes in their diet and physical activity levels. You 
will be one of a minimum of 200 participants in this research study.  
PROCEDURES: You will be asked to complete a set of questionnaires. Following your 
laboratory testing, you will be invited to participate in a second phase, wherein you will 
be asked to complete another set of questionnaire and surveys when you return for one of 
your prenatal visits at approximately 34-36 weeks gestational age. The number of 
questionnaires will depend on whether you are diagnosed with gestational diabetes or not. 
After completion of the questionnaires, your participation in the study is fulfilled  
DURATION: Your participation may take approximately 5 minutes to complete 
questionnaires for Phase 1 today. It will take approximately 2-3 minutes to complete 
Phase 2 if you do not have gestational diabetes and 25 minutes for Phase 2 if you do have 
gestational diabetes.  
RISKS: There are no risks associated with participation in this study or at least none 
greater than you would experience in everyday life.  
BENEFITS: The benefits associated with participation in this study include assisting 
research efforts in understanding how healthcare providers can improve their care and 
counseling for pregnant women with gestational diabetes. Additionally, you participation 
may provide you with a better understanding and an increased awareness of the 
educational components that are involved in caring for and treating gestational diabetes 





CONFIDENTIALITY: All information you reveal in this study will be kept 
confidential. All your data will be assigned an arbitrary code number rather than using 
your name or other personal information that could identify you as an individual. When 
the results of the study are published, you will not be identified by name at any time and 
results will be reported grouped together with others. The data will be destroyed by 
shredding paper documents and deleting electronic files three years after the completion 
of the study. All data in hard copy or electronic copy will be stored in a locked and secure 
location and all computer files will be password protected.  
VOLUNTARY NATURE OF PARTICIPATION: Participating in this study is 
completely voluntary and you may withdraw from the study and stop participating at any 
time without penalty or loss of benefits.  
COMPENSATION: Due to the additional length of time to complete the questionnaires 
in Phase 2 of the study if you do have gestational diabetes; you will be compensated with 
a $10.00 gift card to a local department or grocery store (e.g. Target, Walmart, 
Woodmans, or other) following completion of Phase 2.  
CONTACT INFORMATION: If you have any questions about this research project, 
you can contact Denise Fryzelka by phone at 816-716-9901 or by email at 
dfryzelkacnm@hotmail.com. If you have questions or concerns about your rights as a 
research participant, you can contact Marquette University’s Office of Research 
Compliance at (414) 288-7570 or orc@mu.edu.  
I HAVE HAD THE OPPORTUNITY TO READ THIS CONSENT FORM, ASK 
QUESTIONS ABOUT THE RESEARCH PROJECT AND AM PREPARED TO 
PARTICIPATE IN THIS PROJECT.  
___________________________________________________________________ 
(Printed Name of Participant)  
___________________________________________________________________ 




(Printed Name of Individual Obtaining Consent)  
__________________________________________________________________ 








ACUERDO DE CONSENTIMIENTO PARA LOS PARTICIPANTES DE LA 
INVESTIGACIÓN 
INFLUENCIA DEL PROVEEDOR DE LA SALUD EN LAS MODIFICACIONES DEL 
COMPORTAMIENTO EN DIABÉTICAS GESTACIONALES 
Denise K. Fryzelka, CNM, MS 
Facultad de Enfermería 
 
Ud. ha sido invitada a participar en este estudio de investigación. Antes de que Ud. 
acceda a participar, es importante que Ud. lea y entienda la siguiente información. Su 
participación es completamente voluntaria. Por favor pregunte si no entiende algo antes 
de decidir participar.  
PROPOSITO: El propósito de este estudio de investigación es el de preguntar con 
respecto a prácticas de alimentación y actividad física que Ud. hace y quién y cómo las 
mujeres embarazadas con diabetes gestacional son influenciadas a hacer cambios en su 
dieta y niveles de actividad física. Ud. será una de un mínimo de 66 participantes en este 
estudio de investigación.  
PROCEDIMIENTOS: Le pedirán completar una seria de cuestionarios. Después de la 
prueba de laboratorio, y si se le diagnostica diabetes gestacional le invitarán a que 
participe en un segunda fase en la cual se le pedirá que complete otra serie de 
cuestionarios y encuestas cuando usted venga para una de sus visitas prenatales entre las 
semanas 34-36 aproximadamente. Después de la terminación de los cuestionarios, su 
participación en el estudio se ha completado.  
DURACION: Su participación puede tomar aproximadamente 5 minutos para completar 
los cuestionarios de la primera fase. Tomará unos 2 a 3 minutos más para completar la 
segunda fase si Ud. no tiene diabetes gestacional y 25 minutos completar la segunda fase 
si Ud. tiene diabetes gestacional.  
RIESGOS: No hay riesgos asociados a la participación en este estudio o por lo menos 
ninguno mayor al que usted experimentaría en la vida diaria.  
BENEFICIOS: Las ventajas asociaron a la participación en este estudio incluyen ayudar a 
los esfuerzos de investigación entendiendo como los proveedores de salud pueden 
mejorar los cuidados de salud al aconsejar embarazadas con diabetes gestacional. 
Además, su participación puede darle a usted una comprensión mejor y mayor 




gestacional y de cómo estos previenen o disminuyen los riesgos futuros para desarrollar 
la Diabetes Mellitus.  
 
CONFIDENCIALIDAD: Toda la información que usted revela en este estudio será 
mantenida confidencial. Todos sus datos serán asignados un número de código en vez de 
utilizar su nombre u otra información personal que pudiera identificarla individualmente. 
Cuando los resultados del estudio se publiquen, usted no va a ser nunca identificada por 
nombre y sus resultados se reportaran agrupados con otros. Los datos serán destruidos y 
todo papel será pulverizado tres años después de haber completado el estudio y los 
archivos electrónicos serán destruidos.. Todos los datos en computadores serán 
protegidos con contraseñas y los computadores estarán en un lugar seguro y bajo llave.  
NATURALEZA VOLUNTARIA DE LA PARTICIPACION: El participar en este 
estudio es completamente voluntario y Ud. puede retirarse del estudio y parar de 
participar en cualquier momento sin ningún tipo de multa o pérdida de beneficios.  
COMPENSATION: Si le diagnostican diabetes gestacional y participa en la 
Segunda fase del estudio, se le compensará con una tarjeta de regalo por $10.00 de un 
almacén local de departamento o de la tienda de comestibles (e.g. Target, Walmart, 
Woodmans entre otras.  
INFORMACION DE CONTACTO: si usted tiene alguna pregunta acerca de este 
proyecto de investigación, puede comunicarse con Denise Fryzelka por teléfono al 
816‐716‐9901 o por correo electrónico a dfryzelkacnm@hotmail.com. Si Ud. tiene 
preguntas con respecto a sus derechos como participante Ud. Puede contactar la 
oficina de Cumplimiento de Investigación de la Universidad Marquette al (414) 288-
7570 o orc@mu.edu.  
HE TENIDO LA OPORTUNIDAD DE LEER ESTA FORMA DE 
CONSENTIMIENTO, HE HECHO PREGUNTAS ACERCA DEL PROYECTO DE 
INVESTIGACIÓN Y ESTOY PREPARADA PARA PARTICIPAR EN ESTE 
PROYECTO.  
______________________________________________ 
(Nombre en imprenta de la participante)  
______________________________________________ 














Appendix D:  
 





Phase 1 HPI Research Study 
You have been selected and invited to participate in this research study while you are 
completing laboratory testing for Gestational Diabetes Mellitus (GDM).    
 
Consent: Participation is completely voluntary. Completion of this form indicates your 
willingness to participate in this study. Confidentiality will be maintained, as no personal 
information regarding you will be reported on these forms.   
 
Purpose: Your participation in this study will support research intended to increase the 
knowledge and lend a greater understanding about GDM in pregnancy.   
 
Procedure: You are asked to answer the questions below. If you qualify for the second 
part of the research project and you agree to participate, you will be asked to complete 
additional questionnaires at approximately 34-36 weeks of pregnancy before or following 
a prenatal appointment. After completion of those questionnaires, your participation in the 
study is fulfilled. Please place your name and contact information on the outside of the 
envelope only in order to allow us to contact you regarding the date of an appointment at 
which to complete the forms. Thank you for participating in this important research.  
 
Study Participant #_____________ 
Date _________________________ 
 
Participant Demographic Questionnaire (PDQ) 
• Age _____________________________________ 
• Completed years of education_________________ 
• What is your Race/Ethnicity ______________________? 
• Have you ever had Gestational Diabetes Mellitus:  Yes_____ No______? 
• Do you have a family history of Diabetes Mellitus: Yes_____ No______? 
o If yes, who had Diabetes Mellitus? __________________________________ 
• How long have you lived in the United States? ____________________ 
• What is your primary language? ________________________________ 
• Are you seeing the type of Healthcare provider you desired to see for your  
                  prenatal care?  Y_____ N______ 
 
To be completed by researcher  
• Early GA GDM screening: Yes _____ if yes, indication _____________ No______ 
OR routine GDM screening Yes __________ 
• Parity_________ 




Eating Breakfast Questionnaire + 1 (EBQ+1) 
 
1. How many times last week (past 7 days) did you eat breakfast when you got 
up? (within 2 hours of getting up) _________________times last week? 
 
2. This morning, did you eat any of the following foods for breakfast? (please 
 check all that apply) 
o Milk (1/2 cup) / nut “milk” (for example, almond milk, coconut milk) 
o eggs      
o cheese / cottage cheese     
o meat, poultry, or fish      
o yogurt     
o beans 
o nuts/nut butters (for example, almond butter / peanut butter) 
          If you ate anything else, please write here:  ______________________________ 
 
3. How many portions of vegetables do you eat every day? ___________  
 
Physical Activity Scale (PAS) 
During the past week, even if it was not a typical week for you, how much total time (for the 
entire week) did you spend on each of the following? (Please circle only one number for each 
question)  
How much time total 
during the past week (past 
7 days) … 














1. Stretching or 
strengthening exercises 
(range of motion, using 
weights, etc.) 
0 1 2 3 4 
2. Walk for exercise 0 1 2 3 4 
3. Swimming or aquatic 
exercise 
0 1 2 3 4 
4. Bicycling (including 
stationary exercise bikes) 
0 1 2 3 4 
5. Other aerobic exercise 
equipment (Stairmaster, 
rowing, skiing machine, 
etc.) 
0 1 2 3 4 
6. Other aerobic exercise 
Specify________________
_ 





Phase 2 HPI Research Study 
You have been selected and invited to participate in the second phase of this research 
study due to your experience with Gestational Diabetes Mellitus (GDM).    
 
Consent: Participation is completely voluntary. Completion of these questionnaires 
indicates your willingness to participate in this study. Confidentiality will be maintained, 
as no personal information regarding you will be reported on these forms.  A few pieces 
of information regarding your biometrics will be collected from your medical record 
related to factors effecting GDM after which no more information will be accessed from 
your medical records.  
 
Purpose: Your participation in this study will support research intended to increase the 
knowledge and lend a greater understanding about GDM in pregnancy.   
 
Procedure: You are asked to complete the questionnaires below. After completion of those 
questionnaires, your participation in the study is fulfilled. Thank you for participating in 
this important research.  
 
Study Participant #_____________ 
Date _________________________ 
 
Healthcare Provider Demographic Questionnaire (HPDQ)  
 
• Where do you receive your prenatal care: clinic name? 
___________________________________________ 
• What is the name of your healthcare provider or group? 
____________________________________________ 
• What is the gender of your healthcare provider? 
______________________________________ 
• What is the race/ethnicity of your healthcare provider? 
___________________________________________ 
• What language does your healthcare provider use with you at your visits? 
__________________________________________________________ 
• Does your healthcare provider use an interpreter?   
Yes ________________      No______________  
 
 
 To be completed by researcher  
• Phase 2 BMI: __________ 
• Professional discipline: MD/DO: OB or FP, CNM, NP, PA  
• HP Age ____________       HP Years in practice_________ 





Social Influence Questionnaire (SIQ) 
 
Please tell me how who gave you counseling regarding Gestational Diabetes Mellitus 
(GDM).  
(Can mark more than one) 
1. Nurse/Nurse Practitioner 
2. Midwife 
3. Doctor  
4. Diabetic Nurse-Educator/Registered Dietitian  
5. Other (Provider Type/Specialty) ______________________________ 
 
Please tell me how much influence each healthcare provider or group of healthcare 
providers has / have on decisions you make about your health management, such as food 
and drink intake and physical activity by circling one number from 1 to 5 that best describes 
how you feel. For example, circling number 4 means you feel more like the description of number 
5 (“strongly influences”) than number 1 (“no influence”) but not completely.  
 
                 1                                                                                                  5 
 “no influence”                                                                         “strongly influences” 
 
My ___________ has/or ____________decisions I make about 
my health management such as food/drink intake and 
physical activity… 
1 meaning “no influence 
and 5 meaning “strongly 
influences” 
Nurse/Nurse Practitioner    1       2        3       4        5 
Midwife or Doctor      1       2        3       4        5 
Diabetic Educator/Registered Dietitian     1       2        3       4        5 
Other (Provider type or specialty) 
__________________________ 
   1       2        3       4        5 
 
Social Influence Questionnaire – Healthcare Provider (SIQHP) 
 
Please rate how strongly you think each healthcare provider agrees with the following 
statement on a scale of 1-5 by circling one number from 1 to 5 that best describes how you feel. 
For example, circling number 4 means you feel more like the description of number 5 (“strongly 
agrees”) than number 1 (“strongly disagrees”) but not completely. 
 
                       1                                                                                      5 
      “strongly disagrees”                                                        “strongly agrees” 
 
  
My perinatal healthcare provider (Midwife or Doctor) 
________that … 
1 meaning “strongly 
disagrees” and 5 meaning 
“strongly agrees”  
 
I can treat my Gestational Diabetes if I change what I eat and 
drink now 
    1       2        3       4        5 
I can treat my Gestational Diabetes if I become more physically 
active now 
    1       2        3       4        5 
I could develop Diabetes Mellitus later in life if I do not change 
what I eat and drink now 




I could develop Diabetes Mellitus later in life if I do not become 
more physically active now 
    1       2        3       4        5 
I am able to change what I eat and drink     1       2        3       4        5 
I am able to become more physically active      1       2        3       4        5 
If I begin to change what I eat and drink, I could prevent 
Diabetes Mellitus later in life 
    1       2        3       4        5 
If I become more physically active, I could prevent Diabetes 
Mellitus later in life 
    1       2        3       4        5 
Lot of things get in the way of me changing what I eat and drink 
and/or becoming more physically active  
    1       2        3       4        5 
 
Social Influence Questionnaire – Diabetic Educator (SIQDE) 
 
Please rate how strongly you think each healthcare provider agrees with the following 
statement on a scale of 1-5 by circling one number from 1 to 5 that best describes how you feel. 
For example, circling number 4 means you feel more like the description of number 5 (“strongly 
agrees”) than number 1 (“strongly disagrees”) but not completely. 
 
                       1                                                                                       5 
      “ strongly disagrees”                                                         “strongly agrees” 
 
 
The Diabetic Educator/Registered Dietitian ______ that … 
1 meaning “strongly 
disagree” and 5 meaning 
“strongly agree” 
I can treat my Gestational Diabetes if I change what I eat and 
drink now 
    1       2        3       4        5 
I can treat my Gestational Diabetes if I become more physically 
active now 
    1       2        3       4        5 
I could develop Diabetes Mellitus later in life if I do not change 
what I eat and drink now 
    1       2        3       4        5 
I could develop Diabetes Mellitus later in life if I do not become 
more physically active now 
    1       2        3       4        5 
I am able to change what I eat and drink     1       2        3       4        5 
I am able to become more physically active      1       2        3       4        5 
If I begin to change what I eat and drink, I could prevent 
Diabetes Mellitus later in life 
    1       2        3       4        5 
If I become more physically active, I could prevent Diabetes 
Mellitus later in life 
    1       2        3       4        5 
Lot of things get in the way of me changing what I eat and drink 
and/or becoming more physically active  









                           Quality of Information-Interaction-Gestational Diabetes Mellitus (QOII) 
 
Please circle your answer by selecting one number from 0 to 10. The words below the numbers indicate 
what the 0 or the 10 mean. Pick a number between 0 and 10 that best describes how you feel. For example, 
circling number 7 means you feel more like the description of number 10 than number 0 but not 
completely.  
 
1a. How much information did you need 
from your healthcare provider (nurse, 
midwife, or doctor) about treating 
Gestational Diabetes Mellitus after you 
were told about your diagnosis? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
1b. How much information did you receive 
from your healthcare provider (nurse, 
midwife, or doctor) about treating 
Gestational Diabetes Mellitus after you 
were told about your diagnosis? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                         A great deal 
2a. How much information did you need 
from your healthcare provider (nurse, 
midwife, or doctor) about what changes to 
make in what you eat and drink? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
2b. How much information did you receive 
from your healthcare provider (nurse, 
midwife, or doctor) about what changes to 
make in what you eat and drink? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
2c. How much information did you need 
from the Diabetic Educator/Registered 
Dietitian about what changes to make in 
what you eat and drink? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
2d. How much information did you receive 
from the Diabetic Educator/Registered 
 0      1      2      3      4      5      6      7      8      9      10 




Dietitian about what changes to make in 
what you eat and drink? 
3a. How much information did you need 
from your healthcare provider (nurse, 
midwife, or doctor) about increasing 
physical activity? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
3b. How much information did you receive 
from your healthcare provider (nurse, 
midwife, or doctor) about increasing 
physical activity? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
3c. How much information did you need 
from the Diabetic Educator/Registered 
Dietitian about increasing physical activity? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
3d. How much information did you receive 
from the Diabetic Educator/Registered 
Dietitian about increasing physical activity? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
4a. How much information did you need 
from the Diabetic Educator about how to 
take and record your blood sugars? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
4b. How much information did you receive 
from the Diabetic Educator about how to 
take and record your blood sugars?         
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
5a. How much practice did you need with 
checking your blood sugars before leaving 
your counseling appointment with the 
Diabetic Educator? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
 5b. How much practice did you have with 
checking your blood sugars before leaving 
your counseling appointment with the 
Diabetic Educator? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
  6a. How much information did you need 
from your healthcare provider (nurse, 
midwife, or doctor) about who and when to 
 0      1      2      3      4      5      6      7      8      9      10 




call if you have problems at home after you 
received your diagnosis? 
6b. How much information did you receive 
from your healthcare provider (nurse, 
midwife, or doctor) about who and when to 
call if you have problems at home after you 
received your diagnosis? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
6c. How much information did you need 
from the Diabetic Educator/Registered 
Dietitian about who and when to call if you 
have problems at home after your 
counseling appointment? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
6d. How much information did you receive 
from the Diabetic Educator/Registered 
Dietitian about who and when to call if you 
have problems at home after your 
counseling appointment? 
 0      1      2      3      4      5      6      7      8      9      10 
None                                                          A great deal 
7a. How much did the information 
provided by your healthcare provider 
(nurse, midwife, or doctor) answer your 
specific concerns and questions? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
7b. How much did the information 
provided by the Diabetic 
Educator/Registered Dietitian answer your 
specific concerns and questions? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
8a. How much did your healthcare provider 
(nurse, midwife, or doctor) listen to your 
concerns? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                    Extremely  
8b. How much did the Diabetic 
Educator/Registered Dietitian listen to 
your concerns? 
 0      1      2      3      4      5      6      7      8      9      10 




9a. Was your healthcare provider (nurse, 
midwife, or doctor) sensitive to your 
personal beliefs and values? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
9b. Was the Diabetic Educator/Registered 
Dietitian sensitive to your personal beliefs 
and values? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
10a. Did you like the way your healthcare 
provider (nurse, midwife, or doctor) 
taught you about how to take care of your 
Gestational Diabetes Mellitus?  
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
10b. Did you like the way the Diabetic 
Educator/Registered Dietitian taught you 
about how to take care of your Gestational 
Diabetes Mellitus?  
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
11a. Was the information your healthcare 
provider (nurse, midwife or doctor) 
provided about caring for Gestational 
Diabetes Mellitus presented to you in a 
way you could understand? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                        Always 
11b. Was the information the Diabetic 
Educator/Registered Dietitian provided 
about caring for Gestational Diabetes 
Mellitus presented to you in a way you 
could understand? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                       Always 
12a. Did your healthcare provider (nurse, 
midwife, or doctor) check to make sure 
you understood the information and 
instructions? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
12b. Did the Diabetic Educator/Registered 
Dietitian check to make sure you 
understood the information and 
instructions? 
 0      1      2      3      4      5      6      7      8      9      10 






















13.  Did you receive consistent (the same) 
information from your healthcare provider 
(nurses, midwives, doctors) and Diabetic 
Educator/Registered Dietitian? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                        Always  
14.  Was the information about caring for 
your Gestational Diabetes Mellitus given to 
you at times that were good for you?  
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                       Always 
15.  Was the information you received from 
the Diabetic Educator/Registered Dietitian 
given at times when your family 
member(s) or others could attend? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                       Always 
16a. Did your healthcare provider (nurse, 
midwife, or doctor) help you to feel 
confident in your ability to care for 
Gestational Diabetes Mellitus? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
16b. Did the Diabetic Educator/Registered 
Dietitian help you to feel confident in your 
ability to care for Gestational Diabetes 
Mellitus? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
17a. Did the information your healthcare 
provider (nurse, midwife, or doctor) 
provided about Gestational Diabetes 
Mellitus decrease your anxiety about 
taking care of yourself? 
 0      1      2      3      4      5      6      7      8      9      10 
Not at all                                                  A great deal 
17b. Did the information your Diabetic 
Educator/Registered Dietitian provided 
you about Gestational Diabetes Mellitus 
decrease your anxiety about taking care 
of yourself?  
 0      1      2      3      4      5      6      7      8      9      10 




Multifactor Leadership Questionnaire 5-X (Sample*) 
Healthcare provider name or group___________________________________ 
This questionnaire is to describe the leadership style of the Healthcare Provider 
individual or Group mentioned above as you    perceive it.  
Please answer all items on this answer sheet. If an item is irrelevant, or if you are 
unsure or do not know the answer, leave the answer blank.  
Please answer this questionnaire anonymously. 
 
Judge how frequently each statement fits the Healthcare provider 
(Midwife/Doctor/Nurse Practitioner) you are describing. Use the following rating 
scale:  
 
Not at all     Once in a while      Sometimes     Fairly often   Frequently, if not 
always                                                                                                                                                     
      0                     1                              2                    3                             4 
My healthcare provider (s) (midwife /doctor/nurse practitioner) … 
1. Provides me with assistance 
when showing my efforts in 
making changes for my health 
     0          1          2          3          4 
2. Delays responding to urgent 
questions 
     0          1          2          3          4 
3. Treats me as an individual rather 
than just another patient 
    0          1          2          3          4 
4. Makes clear what one can 
expect to receive when goals are 
achieved 
     0          1          2          3          4 
5. Increases my willingness to try 
harder 
     0          1          2          3          4 
© Altered by permission of publisher, Mind Garden, Inc. © Mind and Garden, Approved 
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 Diabetes Self-Efficacy Scale-Gestational Diabetes Mellitus (DSES) 
 
We would like to know how confident you are in doing certain activities.  
For each of the following questions, please choose the number scale 1-10 below that  
corresponds to your confidence that you can do the tasks regularly at the present time. 
 
Not at all 
confident 
1    2  3  4  5  6  7  8  9  10 
   Totally 
   confident 
Using the scale of 1-10 above, please score the questions below: 
1. How confident do you feel that you can eat your meals every 4 to 5 hours every day, 
including breakfast every day? _____________ 
2. How confident do you feel that you can follow your diet when you have to prepare or 
share food with other people who do not have gestational diabetes? __________ 
3. How confident do you feel that you can choose the appropriate foods to eat when you 
are hungry (for example, snacks)? _____________ 
4. How confident do you feel that you can exercise 15 to 30 minutes, 4 to 5 times a week? 
5. How confident do you feel that you can do something to prevent your blood sugar level 
from dropping when you exercise? _______________ 
6. How confident do you feel that you know what to do when your blood sugar level goes 
higher or lower than it should be? _________________ 
7. How confident do you feel that you can judge when the changes in your illness mean 
you should visit the doctor? __________________ 
8. How confident do you feel that you can control your gestational diabetes so that it does 
not interfere with the things you want to do? ______________ 
 
EBS+1 and PAS – Repeated in Phase 2 
 
Glucose Monitoring Questionnaire (GMQ) 
 
On how many days in the last week did you test your blood sugar levels?  
(If you were sick in the last week, think of the most recent 7 days when you were NOT 
sick)  
 
1. On how many days in the last week (past 7 days) did you test your blood sugar 
levels? ___________________ 
2. On how many days in the last week (past 7 days) did you test your blood sugar 
levels 4 times per day? _______________ 
3. How many times during the last week (past 7 days) were your blood sugar 
results higher than what is recommended? _______________ 
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Objective: To explore associations between healthcare provider professional influence of 
maternity healthcare providers and diabetic nurse-educators on gestational diabetes 
mellitus (GDM) patient engagement in modification of eight healthy eating, physical 
activity, and glucose monitoring behaviors.  
Methods: In an exploratory study that utilized a longitudinal correlational design, 
participants (N=78) completed questionnaires at initial high-risk GDM screening and 34-
36 weeks gestational age. 
Results: Professional influence and quality of information and patient interaction during 
teaching encounters by maternity healthcare providers and diabetic nurse-educators 
contributed to increased breakfast frequency/weekly (p=.09). Maternity healthcare 
providers leadership style, specialty, and provider-patient concordance variables were 
associated with modification of other health behaviors.   
Conclusion: Patients’ perception of their healthcare providers’ influence, quality of 
information and interaction in teaching encounters and leadership style, and patient-
healthcare provider concordance factors influence GDM patients’ engagement in health 
behavior modifications.  
Practice Implications: Self-reflection about professional influence, quality of teaching, 
and leadership style could improve provider capacity to influence health behavior 
modification in GDM patients. Attention to provider-patient concordance can also be an 
influencing factor in health behavior change.  
 
Keywords: Healthcare provider influence, Health behavior modification, Gestational 
diabetes mellitus, Healthy eating, Physical activity, Glucose monitoring   
 
Highlights  
• Maternity and diabetic nurse-educator healthcare providers are professional influencers 
• Professional influence, information and interaction were associated with healthy eating  
• Interpersonal power dynamics of race and gender affect health behavior change 
• Professional influence from nurse-midwives predicted increased physical activity 









  Gestational diabetes mellitus (GDM), diagnosed in pregnancy, has an 
estimated prevalence rate of 9.2%-19.9%, in the US and globally with steadily rising 
incidence rates up to 25% [1-4]. Rates of reoccurrence of GDM in subsequent 
pregnancies range from 30-84%, and up to 74% for developing Diabetes Mellitus (DM) 
[5-7]. Risks for GDM include a complex and inter-related pattern of demographic 
characteristics (such as advanced maternal age, higher parity, non-white race, lower 
economic status, acculturation to the U.S), health history (previous history, pre-
pregnancy obesity, increased intra-pregnancy weight gain, family history of DM), and 
health behaviors (unhealthy eating habits, lack of physical activity) [8-10]. Improperly 
managed or uncontrolled GDM can result in significant pregnancy and long-term 
maternal-child complications, including malformations, pre-eclampsia, preterm delivery, 
macrosomia, maternal and fetal birth injury, childhood/adult obesity, maternal/neonatal 
hypoglycemia, increased labor inductions or operative deliveries, increased miscarriage, 
stillbirth and infant mortality rates [11-13].  
Evidence-based practice for managing GDM and preventing future GDM and DM 
includes recommendations for early high-risk and routine screening in pregnancy, 
postpartum, and lifelong. Treatment modalities include support by reiterative education 
and counseling by healthcare providers on initiation and continuation of health behavior 
modifications to healthy eating, physical activity, and glucose monitoring [14-16]. The 
goal is to prevent complications by establishing and maintaining good glucose control 
throughout the pregnancy and beyond [4,14,17].  
GDM patient-identified barriers to self-management in pregnancy include 
communication problems with healthcare providers, specifically, language discordance, 
lack of discussion time in patient visits, not being heard about needs and inability to 
control sugars, and inadequate verbal or written information [18]. Other discordance 
factors of race, culture, attitude, age, and gender are also potential barriers to healthcare 
provider-patient communication [19-21].  
Multiple sources of social influence have been found to be associated with health 
behaviors [23-25]. As a credible authority, healthcare providers can influence patients to 
engage in health behavior modification and provide informational support and 
recommendations for action. Insufficient GDM/DM knowledge in patient understanding 
around a lifelong risk, and belief that diabetes is transient and will go away after 
childbirth, can impede attentiveness to diet and other lifestyle modification 
recommendations [13,18,22]. While a lack of social support and influence from 
healthcare providers contribute to barriers for women engaging in GDM self-care, 
alternately their influence can potentiate the modification and maintenance of relevant 
health behaviors throughout pregnancy and well beyond the postpartum period [19].  
The Integrated Theory of Health Behavior Change (ITHBC) [26] includes 
constructs for engagement in health behaviors, one of which is social facilitation 
comprised of social support and social influence. One source of social influence is 
professional influence from healthcare providers. An integrated conceptual framework 




name, describe and define the process of “healthcare provider influence” (HPI) as a 
purposeful interpersonal interactive, collaborative, and transformative relationship that 
develops between a patient and a healthcare provider working toward a specific focus of 
health behavior modification [29]. Leadership is characterized as responsive to the 
follower’s needs in aligning goals and objectives, and, through empowerment stimulates, 
inspires and moves followers to meet and exceed performance expectations and strive for 
higher levels of potential [27,28]. Having advanced knowledge of health, disease 
pathology, and prevention/treatment measures to improve health status and outcomes, the 
healthcare provider is their source of expert power. This power can be transferred to a 
patient-centered source of power (called referent power) through professional influence. 
Influence occurs by using transformational leadership skills and increasing the patient’s 
knowledge, internal motivation, and self-efficacy leading to the ability to engage in 
healthy behavior modification and improve health outcomes [30,31].   
Fig. 1 presents the theoretical constructs and components of the ITHBC and 
Leadership theory as represented by HPI concepts and their empirical measures. The 
ITHBC is situated on the conceptual level with constructs of social influence, specifically 
professional influence, knowledge and beliefs, and proximal outcomes, along with 
Transformational Leadership theory, the referent power process for HPI. On the 
theoretical levels, HPI represents the healthcare provider as the professional influencer, 
and includes logistics, concordance, emotive, cognitive, and social/communication 
components as well as behavioral outcomes. On the empirical level, measures of the 







The purpose of the study was to explore possible mechanisms underlying health 
provider influence (HPI) on health behavior modification during pregnancy in GDM 
patients. As GDM patients are cared for by two healthcare provider types whose roles in 
care and counseling are distinct yet complementary, the influence from both maternity 
healthcare providers (HPs) and diabetic nurse-educators (DEs) was the focus in this 
study. GDM-related care and counseling provided by HPs focuses on prenatal maternal-
fetal surveillance, review of glucose results, and a review/reiteration of recommendations 
provided by DEs. Care and counseling from the DE focuses on specific recommendations 
for healthy eating, including nutrient intake/restriction, portions, timing and frequency of 
eating, physical activity, including benefits, frequency, and duration of exercise, and 
glucose monitoring, including demonstration, timing, frequency, desired result ranges, 
and follow-up.  
Specific aims were to determine if 1) HPI, measured as professional influence and 
the quality of interaction and information from HPs and DEs are associated with health 
behavior modifications, specifically, healthy eating (HE), physical activity (PA), and 
glucose monitoring (GM), and 2) patient characteristics (race and language concordance 
and personal/family history of GDM/DM) and HP characteristics (gender concordance, 







This longitudinal correlational design measured patient and HP factors associated 
with change in health behaviors of women with GDM from screening, routinely at 24-28 
weeks gestational age or the initial prenatal visit if high-risk (Phase 1) and subsequently, 




A priori, the sample size estimate of 75 was based on two tested, one mediating, 
and ten total predictor variables for multiple linear regression analyses to achieve a 
desired power of 0.80, a moderate effect size ƒ ² of 0.15, and a significance level of 
p<0.10 (Gpower) [32] for this exploratory study.  
The patient sample was recruited using flyers distributed at seven different 
obstetric, nurse-midwife, and family practices, in an academic medical center and 
federally qualified health clinic settings in a U.S. Midwestern city. Maternity care was 
managed by two HP specialties: nurse-midwives and physicians. Inclusion criteria were 
pregnant women, screened for high-risk GDM status, ≥ 18 years who were English or 
Spanish speakers with literacy levels sufficient to comprehend and complete surveys.  
 
2.4. Ethical considerations 
  
 Clinical site and university IRB approval was obtained. Interested patients 
were contacted, a detailed description of the study provided, and informed consent 
obtained by the principal investigator or trained research assistants. 
 
2.5. Data Collection Instruments  
 
Study instruments were available in English and Spanish; instruments not 
previously available in Spanish were forward and backward translated by certified 
medical translators. These questionnaires were completed by patients at their prenatal 
care appointments in Phases 1 and 2. A participant demographic questionnaire, 
completed in Phase 1, collected information for sample description (patient age, years of 
education, years in the U.S., personal/family history of GDM/DM, insurance, and 
intendedness of pregnancy) as well as items for determining race and language 
concordance with provider. Parity and body mass index were obtained from the patient’s 
health record. A healthcare provider questionnaire completed in Phase 2, included the 
clinic site, HP specialty, age, years in practice, race/ethnicity, gender, language, use of 
interpreter, and GDM management. The following dichotomous variables were 
constructed for concordance between patient and HP response:  race, language, and 
gender, coded as 0= discordant, 1= concordant.  
Two questionnaires, the Social Influence Questionnaire-GDM (SIQ) and the 
Quality of Information-Interaction-GDM (QOII) measure social/communication and 
emotive/cognitive components of HPI. The Multifactor Leadership Questionnaire (MLQ) 




GDM patients, following author permission, licensed if required, and pilot tested with 
content experts. The content validity index for SIQ = .90, QOII = .95, and MLQ = .67. 
All three instruments reflect patients’ perceptions. 
The SIQ measures patients’ perceptions of their HPs influence on their health 
behaviors computed separately for HPs (SIQHP) and DEs (SIQDE). The scale consists of 
provider-belief items paired with a degree of influence item. Both are rated on a 1-5 
scale; the paired items are multiplied, and the resulting scores added together for a total 
range of 9-225. Higher scores indicating greater provider influence on and belief in the 
patient’s ability to modify their behaviors. Prior reliability and validity testing from 
mammography and postpartum weight loss research resulted in Cronbach’s α = .83-.84 
and a Goodness of Fit chi-square, p ≤ .78, model chi-square, p ≤ .01 [33,34]. In this 
study, Cronbach’s α for SIQHP = .86 and SIQDE, α = .87.  
The QOII was modified from the Quality of Discharge Teaching Scale [35] to 
include GDM-behavior modification content. It measures the quality of informational 
content received by the patient and the interactional skills of providers in teaching 
encounters, as reported by patients.  A total QOII score, calculated separately for HPs 
(QOIIHP) and DEs (QOIIDE) is reported as the mean of items, each scored on a 0-10 
scale, with higher scores indicating higher quality teaching. The original scale, tested in 
medical-surgical adult patients, parents of hospitalized children, and postpartum mothers, 
had reliability estimates of Cronbach’s α = .87- .92 [35-37]. In this study, the Cronbach’s 
α for the QOIIHP = .95 and QOIIDE = .93.  
The MLQ, modified from the Multifactor Leadership Questionnaire-5X for eight 
minor stem changes but not domain or content, measures nine leadership characteristics 
to determine dominant leadership style: transformational, transactional, or laissez-faire 
non-leadership. In this study, patients were asked to complete the scale by rating their 
healthcare provider. As laissez-faire non-leadership style did not emerge as a dominant 
style, HP leadership style, was coded as a dichotomous variable: 0= transactional, 1= 
transformational. The MLQ has been used widely in many large, and varied study 
samples, with reliability estimates exceeding α of .80, convergent, divergent and 
construct validity testing supporting the nine-factor scales and leadership composite 
scores, and indices of goodness of fit = .93 in confirmatory factor analysis [27,28, 38,39]. 
In this study, the Cronbach’s α = 0.85.  
The Eating Breakfast Questionnaire (EBQ +1) records the following healthy 
eating (HE) behaviors in three separate scores: breakfast frequency/weekly (HE1), eating 
protein for breakfast (HE2), and daily portions of vegetables (HE3) [40-42]. Correlations 
between Phases 1 and 2 were r =.51, .04, and .70 respectively. Similarly, the Physical 
Activity Scale (PAS) records the following physical activity (PA) behaviors in two 
separate scores: total minutes weekly of stretching/strengthening (PA1) and aerobic 
exercise (PA2). Previous test-retest results for the two scores were, r = .56 and .72 in 
English and r =.91 and .89 in Spanish-speaking adults [40-43]. In this study, correlations 
between Phases 1 and 2 were r =.54 (PA1) and .56 (PA2). The Glucose Monitoring 
Questionnaire (GMQ) extracting 1-item from the Glucose Testing questionnaire [40, 41, 
43] documents the frequency of glucose monitoring days/weekly (GM1), 4 times/daily 
(GM2), and the number of abnormal glucose results/weekly (GM3). In this study, inter-
item correlation of GM1 and GM2 was r = .63.  EBQ+1 and PAS were collected in 






2.6. Data Analyses 
 
Demographic data were analyzed using descriptive statistics (Table 1). Paired t-
tests were performed to determine if there were changes from Phase 1 to 2 in the healthy 
eating and physical activity outcomes (Table 2). Simple and hierarchical multiple linear 
regressions were used to analyze Aims 1 and 2 respectively. Outcomes variables were the 
change scores for EBQ+1 (denoted for the 3 items as ΔHE1, ΔHE2, ΔHE3) and PAS 
(ΔPA1, ΔPA2) and GMQ (1, 2, 3). Separate models were calculated for the influence of 
patient (Table 3), HP (Table 4) and DE (Table 5) characteristics. HPI variables, SIQ and 
QOII were centered and entered into step 1. In step 2, three patient characteristic 
variables were entered. To test moderation, interaction terms between step 1 and 2 
variables were entered into step 3. The same process was repeated with three HP 





3.1. Demographics   
 
 The total sample completing Phase 1 and 2 was 78 patients. Six patients (7.1%) 
were lost to follow-up due to pregnancy loss, transfer of care, or relocation. Maternity 
care was managed by physicians (n=48) and nurse-midwives (n=30). Patients reported 
receiving GDM counseling from HPs (61.5%) and DEs (92.3%). Table 1 presents 
demographic and descriptive data about the patient participants and HPs.  
 
                      
3.2. HPI and Outcomes 
 
Table 2 presents mean scores on HPI measures and changes in outcome variables 
from Phase 1 to Phase 2. Overall, patients reported that both HPs and DEs had some 
professional influence on their health behaviors (SIQHP & SIQDE scores =149-151/225) 
and the quality of interaction and information received from both was similar and 
moderately high (QOII=7.8-8.0/10).  The distribution of HP leadership style was 73.1 % 
(N=57) transformational and 26.9% (N=21) transactional.  Significant increases in 
outcome measures between Phase 1 and Phase 2 occurred for breakfast frequency/weekly 
(ΔHE1), portions of vegetables/daily (ΔHE3) and stretching/strengthening exercise 
minutes/weekly (ΔPA1). Patients reported good adherence to glucose monitoring 
recommendations, performing monitoring on average >6 day per week (GM1), >5 days 
per week of monitoring 4 times/daily (GM2), and with <2 abnormal readings per week 
(GM3).  
 Results of hierarchical regression analyses exploring the association between 
HPI measures of HP professional influence (SIQHP) and quality of information and 
interaction (QOIIHP) and the eight health behavior modification outcomes are presented 




significant model was for increased breakfast frequency/weekly (ΔHE1) where, in step 3, 
SIQHP, QOIIHP, race and language concordance and an interaction effect between 
SIQHP and language discordance were significant with improvement. In table 4, the 
model for ΔPA2 and GM1 were significant in step 2, with gender concordance and HP 
specialty-physician associated with improvement in aerobic exercise minutes/weekly 
(ΔPA2), and gender discordance and transformational leadership associated with more 
glucose monitoring days/weekly (GM1). At step 3, testing interaction effects, the only 
significant model was for ΔPA1, where gender concordance, HP specialty-physician and 
SIQHP/HP specialty-nurse-midwife and SIQHP/transformational leadership interactions 
were significantly associated with improvements in stretching/strengthening 
minutes/weekly (ΔPA1). Supplementary tables S1-S2 present the full analytic model 
results for all eight outcomes.  
 Table 5 presents the significant model results between HPI measures of DE 
professional influence (SIQDE) and quality of information and interaction (QOIIDE). 
QOIIDE was positively associated with breakfast frequency/weekly (ΔHE1). 
Supplementary table S3 presents the full analytic model results for all eight outcomes.  
 
 
4. Discussion and Conclusion  
 
4.1. Discussion  
 
This is the first study to use measures of ‘professional influence’ in examining the 
role of the healthcare provider on change in health behaviors. Professional influence 
measures of social influence and quality of information and interaction were used as 
predictors of eight health behaviors. There were no significant differences in professional 
influence and quality of information and interaction scores between HPs and DEs. 
However, DEs more frequently provided patients with their GDM counseling. Although 
significant improvements were found in two healthy eating (ΔHE1, ΔHE3) and one 
physical activity behavior (ΔPA1), only breakfast frequency/weekly (ΔHE1) was 
associated with professional influence measures. Both physical activity (ΔPA1, ΔPA2) 
and one glucose monitoring (GM1) behavior were associated with HP characteristics.  
These findings highlight the complementary roles of the HP and DE in GDM 
management and suggest that the influence of social/professional influence is an 
important feature of their roles. The findings also point out that, while education is an 
important professional strategy for behavior change, HP professional influence is an 
interactional strategy with potentially positive benefits.  The effect sizes in this study are 
small suggesting lack of recognition and under-utilization of the power of influence. HPs 
have a broader scope of maternity care management and counseling is generally targeted 
to ameliorating glucose results. Healthy eating and physical activity are often not 
addressed by HPs prenatally due to insufficient time and knowledge [45,46]; this 
counseling in health behavior modification is left to the DE.  
HP transformational leadership style influenced some outcomes, supporting it as a 
potential mechanism for influencing health behavior modification. This style concentrates 
on influencing individual personal transformation via inspirational motivation and 




transformational leadership skills predicted increased stretching/strengthening exercises 
and HPs who used these same leadership styles also increased glucose monitoring 
frequency. Glucose monitoring provides biofeedback that can increase motivation during 
the pregnancy for active engagement in self-managing GDM. While transactional 
leadership style theoretically could promote the reward of a healthy pregnancy and baby 
for improvement in healthy behavior outcomes, the absence of association supports the 
role of transformational leadership as necessary for professional influence.   
Gender concordance may also be an influencing factor on health behavior 
improvements in GDM. Female providers were stronger influencers of increasing or 
maintaining exercise in pregnancy, a challenge for many women as pregnancy advances 
due to increased fatigue and discomfort and decreased energy. Female HPs may be more 
comfortable in addressing exercise and female patients may be more receptive to a 
gender concordant provider. Professional influence by nurse-midwives (HP specialty) 
was positively associated with increased stretching/strengthening exercises. Many of the 
female providers in this study were nurse-midwives, which may have prompted a greater 
influence on health promoting behaviors. Although research has shown that pregnancy 
aerobic exercise recommendations are not always consistently reviewed or known by 
HPs, nurse-midwives were more likely than physicians to recommend exercise [45,46]. 
The association of gender concordance with increased physical activity and decreased 
glucose monitoring may reflect the correlation between improved glycemic control and 
decreased need for the same frequency of monitoring. It is important to consider in future 
studies whether this finding is reflective of the HP specialty (physician/nurse-midwife) or 
gender [47,48]. 
Language concordance and race discordance were associated with improved 
breakfast frequency (HE1) as was professional influence when there was language 
discordance between the HP and patient. Professional influence predicts improvement 
when an interpreter is used in patient encounters or the value of concordance may be lost 
if the provider is trying to interact in a concordant language but is not fluent. Similarly, 
race concordance may be interpreted differently by different patients. The referent power 
may be more influential in some HP/patient race pairs but not others.  Evidence to 
support the association of race concordance to positive health outcomes in minority 
populations has been inconsistent and inconclusive in patient-provider communication 
concordance research [49,50].  
Taken together, the findings provide beginning evidence that HPs can be 
professional influencers of patient health behavior change through social influence, 
quality of information and interaction, leadership style and concordant factors.   
 
4.1.1. Limitations 
This study was an exploration of relationships between provider factors and GDM 
patient health behavior outcomes. To facilitate the exploratory purpose of the study, aims 
were tested separately. The numerous equations raise the possibility of type 1 error. Based 
on projected availability of the target sample, the study was powered for p<0.10; thus, 
increasing the possibility of type 1 errors. The associations identified in this analysis should 
be considered opportunities for further study.  
Additional limitations include the use of a convenience sample and self-reported 




reporting expectations versus reality [51,52]. Many single items were used for the 
outcome measures which produced inconsistent results across the various measures. The 
availability of a single composite measure of health eating and physical activity specific 
to GDM would improve future research in this area. While outcome measures previously 
tested with English/Spanish-speaking patients in DM studies were selected, the MLQ is a 
lengthy and time intensive questionnaire which has not been used for patient perspective 
of their HPs and thus may not be the optimal measure of leadership in this context.   
 
4.1.2. Future Research 
The results of this study raise additional questions that warrant further exploration 
into HPI and set the trajectory for future research. What factors are associated with better 
social facilitation of health behavior modification in GDM and other health conditions? 
Do other factors associated with the provision of health care services (such as visit time, 
number of encounters), additional patient and healthcare provider characteristics (such as 
patient-perceived age-range, BMI-range, values and beliefs concordance) impact the 
health providers ability to influence health behavior modification? In the context of 
pregnancy or other illness in which morbidity and mortality is a greater risk, other 
components of the conceptual model of professional influence (e.g. patient fear for own 
or baby’s health, an emotive component of the HPI model), should be considered. To 
understand if and how different HP leadership styles influence proximal and distal 
outcomes, a leadership questionnaire specific to healthcare providers, is needed to 
evaluate patient perceptions of HPs specific to HPI.  Including other influencers, such as 
family or community health workers, may contribute to the effect of professional 
influence for increased behavior change as seen in other research [34].  
 
4.2. Conclusion  
 
This exploratory study provided initial insight into the role of healthcare provider 
influence on health behavior modification in GDM patients and beginning evidence that 
HPs can be professional influencers through social influence, quality of information and 
interaction, and transformational leadership in facilitating patient health behavior change. 
The study demonstrated that patient’s perceptions of the professional influence, quality of 
information and interaction, leadership style, and concordance factors can play a role in 
healthy eating (breakfast frequency), physical activity (stretching/strengthening and 
aerobic exercise) and daily glucose monitoring.   
 
4.3.  Practice Implications   
The findings support the recommendation that health care providers need to better 
understand how health behavior change is adopted and their role in facilitating these 
changes via their professional influence [26]. This influence derives from their social 
influence (their beliefs in patient’s ability to overcome barriers and make optimal changes 
in behaviors and the degree of influence exerted) and the quality of interaction and 
information in patient-provider interactions including styles used.  To improve influence, 
HPs and DEs should engage in reflective practice [53,54] to evaluate their current beliefs 
about their role in health behavior modification, the degree of influence they actively 




nature of the information content and interaction style in patient-provider encounters and 
the role of concordance factors with patients. Greater awareness sets the stage for 
intentional modifications to leadership style and content that can improve influencing 
potential.   
Transformational leadership skills can be useful to increase self-knowledge of 
how behavior modification in pregnancy can reach far beyond the benefits of treating 
GDM, into the lifelong outcomes of prevention/delaying DM, decreasing personal and 
child risks, and improving overall maternal mental/physical health, well-being, and 
quality of life. An awareness of how glucose results correlate to timing, type and amount 
of foods, and type and duration of physical activity provide specific self-management 
guidelines. Using strategies to increase listening and sensitivity, answer respectfully, 
inquire about and decrease anxiety, increase self-efficacy, improve patient confidence in 
abilities, and inquire about what works best for patients will assist in empowering and 
influencing decisions could transform their future.  
Most importantly, healthcare providers should be effective professional 
influencers of health behavior.  They must recognize their power to influence and should 
engage proactively throughout the childbearing cycle and lifelong to contribute to the 
prevention of GDM/DM and related chronic health problems while optimizing patient 
quality of life.  
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Table 1  





 Mean(SD) Range Mean(SD) Range 
Age 32.06(5.14) 18-41 41.69(6.74) 28-55 
Education  14.75(4.48)    3-23  
HP Practice Years    11.89(5.45)       2-27 
Year in US 22.3(12.05)     .3-41   
BMI Pre-pregnant 30.07(7.28)     19.4-59.3  
   N(%)    N(%) 
Gender 
  Female 







  Nurse-Midwife 
  Physician 




  White 
  Black 
  Asian 
  Latina 




 9(11.5)  
22(28.2) 
  1(1.3) 
  
 69(88.5) 
   3(3.8)  
 
 
   6(7.7) 
Primary language 
  English 
  Spanish 
  Other 
Language Used by HP 
  English 
  Spanish 











   6 (7.7) 
  18(23.1) 
Insurance 
  Medicaid 






Nulliparity 26(33.3)  
Intended pregnancy 56(71.8)  
GDM counseling 
                  HP 
               .  DE 
                  HP+DE   











Notes: BMI: Body Mass Index; GDM: Gestational Diabetes Mellitus; HP: Healthcare Provider 
      










































































HPI Measures (Phase 2)  

































   8.01(1.98) 
 
  7.79(1.87) 
MLQ  
   TFL (5) 










Outcome Measures (Phases 1 and 2) 
Instrument (# items) 
 




P value for 
∆ (P2-P1) 
t (1,77) sig (p) 
EBQ+1 
HE1 (1) 
P1          
P2       
∆HE1(P2-P1) 
HE2 (1) 
P1        
P2   
∆HE2 (P2-P1) 
HE3 (1)          































  .51(2.03) 
 
  .82(.39) 
  .88(.32) 



















































































Outcome Measures (Phase 2) 
GMQ  
P2 GMQ1 (1) 
P2 GMQ2 (1) 













Notes. ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score,  
∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, EBQ+1: Eating Breakfast Questionnaire,  
GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, GMQ: Glucose Monitoring Questionnaire,  
MLQ: Multifactor Leadership Questionnaire, P1: Phase 1, P2: Phase 2, QOIIDE: Quality of Information/Interaction-Diabetic Educator,  
QOIIHP: Quality of Information/Interaction-Healthcare Provider, PAS: Physical Activity Scale; SIQDE: Social Influence-Diabetic Educator,  







Hierarchical Regression of Health Behavior Modifications on Healthcare Providers  
Professional Influence and Patient Characteristics 
Healthcare Provider Professional Influence and 
Patient Characteristics  
 Model Statistics 
Health Behaviors 
Healthy Eating 
Step 1           ∆HE1 
R2 =              .04 
Adj R2=        .02 
p=                 .21 
    β                p   
SIQHP -.03              .84 
QOIIHP  .21              .09 
Step 2 R2=               .11 
Adj R2=        .05 
R2∆=.            .07 
p=                 .15 
SIQHP -.002            .99 
QOIIHP  .2                .12 
Race Concordance: 0=discordant, 1= concordant -.29              .03 
Language Concordance: 0= discordant, 1= concordant   .2                .14 
GDMPFH: 0= negative, 1= positive -.03              .83 
 Step 3 R2=               .27 
Adj R2=        .14 
R2∆=             .16 
p=                 .04                       
SIQHP  .5                .05 
QOIIHP  .7                .04 
Race Concordance: 0=discordant; 1= concordant -.28              .03 
Language Concordance: 0= discordant, 1= concordant   .22              .10 
GDMPFH: 0= negative, 1= positive -.06              .58 
Race Concordance*SIQHP  .16              .34 
Race Concordance*QOIIHP -.22              .23 
Language Concordance*SIQHP -.52              .04 
Language Concordance*QOIIHP -.1                .78 
GDMPFH*SIQHP -.25              .31 
GDMPFH*QOIIHP -.24              .36 
Notes: GDMPFH: Gestational Diabetes Mellitus/Diabetes Mellitus Personal/Family History, ∆HE1: Healthy Eating 1 Change Score, 





Table 4  
Hierarchical Regressions on Healthcare Provider Professional Influence and Healthcare Provider 
Characteristics 
Healthcare Provider Characteristics 
Model Statistics 
Health Behaviors 
Physical Activity  Glucose 
Monitoring 
Step 1 ∆PA1 
R2=            .02 
Adj R2=    -.01 
p=              .48 
∆PA2 
R2=            .001 
Adj R2=    -.03 
p=              .95 
GM1 
R2=            .02 
Adj R2=    -.003 
p=              .43 
   β                p     β                p     β                p   
SIQHP -.05            .67 .04             .74 -.13            .31 
QOIIHP -.11            .37 -.02            .89 -.05            .71 
Step 2 R2=            .08 
Adj R2=     .02 
R2∆=          .06 
p=              .19 
R2=            .09 
Adj R2=     .03 
R2∆=          .09 
p=              .07 
R2=            .12 
Adj R2=     .06 
R2∆=          .09 
p=              .06 
SIQHP -.1              .46 .05             .67 -.17            .19 
QOIIHP -.11            .40 -.03            .84 -.02            .84 
Gender concordance: 0=discordant, 1=concordant                           .28             .04 .19             .05 -.23            .09 
MLQ: 0=Transactional, 1=Transformational .03             .81 -.16            .17 .23             .05 
HP specialty: 0=physician, 1=nurse-midwife -.23            .1 -.25            .06 .18             .19 
 Step 3 R2=            .22 
Adj R2=     .09 
R2∆=.         .14 
p=              .09 
R2=            .18 
Adj R2=     .05 
R2∆=          .09 
p=              .32 
R2=            .21 
Adj R2=     .08 
R2∆=          .10 
p=              .26 
SIQHP -.5              .16 -.26            .47 -.68            .06 
QOIIHP .19             .52 .61             .05 .38             .2 
Gender concordance: 0=discordant, 1=concordant                           .27             .05 .27             .19 -.28            .05 
MLQ :0=Transactional, 1=Transformational .06             .61 -.2              .12 .28             .03 
HP specialty: 0=physician, 1=nurse-midwife) -.24            .08 -.22            .12 .17             .21 
Gender Concordance*SIQHP -.3              .28 .08             .77 -.01            .98 
Gender Concordance*QOIIHP .03             .91 -.31            .17 -.23            .31 
MLQ*SIQHP .43             .1 .18             .49 .56             .04 
MLQ*QOIIHP -.34            .2 -.49            .08 -.33            .22 






Notes GM1: Glucose  Monitoring 1, MLQ: Healthcare Provider Leadership Style, ∆PA1: Physical Activity 1 Change Score,  
∆PA2: Physical Activity 2 Change Score, QOIIHP: Quality of Information/Interaction- Healthcare Provider,  









Table 5  
Multiple Linear Regression of Health Behavior Modifications on Diabetic Educators Professional Influence 
Model  Healthy Eating  
          ∆HE1 
R2=           .08 
Adj R2=    .06 
p=             .04 
   β             p   
SIQDE -.12           .37 
QOIIDE .34            .01 
Notes: ∆HE1: Healthy Eating 1 Change Score, QOIIDE: Quality of Information/Interaction-Diabetic Nurse Educator,  
SIQDE: Social Influence-Diabetic Educator, All other models p>0.1 
  






Fig 1. Conceptual Model for Professional Influence 
Notes: * Theories/concepts and measures included in the study; GDM: Gestational Diabetes Mellitus 
Proximal health outcomes 
*Eating Breakfast+1
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Table S1  




Healthy Eating  Physical Activity  Glucose Monitoring 
Model 1      
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        .57 
∆PA1 
.02 
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.004 
        .33 
GM3 
.01 
        -.02 
.79 
    β            p     β             p     β            p     β            p    β            p    β            p     β            p     β            p   
SIQHP -.03         .84 -.12         .35 .02         .85 -.05         .67  .04        .74 -.13         .31 -.18         .15 -.08         .52 
QOIIHP  .21         .09  .14         .27 .11         .37 -.11         .37 -.02        .89 -.05         .71  .03         .80  .002       .99 
Model 2                    R2=   
                           Adj R2= 
                               R2∆= 






















       -.02 
.02 
.64 
         .03 
       -.04 
  .003 
.98 
        .04 
       -.02 
.04 
.42 
    β            p     β             p     β            p     β            p    β            p    β            p     β            p     β            p   
SIQHP -.002       .99 -.12         .32 -.01        .95 -.05         .68  .06        .61 -.14         .26 -.18         .15 -.07         .58 
QOIIHP  .2           .12  .14         .28 .13         .31 -.12         .36 -.07        .61 -.001       .99  .05         .72 -.04         .76 
RC           0=discordant  
                1 = concordant 
-.29         .03 
 
-.11         .42 
 
.15         .25 
 
-.11         .40 
 
-.09        .49 
 
 .12         .37 
 
-.002       .99 
 
-.16         .23 
 
LC           0= discordant 
                1= concordant  
 .2           .14 
 
 .11         .40 
 
-.03        .83 
 
.07          .60 
 
-.1          .46 
 
 .05         .70 
 
 .06         .69 
 
-.003       .98 
 
GDMPFH    0= negative 
                    1= positive 
-.03         .83 
 
 .18         .14 
 
.22         .06 
 
.11          .37 
 
-.09        .47 
 
-.03         .81 
 
-.01         .96 
 
 .1           .42 
 
Model 3                    R2=   
                           Adj R2=  
                               R2∆= 
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.09 
.36 
    β            p     β             p     β            p     β            p    β            p    β            p     β            p     β            p   
SIQHP  .5           .05 -.06         .84 -.002    1.0 -.21         .46      .07        .79 -.28         .32 -.49         .07 -.05         .87 




RC           0=discordant  
                1 = concordant 
-.28         .03 -.12         .38  .16        .25 -.13         .35 -.07        .61  .11         .43  .03         .83 -.15         .28 
LC           0= discordant 
                1= concordant  
.22          .10  .19         .20 -.03        .83 . 06         .70 -.11        .47  .06         .68 -.01         .95 -.11         .44 
GDMPFH     0= negative 
                     1= positive 
-.06         .58  .17         .17  .25        .04  .13         .29 -.1          .44 -.02         .88  .000       .10  .13         .30 
RC*SIQHP  .16         .34  .11         .54 -.21        .26  .02         .91  .02        .93  .01         .94  .05         .78  .24         .20 
RC*QOIIHP -.22         .23 -.08         .67 -.21        .28 -.08         .68  .06        .76  .04         .84  .05         .79 -.38         .05 
LC*SIQHP -.52         .04 -.07         .79   .09        .73  .1           .73   .04       .89  .18         .53  .04         .89 -.2           .46 
LC*QOIIHP -.1           .78 -.47         .20 -.02        .96  .11         .77  -.01       .99 -.12         .75  .43         .24   .77         .04 
GDMPFH*SIQHP -.25         .31 -.12         .65  .04        .86  .06         .83  -.04       .89 -.01         .96  .32         .22 -.02         .94 
GDMPFH*QOIIHP -.24         .36  .07         .81 -.22        .42  .16         .58  -.2         .48  .13         .65 -.43         .13 -.42         .13 
Notes: : :  significant finding p≤.1, GDMPFH: Gestational Diabetes Mellitus/Diabetes Mellitus Personal/Family History, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy 
Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score, LC: Language Concordance, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, QOIIHP: 




Table S2  
Hierarchical Regressions of Healthy Eating (HE) Physical Activity (PA) and Glucose Monitoring (GM) Behaviors on  





Healthy Eating  Physical Activity  Glucose Monitoring 
Model 1 
                                    R2=   
                             Adj R2=  

































    β             p     β            p     β            p     β            p     β            p     β            p     β            p     β            p   
SIQHP -.03         .84 -.12         .35 .02         .85 -.05         .67 .04         .74 -.13         .31 -.18         .15 -.08        .52 
QOIIHP .21          .09 .14          .27 .11         .37 -.11         .37 -.02        .89 -.05         .71 .03          .8 .002       .99 
Model 2                      R2=   
                             Adj R2=  
                                 R2∆= 
                                     p= 
































      β             p     β            p     β            p    β            p    β            p     β            p     β            p      β            p   
SIQHP .03          .79 -.14         .30 .04         .79 -.1           .46 .05         .67 -.17         .19 -.21         .12 -.03        .84 
QOIIHP .19          .13 .13          .30 .1           .46 -.11         .40 -.03        .84 -.02         .84 .05          .71 .02         .90 
GC:0=discordant;  
      1 = concordant 
.08          .71 
 
.09          .53 
 
.06         .66 
 
.28          .04 
 
.19         .05 
 
-.23         .09 
 
-.04         .78 
 
-.27        .05 
 
MLQ: 0=Transactional, 
          1=Transformational 
-.24         .04 
 
.05          .67 
 
-.05        .68 
 
.03          .81 
 
-.16        .17 
 
.23          .05 
 
.1            .41 
 
-.11        .35 
 
HP specialty :0= physician 
               1=nurse-midwife 
-.08         .70 
 
-.01         .93 
 
.02         .90 
 
-.23         .1 
 
-.25        .06 
 
.18          .19 
 
-.01         .94 
 
.06         .64 
 
 Model 3                     R2=   
                             Adj R2=  
                                 R2∆= 

































    β            p     β             p     β            p     β            p    β            p    β            p     β            p     β            p   
SIQHP .45          .22 .31          .42 .2           .58 -.5           .16 -.26        .47 -.68         .06 -.87         .02 -.25        .52 
QOIIHP .04          .91 -.04         .90 .52         .10 .19          .52 .61         .05 .38          .2 .26          .41 .03         .94 
GC:0=discordant;  
      1 = concordant 
.12          .40 .13          .40 -.02        .90 .27          .05 .27         .19 -.28         .05 -.05         .75 -.27        .07 
MLQ: 0=Transactional, 
          1=Transformational 
-.31         .01 -.03         .83 -.09        .48 .06          .61 -.2          .12 .28          .03 .18          .16 -.09        .5 
HP specialty:0= physician 
               1=nurse-midwife 











GC*SIQHP -.24         .39 -.2           .5 .12         .67 -.3           .28 .08         .77 -.01         .98 -.09         .76 .06         .85 
GC*QOIIHP -.06         .78 -.14         .56 .2           .38 .03          .91 -.31        .17 -.23         .31 .07          .75 -.01        .97 
MLQ*SIQHP -.43         .11 -.46         .1 -.28        .3 .43          .1 .18         .49 .56          .04 .64          .02 .18         .52 
MLQ*QOIIHP .09          .74 .22          .44 -.48        .08 -.34         .2 -.49        .08 -.33         .22 -.27         .32 -.03        .91 
HP specialty*SIQHP .2            .31 .13          .53 .07         .75 .48          .02 .16         .42 .06          .74 .3            .13 .03         .9 
HP specialty*QOIIHP .29          .09 .22          .22 -.31        .07 -.1           .53 .05         .75 .06          .73 -.11         .5 .04         .79 
Notes:  significant finding p≤.1, GC: Gender Concordance, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy Eating 1 Change Score, ∆HE2: 
Healthy Eating 2 Change Score, ∆HE3: Healthy Eating 3 Change Score, MLQ: Healthcare Provider Leadership Style, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, 
QOIIHP: Quality of Information/Interaction- Healthcare Provider, SIQHP: Social Influence- Healthcare Provider 
Table S3  
Multiple Linear Regression of Healthy Eating (HE) Physical Activity (PA) and Glucose Monitoring (GM) Behaviors on  
Diabetic Nurse Educator Professional Influence 
Model Statistics Healthy Behaviors 
Healthy Eating  Physical Activity  Glucose Monitoring 
Model  
                         R2=  
                  Adj R2=  











       -.02 







       -.03 
      1.0 
GM1 
.01 








       -.02 
        .92 
    β              p     β               p     β              p     β             p     β             p     β             p     β             p     β             p   
SIQDE -.12           .37 -.15           .27 .05           .74 -.13           .35 .01           .95 .13           .37 .15           .29 .04           .78 
QOIIDE  .34           .01 .16            .24 .03           .83 -.08           .58 .003         .98 -.07          .59  -.14          .3 -.05          .7 
Notes: significant finding p≤.1, GM1: Glucose Monitoring 1, GM2: Glucose Monitoring 2, GM3: Glucose Monitoring 3, ∆HE1: Healthy Eating 1 Change Score, ∆HE2: Healthy Eating 2 Change 
Score, ∆HE3: Healthy Eating 3 Change Score, ∆PA1: Physical Activity 1 Change Score, ∆PA2: Physical Activity 2 Change Score, QOIIDE: Quality of Information/Interaction-Diabetic Educator, 
SIQDE: Social Influence- Diabetic Educator 
 
